8192019 1-s20-S0928493115303222-main (1)
httpslidepdfcomreaderfull1-s20-s0928493115303222-main-1 111
Electrospinning of PLGAgum tragacanth nano1047297bers containingtetracycline hydrochloride for periodontal regeneration
Marziyeh Ranjbar-Mohammadi a M Zamani bc MP Prabhakaran c S Hajir Bahrami d S Ramakrishna bc
a Textile Engineering Group Department of Engineering University of Bonab Bonab Iranb Mechanical Engineering Department National University of Singapore Singaporec Nanoscience and Nanotechnology Initiative Faculty of Engineering National University of Singapore Singapored Textile Engineering Department Amirkabir University of Technology Tehran Iran
a b s t r a c ta r t i c l e i n f o
Article history
Received 14 May 2015
Received in revised form 23 August 2015
Accepted 27 August 2015
Available online 3 September 2015
Keywords
Gum tragacanth
PLGA
Periodontal regeneration
Electrospun nano1047297bers
Coaxial electrospinning
Controlled drug release is a process in which a predetermined amount of drug is released for longer period
of time ranging from days to months in a controlled manner In this study novel drug delivery devices were
fabricated via blend electrospinning and coaxial electrospinning using poly lactic glycolic acid (PLGA) gum
tragacanth (GT) and tetracycline hydrochloride (TCH) as a hydrophilic model drug in different compositions
and their performance as a drug carrier scaffold was evaluated Scanning electron microscopy (SEM) results
showed that fabricated PLGA blend PLGAGT and core shell PLGAGT nano1047297bers had a smooth and bead-less
morphology with the diameter ranging from 180 to 460 nm Drug release studies showed that both the fraction
of GT within blend nano1047297bers and the corendashshell structure can effectively control TCH release rate from
the nano1047297brous membranes By incorporation of TCH into corendashshell nano1047297bers drug release was sustained
for 75 days with only 19 ofburst release within the1047297rst 2 h The prolonged drug release together with proven
biocompatibility antibacterial and mechanical properties of drug loaded core shell nano1047297bers make them a
promising candidate to be used as drug delivery system for periodontal diseases
copy 2015 Elsevier BV All rights reserved
1 Introduction
Drug delivery systems are engineered technologies for the con-
trolled release of therapeutic agents to achieve therapeutic purposes
in humansor animals In recentyears themarket fordrug delivery tech-
nology (DDT) has increased tremendously [1] and it is forecasted
to reach $136 billion by 2021 [2] Controlled drug release systems
have shown bene1047297ts over conventional drugs [3] such as improved
adequacy reduced side effects improved patient compliance and re-
duced toxicity [45] Electrospinning is one of the developed techniques
which enables the design and production of nanostructured drug car-
riers with high loading capacity encapsulation ef 1047297ciency multi-drug
delivery with ease of operation and cost-effectiveness [67] In most
cases drugs are blended with the polymeric solution to produce drug
incorporated nano1047297bers which might result in low delivery ef 1047297ciency
and burst release [8] while other electrospinning techniques such as
emulsion or coaxial electrospinning showed capabilities to overcome
some of these problems [910] Use of nano1047297brous scaffolds loaded
with antibiotic drugs for biomedical applications especially for treat-
ment of infections after tissue damages such as burn ulcers surgery
or periodontal disease has evoked considerableinterest[11] Mefoxin in-
corporated poly(lactide-co-glycolide) membrane displayed a controlled
release of the drug for over 6 days [12] Kenawyet al [13] fabricated tet-
racycline hydrochloride (TCH) loaded poly(ethylene-co-vinyl acetate)
poly(lactic acid) and their blends then they reported controlled release
of drug over 5 days However controlled release of antibiotics is required
fora longerperiod of time fortreatment of some of thechronicinfections
such as periodontal diseases Nevertheless long term release of hydro-
philic drugs (such as TCH) from nano1047297brous scaffolds is still challenging
due to high solubility of the drug molecule in aqueous mediums It was
previously demonstrated that the compatibility between hygroscopic
properties of drug and polymer is essential to obtain a sustained drug
release from nano1047297brous delivery system [1415]
Poly lactic-co-glycolicacid (PLGA) is a Food and Drug Administration
(FDA) approved synthetic polymer and is one of the most attractive
polymeric candidates used for the fabrication of drug delivery devices
[16] Gum tragacanth (GT) on the other hand is a branched heteroge-
neous and anionic polysaccharide with properties such as moisture ab-
sorption hydrocolloid formation water solubility drug holding and
releasing abilities and it is categorized as generally recognized as safe
Materials Science and Engineering C 58 (2016) 521ndash531
Correspondenceto MP PrabhakaranAmirkabirU niversity of Technology 424Hafez
Ave Tehran Iran
Correspondence to H Bahrami Nanoscience and Nanotechnology Initiative
E3-05-14 Faculty of Engineering 2 Engineering Drive 3 National University of Singapore
Singapore
E-mail addresses nnimppnusedusg (MP Prabhakaran) hajirbautacir
(SH Bahrami)
httpdxdoiorg101016jmsec201508066
0928-4931copy 2015 Elsevier BV All rights reserved
Contents lists available at ScienceDirect
Materials Science and Engineering C
j o u r n a l h o m e p a g e w w w e l s e v i e r c o m l o c a t e m s e c
8192019 1-s20-S0928493115303222-main (1)
httpslidepdfcomreaderfull1-s20-s0928493115303222-main-1 211
(GRAS) material at a level of 020ndash130 in food stuffs This natural bio-
polymer is a mixture of two soluble and insoluble polysaccharides
Tragacanthin a galacturonic acid part of tragacanth which is water
soluble and branched with high molecular weight which gives highly
viscous solutionsand bassorinthe other part of tragacanth is a complex
of methoxylated acids that is insoluble in water and swells to form a gel
or viscous solution [17ndash19] Itis approved asa food additive inEuropean
Unionand has the numberE 413 in the list ofadditivescon1047297rmedby the
Scienti1047297
c Committee for Food of the European Community [20] GTalsoexhibited signi1047297cant potency for wound healing in the form of mucilage
or blended nano1047297bers with PCL or PVA because of an acceleration in
collagenation and proliferation phases of the wound repair [21ndash23]
Thus we hypothesized that incorporation of hydrophilic drugs into
composite nano1047297bers of PLGA and GT could provide a more sustained
and prolonged release of the drug due to better hygroscopic compati-
bility of the drug and polymeric matrix
Here for the1047297rst time we aim towards the fabrication of composite
scaffolds of PLGA and GT at various ratios via blending and coaxial
electrospinning Further we investigated the controlled release of
TCH incorporated within these nano1047297bers along with the physical
characteristics (ie wettability porosity) mechanical properties and
cytocompatibility of the composite nano1047297bers which are critically im-
portant for a nano1047297brousmat to be employed as scaffolds for periodon-
tal disease treatment
2 Experimental procedure
21 Materials
PLGA with lactic acidglycolic acid (LAGA) ratio of 7525 with an
intrinsic viscosity of 072 dl gminus1 was purchased from Boehringer
Ingelheim Pharma GmbH amp Co (Ingelheim Germany) Gum tragacanth
used in this study was a high quality ribbon type collected from the
stems of Fluccosus species of Astragalus bushes grown in the central
areas of Iran TCH (purity N 95) and 111333-hexa1047298uoro-2-propanol
(HFP) was purchased from Sigma Aldrich Human dermal 1047297broblasts
(HDFs) wereobtained from American Type Culture CollectionDulbecco
modi1047297ed Eagles medium (DMEM) fetal bovine serum (FBS) penicillinstreptomycin solution and trypsin-ethylene diamine tetra acetic acid
were purchased from Gibco Invitrogen Corp USA
22 Blend and corendashshell electrospinning
Electrospinning was performed to prepare blend nano1047297bers of
PLGA-GT (PG) in three different weight ratios including 1000 7525
5050 (wt) Polymers were dissolved in HFP for making a total con-
centration of 16 (wv) For fabrication of drug containing nano1047297bers
5 (ww) TCH (based on the total weight of PLGA and GT) was added
and stirred for 30 min Prepared solution was loaded into individual
3-mL syringe attached to a 25G blunted stainless steel needle and a
high voltage of 15 kV was applied to the tip of the needle The 1047298ow
rate of the solutions was maintained at 10 mLh using a syringe pump(KDS 100 KD Scienti1047297c Holliston MA) For fabrication of core shell
nano1047297bers PLGA was dissolved in HFP to obtain 16 (wv) solution
which was used as the shell GT was dissolved in water to obtain 2
(wv) solution and stirred overnight to be used as the core solution
The polymer solutions were separately fed into 3 mL standard syringes
attached to a coaxial nuzzle The inner diameter of shell capillary was
084 mm while the smaller capillary had outer and inner diameters of
056 mm and 030 mm respectively A high voltage of 15 kV (Gamma
High Voltage Research Ormond Beach FL) was applied while the 1047298ow
rate of the shell and core was maintained at 10 mLh and 02 mLh re-
spectively and the polymer solution was drawn into 1047297bers To make
TCH incorporated core shell 1047297bers TCH was added to the core solution
(5 ww) based on the total amount of PLGA and GT considering the
concentration and 1047298aw rate of core and shell solutions Nano1047297bers
were deposited on aluminum wrapped collector at a distance of 15 cm
from the needle tip dried overnight under vacuum and used for charac-
terization drug release and cell proliferation experiments
23 Characterization of nano 1047297bers
The morphology of the electrospun nano1047297bers was studied under a
Field Emission Scanning Electron Microscope (FESEM JEOL JSM-6701-
F Japan) after sputter coating with gold (JEOL JFC-1200 1047297
ne coater Japan) at an accelerating voltage of 15 kV Diameters of the electrospun
1047297bers were analyzed from the SEM images using image analysis soft-
ware (Image J National Institutes of Health USA) Corendashshell structure
of drug loaded PLGA-GT (PG(cs)-TCH) nano1047297bers was examined using
transmission electron microscopy (TEM) (JEOL JFM-3010 Japan) At-
tenuated total re1047298ectance Fourier transform infrared (ATR-FTIR) spec-
troscopic analysis of the electrospun scaffolds was ful1047297lled using a
Nicolet Avatar 380 spectrometer (Thermo Nicolet Waltham MA) over
the range of 600ndash3800 cmminus1 at a resolution of 4 cm
The pore size of the nano1047297brous scaffolds was studied using a CFP-
1200-A capillary 1047298ow porometer (PMI New York NY) Three samples
of each type of nano1047297bers with the same thickness and a dimension of
2 times 2 c m2 were used for measuring the pore size Galwick with a surface
tension of 159 dynescm (PMI New York NY) was used as the wetting
liquid Wettability of the nano1047297bers was determined via contact angle
measurement and a sessile drop method-based video contact angle
system (VCA Optima AST Products Billerica MA) was used for this
purpose The size of the distilled water droplet was set at 10 μ L
The mechanical properties of the electrospun membranes were de-
termined by a uniaxial tensile machine (Instron5943 Canton MA)
with a load cell capacity of 10 N and cross head speed of 5 mm minminus1
All nano1047297ber tape samples were cut in the form of rectangular shape
with dimensions of 30 times 10 mm2 At 1047297rst a white window paper tem-
plate wascut andnano1047297brous tapes were glued onto thetop andbottom
areas of the window It was placed between the grips of the tensile
testing machine and after closing the grips the other sides of the win-
dow papers were cut by a scissor Tensile test was carried out for the
as obtained dry electrospun mats and the 48 h phosphate-buffered sa-
line (PBS) hydrated scaffolds A minimum of six specimens of individualscaffolds were tested
24 Nano 1047297ber degradation studies
To perform the biodegradability test the 1047297bers on cover slips were
immersed in PBS (pH of 74) and incubated for a period of 40 days at
37 degC At eachspeci1047297c time point the scaffolds were washed and subse-
quently driedin a vacuum oven for 48 h The morphology changes were
studied by FESEM
25 TCH release from electrospun nano 1047297bers
Release of TCH from electrospun nano1047297bers was measured using a
UVVIS instrument (Shimadzu 3600 UV ndashVIS-NIR Spectrophotometer)Forthisthe drug containing nano1047297brousmats wereaccuratelyweighed
placed in tightlycapped glass bottle soaked in 1 mL of PBS (pH 74) and
kept in shaking incubator at 37 degC and 150 rpm The UV absorbance of
TCH released in buffer solution was determined at λmax = 362 nm
and converted to the TCH concentration according to the calibration
curve of TCH in the same media [24] The cumulative release of TCH
against release time was further plotted Fig 1 givesthe graphical repre-
sentation of the preparation of nano1047297bers and studying release proper-
ties of them
26 Cell culture and proliferation studies
In vitro biocompatibility of electrospun mats was evaluated
using human dermal 1047297broblast (HDF) cells The proliferation test
522 M Ranjbar-Mohammadi et al Materials Science and Engineering C 58 (2016) 521ndash531
8192019 1-s20-S0928493115303222-main (1)
httpslidepdfcomreaderfull1-s20-s0928493115303222-main-1 311
was done using a colorimetric 3-(45-dimethylthiazol-2-yl)-5-(3-
carboxymethoxyphenyl)-2(4-sulfophenyl)-2H tetrazolium (MTS) assay
(CellTiter 96 AQueous One solution Promega USA) In brief 1047297broblasts
were cultured in DMEM augmented with 10 FBS and 1 antibiotic
and antimycotic solutions in a 75 cm2 cell culture 1047298ask Cells were cul-
tured in a humidi1047297ed incubator at 37 degC with 5 CO2 and the mediawere replaced every two days The nano1047297brous scaffolds were sterilized
under UV radiation for 2 h washed 3 times with PBS and then sank in
DMEM overnight before cell seeding For cell seeding the cells were de-
tached by adding 025 of trypsin containing 01 EDTA centrifuged
counted using a hemocytometer and seeded on the scaffolds placed
in a 24-well plate and tissue culture polystyrene (TCP as control) at a
density of 5000 cells per well After 1 3 and 5 days 1047297broblast seeded
scaffolds were rinsed with PBS and 20 of MTS reagent in serum-free
medium was added After incubation for 3 h aliquots were pipetted
into a 96-well plate and absorbance of the obtained dye was measured
at 492 nm using a spectrophotometric plate reader (FLUO star Optima
BMG Lab Technologies and Germany) The intensity of the obtained
color is directly proportional to the metabolic activity of the cell
population
27 Antibacterial properties
Theantimicrobialbehaviorof PG(cs) PG 7525-TCH and PG(cs)-TCH
nano1047297bers was studied by agar plate method Staphylococcus aureus
ATCC 25923 and Pseudo aeruginosa ATCC 27853 were used as Gram-
positive and Gram-negative bacteria respectively MuellerndashHinton
agar media were sterilized in an autoclave at 121 degC for 20 min under
15 lbsin2 pressures A loop of each bacterium was inoculated on 5 mL
of nutrient broth and incubated at 37 degC for 24 h then cultured in nutri-
ent agar plate The disk shape samples of nano1047297brous mat were steril-
ized by ultraviolet light for 2 h and were placed in a plate Then the
plates were held in an incubator for 24 h Images from the samples
were used for assessing the antimicrobial behavior
28 Statistical analysis
Alldata presentedare expressedas mean plusmn standard deviation(SD)
Statistical analysis was carried out using one-way analysis of variance
(ANOVA) followed by Tukey post hoc test for multiple comparisons
and signi1047297cance was considered at p le 005
3 Results
31 Physical and chemical characterization of nano 1047297bers
The SEM micrographs of the electrospun nano1047297bers are shown in
Fig 2 The optimization of the electrospinning conditions with respect
to the concentration of the polymer applied voltage 1047298ow rate and
distance between the collector and the needle tip was performed thus
producing a continuous stretch of 1047297bers At the optimized condition
uniform bead-free 1047297bers of PLGA blend PG and PG(cs) nano1047297bers
were fabricated by blend and coaxial electrospinning Addition of the
natural polysaccharide (GT) to PLGA produced compositePG nano1047297bers
with diameters much lower than those of PLGA (Table 1) The 1047297ber di-ameter of pure PLGA PG 7525 and PG 5050 without TCH was obtained
as 460 plusmn 16 296 plusmn 25 and 187 plusmn 26 nm respectively which indicates
the reduction in 1047297ber diameter of the composite scaffolds using higher
amounts of gum tragacanth in PG nano1047297bers
At the same time TCH incorporation into PLGA nano1047297bers de-
creased the 1047297ber diameter while TCH loaded PG scaffolds did not ex-
hibit signi1047297cant changes in 1047297ber diameter compared with drug free
scaffolds Fig 2 also exhibited the formation of smooth continuous
and beadless PG(cs) and PG(cs)-TCH nano1047297bers with a diameter of
399 plusmn 31 and 180 plusmn 24 nm respectively Similar to pure PLGA nano-
1047297bers the diameter of TCH loaded core shell nano1047297bers was signi1047297-
cantly lower than that of drug free PG(cs) nano1047297bers Fig 3 shows
the TEM image of drug loaded PG(cs) nano1047297bers prepared by coaxial
electrospinning The TEM micrographof the coaxially electrospun1047297bers
Fig 1 Graphical representation of the preparation of nano1047297bers and studying release properties
523M Ranjbar-Mohammadi et al Materials Science and Engineering C 58 (2016) 521 ndash531
8192019 1-s20-S0928493115303222-main (1)
httpslidepdfcomreaderfull1-s20-s0928493115303222-main-1 411
clearly shows the lsquocorersquo compartment embedded within the shell of the
polymer
The results of pore size measurements are shown in Table 1 The
pore size of the nano1047297brous mats was signi1047297cantly decreased by addi-tion of both GT and drug compared to pure PLGA and similar PG
drug-free scaffolds respectively
The ATR-FTIR spectra of the electrospun PLGA nano1047297bers (Fig 4A)
showed peaks at 1757 cmminus1 1452 cmminus1 1186 cmminus1 and 1089 cmminus1
which correspond to the carbonyl group (CndashO bond) ether group
(CndashOndashC) and methyl group (CndashH) respectively In PG blend nano1047297bersthe peaks of GT have been partially overlapped by the peaks of PLGA
itself and hence the OH peaks appeared weaker for these scaffolds
For drug loaded PLGA nano1047297bers the carbonyl peak appeared broad-
ened because of the hydrogen bonding between the hydroxyl groups
of TCH and C=O groups of PLGA Within the spectra of PLGATCH
scaffolds the stretching frequencies at 1614 and 1579 cmminus1 corre-
spond to the carbonyl groups in A and C rings of TCH respectively
(Fig 4AB) These peaks were seen for the drug loaded PG nano1047297bers
prepared by blend electrospinning but were not obviously visible for
the corendashshell PG-TCH nano1047297bers A mild shift in carbonyl group
wavelength from 1760 to 1754 cmminus1 for drug loaded PG nano1047297bers
in comparison with PG nano1047297bers might have occurred due to the
weakening of some bonds due to hydrogen bonding between drug
and PLGA or GT
Fig 2 Morphology andsize distribution of electrospunnano1047297bersP as PLGA P-TCH as PLGA-TCH PG as PLGAGT PG-TCH as PLGAGT-TCH PG(cs)as coreshell PLGAGT andPG(cs)-TCH
as core shell PLGAGT-TCH)
Table 1
Diameter and pore size of electrospun nano1047297bers
Scaffold Fiber diameter (nm) Average thickness (μ m) Pore size (μ m)
PLGA 460 plusmn 16 6120 292 plusmn 002
PLGA-TCH 288 plusmn 33 6176 095 plusmn 003
PG 7525 296 plusmn 25 6190 180 plusmn 001
PG 7525-TCH 221 plusmn 42 6134 099 plusmn 004
PG 5050 187 plusmn 26 6095 10 plusmn 001
PG 5050 -TCH 180 plusmn 24 6086 063 plusmn 002
PG(cs) 399 plusmn 31 6156 135 plusmn 002
PG(cs)-TCH 197 plusmn 42 6102 12 plusmn 003
524 M Ranjbar-Mohammadi et al Materials Science and Engineering C 58 (2016) 521ndash531
8192019 1-s20-S0928493115303222-main (1)
httpslidepdfcomreaderfull1-s20-s0928493115303222-main-1 511
The surface property (interaction with water) of the electrospun
scaffolds was determined dynamically by water contact angle measure-
mentfor a periodof 30s Asshownin Fig 5 with increasing amounts of
GT within the PG composites the hydrophilicity of the nano1047297brous
membrane increased such that PG 7525 and 5050 scaffolds showed
a contact angle value of 85 plusmn 3deg and 76 plusmn 2deg respectively after 30 s
The water contact angle of drug loaded PG nano1047297bers was signi1047297cant-
ly lower than that of drug free PG scaffolds due to the hydrophilic
properties of TCH At the same time the PG(cs) nano1047297bers were more
hydrophilic than the PLGA nano1047297bers However the hydrophilicity of
PG(cs) was lesser compared to PG nano1047297bers due to the presence of
the hydrophilic GT within the core of the nano1047297bers
32 Mechanical properties of as-spun and hydrated scaffolds
The mechanical properties of electrospunnano1047297brousscaffolds with
or without drug including their tensile strength strain at break andelastic modulus were evaluated and are shown in Fig 6 and Table 2
In dry condition the average tensile strength of PLGA nano1047297bers was
obtained as 422 plusmn 002 MPa (Fig 6A) and it exhibited a strain at
break of 11874 plusmn 117 Comparing the stressndashstrain curves of the dif-
ferent scaffolds we found that addition of GT into PLGA nano1047297bers sig-
ni1047297cantly decreased the tensile strength of the nano1047297bers and reduced
the breaking strain (Fig 6B and C) Moreover the results of our studies
showed that PG nano1047297bers had a reduced elastic modulus compared
to pure PLGA nano1047297bers (Table 2) The average tensile strength and
elongation at break of PG(cs) were 332 plusmn 003 MPa and 10283 plusmn
301 respectively which was signi1047297cantly higher than blend nano1047297-
bers (Fig 6D and Table 2) For all formulations incorporation of TCH
into nano1047297bers reduced the tensile strength and elongation at break
while the elastic modulus was increased compared to the scaffolds
without drug
The results of the tensile properties of PBS-hydrated electrospun
scaffolds after 2 days are shown in Fig 7 and Table 2 All the nano1047297bers
without drug showed reduced tensile strength and strain after 2 days
of hydration compared to the dry state except PG 5050 (Fig 7C) with
no signi1047297cant changes Moreover none of the TCH loaded nano1047297bers
Fig 3 TEM micrograph of TCH loaded PG(cs) nano1047297bers
Fig 4 (A)ATR-FTIR spectraof nano1047297bers (P as PLGA P-TCH as PLGA-TCH PG as PLGAGT PG-TCH as PLGAGT-TCH PG(cs)as core shell PLGAGT PG(cs)-TCH as coreshellPLGAGT-TCH)
525M Ranjbar-Mohammadi et al Materials Science and Engineering C 58 (2016) 521 ndash531
8192019 1-s20-S0928493115303222-main (1)
httpslidepdfcomreaderfull1-s20-s0928493115303222-main-1 611
8192019 1-s20-S0928493115303222-main (1)
httpslidepdfcomreaderfull1-s20-s0928493115303222-main-1 711
value of elastic modulus (2200plusmn 167 MPa) in wet condition compared
to other formulations (Fig 7D and Table 2)
33 Degradation behavior of nano 1047297bers
Drug diffusion can be affected by scaffolds topology and morpholo-
gy Thusthe topological and morphological changes duringdegradation
might be able to control drug release rate from the nano1047297brous scaf-
folds Fig 8 presents the SEM images of the scaffolds after in vitro deg-
radation for a period of 40 days The 1047297brous structure of PLGA and
PG(cs) scaffolds with and without TCH was partially preserved after
40 days of degradation However blend PG scaffolds with and without
drug swelled to a large extent resulting in loss of nano1047297brous morphol-
ogy within similar time scale These results are in agreement with
higher wettability of PG nano1047297bers compared to PLGA and PG(cs)
nano1047297bers
34 Drug delivery
In this paper we determined the released amounts of TCH by mea-
suringthe absorbance at 362nm using an ultraviolet visible spectropho-
tometer Thereleaseof TCHfrom variouselectrospun scaffoldsis plotted
in Fig 9A amp B PLGA nano1047297bers exhibited an initial burst release of
2320 within the 1047297rst 2 h (Fig 9B) and reached a plateau within
7 days by releasing only 35 of TCH content The burst release of TCH
from PG 7525 nano1047297bers was very similar to pure PLGA (2479)
while PG 5050 had a signi1047297cantly higher amount of TCH (4830) re-
leased in the 1047297rst 2 h followedby a veryfast release of90of drugcon-
tent within 5 days However PG 7525 composite nano1047297bers showed
a sustained TCH release up to a period of 25 days the time point that
it reached to the plateau state For the core shell nano1047297bers where
TCH was incorporated in the core along with GT the burst release was
signi1047297cantly lower (19) compared to both pure PLGA and PG blend
Table 2
Tensile properties of the electrospun nano1047297bers under dry and wet conditions
Samples Dry scaffolds Wet scaffolds
T (μ m) EM (MPa) UTS (MPa) SB () T (μ m) EM (MPa) UTS (MPa) SB ()
PLGA 5680 7600 plusmn 360 422 + 002 11874 plusmn 117 5001 6900 plusmn 180 255 plusmn 003 6409 plusmn 112
PLGA-TCH 5802 8433 plusmn 781 258 plusmn 003 1592 plusmn 212 5277 6236 plusmn 283 171 plusmn 009 1158 plusmn 178
PG 7525 5499 4334 plusmn 223 230 plusmn 002 2240 plusmn 212 5686 4273 plusmn 136 170 plusmn 008 1517 plusmn 113
PG 7525-TCH 5307 6410 plusmn 334 101 plusmn 005 1350 plusmn 691 5430 5211 plusmn 219 102 plusmn 009 1133 plusmn 501
PG 5050 5503 3295 plusmn 100 093 plusmn 003 1392 plusmn 406 5333 3290 plusmn 110 089 plusmn 008 1422 plusmn 113
PG 5050-TCH 5409 3962 plusmn 131 072 plusmn 006 883 plusmn 702 5602 3381 plusmn 187 040 plusmn 010 775 plusmn 398
PG(cs) 5204 4020 plusmn 171 332 plusmn 003 10283 plusmn 301 4903 10532 plusmn 121 215 plusmn 002 3667 plusmn 113
PG(cs)-TCH 5375 4832 plusmn 413 151 plusmn 007 1424 plusmn 451 4889 2200 plusmn 167 157 plusmn 003 3341 plusmn 315
T average thickness of nano1047297bers EM elastic modulus UTS ultimate tensile strength SB strain at break
Fig 7 Mechanical properties of PBS hydrated (A) PLGA PLGA-TCH (B) PG 7525 PG 7525-TCH (C) PG 5050 PG 5050-TCH (D) PG(cs) and PG(cs)-TCH electrospun membranes after
48 h (P as PLGA P-TCH as PLGA-TCH PG 7525 as PLGAGT7525PG 7525-TCHas PLGAGT7525-TCHPG 5050 as PLGAGT5050 PG 5050-TCHas PLGAGT5050-TCHPG(cs)as core
shell PLGAGT PG(cs)-TCH as core shell PLGAGT-TCH)
527M Ranjbar-Mohammadi et al Materials Science and Engineering C 58 (2016) 521 ndash531
8192019 1-s20-S0928493115303222-main (1)
httpslidepdfcomreaderfull1-s20-s0928493115303222-main-1 811
nano1047297bers Following burst releasePG(cs) scaffolds showed a prolonged
sustained release over the entire study period (75 days) by releasing
6810 of the total TCH content by this time
35 Proliferation of 1047297broblasts on electrospun scaffolds
The cytocompatibility of the electrospun scaffolds was evaluated by
MTS assay after culturing 1047297broblasts on the nano1047297bers over a period of
13 and 5 daysandtheresultsareshownin Fig 10 Cell proliferation on
all the scaffolds (with or without drug) was found to increase with cul-
ture time similar to thetrend observed on tissueculture plates (TCP) At
days 1 and 3 of cell culture GT contained nano1047297bers (both blended and
corendashshell) without drug exhibited improved cell viability compared
to PLGA membranes The same trend was observed for TCH incorpo-
rated nano1047297bers though the presence of TCH slightly decreased cell
growth for some of the formulations compared to drug free nano1047297bers
However after 5 days TCH-loaded PG and PG(cs) nano1047297brous mats did
not exhibit signi1047297cant increase in cell viability compared to PLGA-TCH
Fig 8 SEMimagesof degraded nano1047297bersafter40 days(P as PLGA P-TCH as PLGA-TCHPG 7525 asPLGAGT 7525PG 7525-TCH as PLGAGT7525-TCH PG 5050as PLGAGT5050 PG
5050-TCH as PLGAGT 5050-TCH PG(cs) as core shell PLGAGT PG(cs)-TCH as core shell PLGAGT-TCH)
Fig 9 Release pro1047297le of TCH from PLGA-TCH PG 7525-TCH PG 5050-TCH PG(cs)-TCH electrospun scaffolds A) Entire release time B) initial burst release
528 M Ranjbar-Mohammadi et al Materials Science and Engineering C 58 (2016) 521ndash531
8192019 1-s20-S0928493115303222-main (1)
httpslidepdfcomreaderfull1-s20-s0928493115303222-main-1 911
nano1047297bers Moreover none of the electrospun scaffolds showed signif-
icant changes in cell viability after 5 days compared to TCP This is an in-
dication of cytocompatibility of the scaffolds essential for applications
such as treatment of periodontal diseases
36 Antibacterial properties
In this work the antibacterial activity of TCH-loaded PG(cs) PG
7525-TCH and PG(cs)-TCH nano1047297bers was investigated using S aureus
and Pseudomonas aeruginosa as model bacteriaThe drug loadedsamples
showed clear bacterial inhibition rings against Gram-positive bacteria
(S aureus) which is known to be a TCH-sensitive Gram-positive spheri-
cal bacterium that causes a wide range of suppurative infections The
bacterial inhibition ring was smaller on the nano1047297bers containing
Gram-negative bacteria (P aeruginosa) (Fig 11) These observations
may be related to structural differences between two different bacteria
Gram-negative bacteria are more resistant due to the thick lipopolysac-
charide wall structure
4 Discussion
Periodontitis is a major chronic in1047298ammatory disorder that can lead
to the loss of periodontal support for the periodontal ligament which
leads to the formation of an abnormal gap between the tooth and gum
[25] If the process continues the tooth can eventually get lost For
chronic periodontitis local antimicrobial agents are used as an adjunct
to scaling root planning and restoring the periodontalhealth [25] Mul-
tiple investigations have been conducted to incorporate antibiotics into
the polymeric carriers in order to develop a DDS for treatment of peri-
odontal diseases Polymeric DDS were designed in different structures
Fig 10 Proliferation of 1047297broblasts on electrospun nano1047297bers measured by MTS assay (P as PLGA P-TCH as PLGA-TCH PG 7525 as PLGAGT7525PG 7525-TCHas PLGAGT7525-TCH
PG 5050 as PLGAGT 5050 PG 5050-TCH as PLGAGT 5050-TCH PG(cs) as core shell PLGAGT PG(cs)-TCH as core shell PLGAGT-TCH)
Fig 11 Antibacterial properties of nano1047297bers A) PG(cs) B) PG 7525-TCH and C) PG(cs)-TCH
529M Ranjbar-Mohammadi et al Materials Science and Engineering C 58 (2016) 521 ndash531
8192019 1-s20-S0928493115303222-main (1)
httpslidepdfcomreaderfull1-s20-s0928493115303222-main-1 1011
such as1047297lms microparticles and1047297bers using bothsynthetic and natural
polymers [26]
TCHis oneof the widely employed antibiotics with proven effective-
nessin acceleration of periodontal treatment [27] TCHwith low toxicity
is a broadspectrum antibiotic which can be applied for thetreatment of
diseases caused by Gram-negative and Gram-positive microorganisms
by inhibiting protein synthesis in the bacteria [28] Besides its antibiotic
property it exhibits anti-in1047298ammatory properties and has the ability
to promote the attachment of 1047297
broblasts TCH has also been reportedas an inhibitor of the activity of proteinases and hence it can be used
to treat or prevent diseases related to proteinase imbalancerheumatoid
arthritis periodontitis and osteomyelitis [29] Previous studies showed
that the long term routine use of TCH for several months resulted
in clinically favorable effects for periodontal disease [30] Controlled
release of TCH was attempted by various researchers using various
drug delivery systems such as supramolecular gels based on amphi-
philic 345-trihydroxybenzoic derivatives[31] device based on ethylene
vinyl acetate (EVA) copolymer [32] and porous calcium phosphate
polyhydroxy butyrate composites [33] for various applications
Recent advances in the1047297eld of nanotechnology enable the fabrication
of nano1047297brous constructs containing drugs such that they have the ar-
chitectural features and morphological similarities matching the native
extracellular matrix (ECM) [3435] Unique properties of nano1047297bers
such as the high surface area high loading ease of operation and cost
effectiveness make them more suitable as drug delivery vehicles How-
ever drug release characteristics (eg burst release release rate and
duration) are signi1047297cantly in1047298uenced by extent of drug encapsulation
into thenano1047297brous scaffolds whichis greatly dependent to material se-
lection as well as the drug incorporation method [3626] In general
drugs can be incorporated into nano1047297bers via various methods such as
coatings blending co-axial and emulsion electrospinning [26] Recent
developments in this direction progressed with the application of nano-
1047297bers as drug delivery systems for periodontal diseases For example
Zamani et al [26] fabricated PCL nano1047297bers containing metronidazole
benzoate where the drug release was continued for a period of 15 days
In this study we explored the incorporation of TCH into a new
bicomponent carrier PLGA-gum tragacanth (GT) via two different
technics of blend electrospinning and coaxial electrospinning GT themedicinally imported polysaccharide consists of two major fractions a
water-soluble (tragacanthic acid and small amount of arabinogalactan)
and an insolublebut water-swellable fraction named bassorinGT exhib-
ited a considerable potency for wound healing in the form of mucilage
[21] or skin regeneration capability in the form of blend nano1047297bers
with PCL or PVA [2223] Due to the mentioned structural and composi-
tional advantages natural availability antibacterial properties and low
cost we believe that TCH loaded PG and PG(cs) 1047297bers can be employed
as a proper drug delivery system for multiple applications including
treatment of periodontal diseases We aimed to explore the effect of in-
corporation method (blending vs coaxial electrospinning) on the phys-
ical characteristics of the nano1047297bers and TCH release behavior from
PG and PG(cs) nano1047297bers Moreover the biocompatibility of the drug
loaded membranes was investigatedThe SEM images (Fig 2) showed that uniformly distributed nano1047297-
bers without beads were formed from all formulations Blending GT
with PLGA decreased the diameter of nano1047297bers Incorporation of TCH
into PLGA and PG(cs) nano1047297bers also reduced the 1047297ber diameter
while addition of the drug into the blend PG nano1047297bers did not cause
further reduction in diameter of the nano1047297bers (Table 1) The possible
reason for the reduction of the diameter of the nano1047297bers is that both
GT and TCH may improve the polarity of the solution which subse-
quently increases the electrical conductivity of the solution Moreover
PG(cs) nano1047297bers exhibited reduced diameter which can be attributed
to theuse of water as the core solvent High dielectric constant of water
(801 at 25 degC) is an indication of the ability of solution to carry more
electrical charges resulting in higher elongation forces and formation
of thinner nano1047297bers under the electrical 1047297eld [37]
The results of mechanical studies showed that PG membranes ex-
hibited less tensile strength compared to PLGA (Figs 6 and 7) This
canbe relatedto theeasier slippage of polymer chainsunder loadingbe-
cause of less entanglements and weak physical interactions among the
chains of mixed polymers [38] Another reason for lower strength of
PG 1047297bers can be the low mechanical strength of GT itself Moreover
TCH could also decrease the tensile strength as well as breaking strain
of all formulations due to probable plasticizing effect of TCH molecules
for polymer chains However the breaking strain of pure PLGA was de-creased more than seven timeswhile blend PG nano1047297bers had less than
50 reduction in strain at the presence of TCH compared to the similar
membranes without drug This can be attributed to the highly branched
structure of GT which intrinsically limited the elongation of its polymer
chains under the loading resulting in alleviation of the in1047298uence of TCH
on reduction of strain at break Mechanical behavior of the nano1047297bers
under wet condition is another factor of consideration since the mem-
branes inserted into the periodontal pocket are exposed to moist condi-
tion Results of mechanical studies under wet conditions showed that
except PG 5050 nano1047297bers other TCH loaded membranes preserved
their tensile strength in wet condition Interestingly the effect of TCH
on breaking strain of PG(cs) was dependent to drywet state of the
membrane In dry state addition of TCH caused a drastic decline in
breaking strain similar to pure PLGA since smaller amount of GT existed
in PG(cs) nano1047297bers compared to blend PG nano1047297bers However there-
duction in breaking strain of PG(cs) was limited to the extent compara-
ble to blend PG nano1047297bers in wetcondition This canbe attributed to the
more pronounced role of GT in hydrated state due to swelling effect of
this natural polymer resultingin distributionand occupationof a higher
volumeof the nano1047297bers by this polymer Forthe membraneswhichare
supposed to be inserted into theperiodontalpocket it is necessaryto in-
sure that the membrane possesses enough mechanical strength and ri-
gidity to be inserted into the pocket and retain its integrity during the
release time On the other hand the membrane should remain 1047298exible
and soft enough in the wet environment to conform to the periodontal
pocket and meet patient compliance [26] Elastic modulus is a good in-
dicator of the stiffness of a material Among various TCH incorporated
composite nano1047297bers PG(cs) exhibited the highest tensile strength
in both dry and wet conditions while its wet modulus was signi1047297-cantly lower than blend nano1047297bers That means TCH loaded PG(cs)
membranes may provide a proper texture to be easily inserted into
periodontal pocket with a certain amount of back pressure and remain
comfortably in the pocket with the lowest rigiditystiffness among the
composite nano1047297bers
The release kinetics of TCH from electrospun PLGA PG 7525
PG 5050 and PG(cs) scaffolds was studied for a period of 75 days
(Fig 9) For all the formulations initial burst release was attributed to
the release of surface connected drug [39] followed by a controlled re-
lease attributed to molecular diffusion through the polymer phase In
case of blended PG nano1047297bers the presence of hydrophilic PG segments
which are randomly distributed across the diffusion path can signi1047297-
cantly facilitate water uptake and swelling of the polymeric matrix
Therefore faster diffusion of the drug molecules out of the nano1047297bersoccurred resulting in higher release rate within the 1047297rst few days and
reaching a plateau after a certain period of time As expected the
explained effect of GT on release rate was enhanced by increasing the
fraction of this polymer in the blend such that the entire amount of
TCH was released from PG 5050 in 20 days These observations are in
agreement with wettability results which con1047297rmed the promoted
wettability of the scaffolds at higher ratios of GT in the nano 1047297bers
(Fig 5) However when GT was employed as the core along with TCH
the likelihood of having drug molecules as well as GT hydrophilic
segments onnear the surface of nano1047297bers is reduced In this case the
hydrophobic PLGA shell could control the water uptake and swelling
of the hydrophilic core material resulting in lowered burst release as
well as prolonged release of TCH in a sustained fashion for 75 days
The prolonged TCH release from PG(cs) nano1047297bers validates the use of
530 M Ranjbar-Mohammadi et al Materials Science and Engineering C 58 (2016) 521ndash531
8192019 1-s20-S0928493115303222-main (1)
httpslidepdfcomreaderfull1-s20-s0928493115303222-main-1 1111
core shell structure for periodontal treatment since the elimination of
hardened bacteria in periodontal pocket requires sustained exposure
to antibiotics [40]
The cytocompatibility studies showed that GT could successfully
support cell growth on nano1047297brous membranes in both blending and
corendashshell architecture This might be attributed to the more hydro-
philic properties of GT contained membranes which improves protein
adsorption and subsequent cell attachment and proliferation [4142]
On the other hand incorporation of TCH showed to decrease cellgrowth in some of the formulations due to the inhibitory effect of this
drug on mitochondrial protein synthesis [43] However none of the
GT contained scaffolds showed signi1047297cant changes in cell viability com-
pared to the control which demonstrates good cytocompatibility of
the composite membranes Antibacterial assessment of drug loaded
PG and PG(cs) nano1047297bers showed that these scaffolds are strong
enough against of S aureus bacteria
5 Conclusion
In the present study TCH-loaded blend and core shell nano1047297bers
with smooth and bead-less morphology were successfully fabricated
from PLGA and GT for application as new and controlled drug delivery
systems The release rate of TCH in PG blend nano1047297bers increased
with the increase of GT ratio due to enhanced hydrophilicity of the
electrospun nano1047297bers Compared to PG blend nano1047297bers PG(cs) mem-
branes showed a more prolonged release of TCH for 75 days with lower
burst release of the drug within the 1047297rst 2 h Among various formula-
tions PG(cs) nano1047297bers exhibited the highest tensile strength in both
dry and wet conditions while its wet modulus was signi1047297cantly lower
than blend nano1047297bers Thus the TCH loaded PG(cs) membranes might
be strong enough to be easily inserted into periodontal pocket and sus-
tainably release the incorporated drug while affording patient compli-
ance with low rigiditystiffness of the membrane during the treatment
Thesecharacteristics along with the proven cytocompatibility and anti-
bacterial properties of TCH loaded scaffolds suggest the particular ben-
e1047297ts of composite corendashshell nano1047297bers to be used as a drug delivery
system for periodontal diseases
Acknowledgments
This study was supported by the NRF-Technion grant (WBS No
R-398-001-065-592) and the Nanoscience and Nanotechnology Initia-
tive in the National University of Singapore
References
[1] B Felice MP Prabhakaran AP Rodriacuteguez S Ramakrishna J Mater Sci Eng C 4(2014) 178ndash195
[2] P Boisseau B Loubaton C R Phys 12 (2011) 620ndash636
[3] T Allen P Cullis Science 303 (2004) 1818ndash1822[4] Y Malam M Loizidou AM Seifalian Trends Pharmacol Sci 30 (2009) 592ndash599[5] J Zhang R Misra Acta Biomater 3 (2007) 838ndash850[6] B Wang Y Wang T Yin Q Yu Chem Eng Commun 197 (2010) 1315ndash1338[7] ZX Meng XX Xu WZheng HM Zhou LLi YF ZhengX LouJ Colloids SurfB 84
(2011) 97ndash102[8] G Jin MP P rabhakaran D Kai S Ramakrishna Eur J Pharm Biopharm 85 (2013)
689ndash698[9] W QianDGYu YLi YZ LiaoX WangL WangInt JMolSci15 (2014) 774ndash786
[10] H Qi P Hu J Xu A Wang Biomacromolecules 7 (2006) 2327ndash2330[11] TP Chaturvedi R Srivastava AK Srivastava V Gupta VP Kumar Int J Pharm
Investig 2 (2012) 213ndash
217[12] K Kim YK Luu C Chang D Fang BS Hsiao B Chu M Hadjiargyrou J ControlRelease 98 (2004) 47ndash56
[13] R Kenawy GL Bowlin K Mans1047297eld J Layman DG Simpson EH Sanders GEWnek J Control Release 81 (2002) 57ndash64
[14] J Zeng L Yang Q Liang X Zhang H Guan X Xu X Chen X Jing J ControlRelease105 (2005) 43ndash51
[15] X Xu L Yang X Xu X Wang X Chen Q Liang J Zeng X Jing J Control Release108 (2005) 33ndash42
[16] HK Makadia S Siegel Polymers (Basel) 3 (2011) 1377ndash1397[17] MU Adikwu Bentham Science Publishers (2009)[18] A Rasul M Iqbal G Murtaza MK Waqas M Hanif Acta Pol Pharm 67 (2010)
517ndash522[19] B Singh V Sharma Carbohydr Polym 101 (2014) 928ndash940[20] DMW Anderson MME Bridgeman Phytochemistry 24 (1985) 2301ndash2304[21] A Moghbel AAHemmatiH Agheli I RashidiK Amraee Arch Iran Med8 (2005)
257ndash262[22] M Ranjbar-MohammadiSH BahramiMT Joghataei J Mater SciEng C 33 (2013)
4935ndash4943
[23] M Ranjbar-Mohammadi SH Bahrami J Mater Sci Eng C 48 (2015) 71ndash79[24] CL He ZM Huang XJ Han J Biomed Mater Res A 89 (2009) 80ndash95[25] S PappalardoOA Baglio C Cappello S Guarrera M De Benedittis M Petruzzi RF
Grassi Minerva Stomatol 55 (2006) 655ndash661[26] M Zamani M Morshed J Varshosaz M Jannesari Eur J Pharm Biopharm 75
(2010) 179ndash185[27] G Isik S Ince F Saglam U Onan J Clin Periodontol 24 (1997) 589ndash594[28] AN Sapadin R Fleischmajer J Am Acad Dermatol 54 (2006) 258ndash265[29] ZR Domingues ME Cortes TA Gomes HF Diniz CS Freitas JB Gomes AMC
Faria RD Sinisterra Biomaterials 25 (2004) 327ndash333[30] RA Seymour PA Heasman J Clin Periodontol 22 (1995) 22ndash35[31] L Chen J Wu L Yuwen T Shu M Xu M Zhang T Yi Langmuir 25 (2009)
8434ndash8438[32] S Kalachandra L Dongming S Offenbacher J Mater Sci Mater Med 13 (2002)
53ndash58[33] LMedvecky R StulajterovaJ BriancinChemPap 61 (2007) 477ndash484 (composites)[34] E Vatankhah MP Prabhakaran G Jin L GhasemiMobarakeh S Ramakrishna
J Biomater Appl 28 (2013) 909ndash921[35] MC Bottino V Thomas G Schmidt YK Vohra TMG Chua MJ Kowolik GM
Janowski Dent Mater 2 (2012) 703ndash721[36] M Zamani MP Prabhakaran S Ramakrishna Int J Nanomedicine 8 (2013)
2997ndash3017[37] WK Son JH Youk TS Lee WH Park Polymer 45 (2004) 2959ndash2966[38] Y Zhang H Ouyang CT Lim S Ramakrishna ZM Huang J Biomed Mater Res B
Appl Biomater 72B (2005) 156ndash165[39] DH LewisIn M Chasin RLanger (eds) NewYork MarcelDekker Inc (1990)1ndash43[40] WJ Loesche NS Grossman Clin Microbiol Rev 14 (2001) 727ndash752[41] S Fleischer A Shapira O Regev N Nseir E Zussman T Dvir Biotechnol Bioeng
111 (2014) 1246ndash1257[42] R Ravichandran R Sridhar JR Venugopal S Sundarrajan S Mukherjee S
Ramakrishna Macromol Biosci 14 (2014) 515ndash525[43] C van den Bogert G van Kernebeek L Leij AM Kroon Cancer Lett 32 (1986)
341ndash351
531M Ranjbar-Mohammadi et al Materials Science and Engineering C 58 (2016) 521 ndash531
8192019 1-s20-S0928493115303222-main (1)
httpslidepdfcomreaderfull1-s20-s0928493115303222-main-1 211
(GRAS) material at a level of 020ndash130 in food stuffs This natural bio-
polymer is a mixture of two soluble and insoluble polysaccharides
Tragacanthin a galacturonic acid part of tragacanth which is water
soluble and branched with high molecular weight which gives highly
viscous solutionsand bassorinthe other part of tragacanth is a complex
of methoxylated acids that is insoluble in water and swells to form a gel
or viscous solution [17ndash19] Itis approved asa food additive inEuropean
Unionand has the numberE 413 in the list ofadditivescon1047297rmedby the
Scienti1047297
c Committee for Food of the European Community [20] GTalsoexhibited signi1047297cant potency for wound healing in the form of mucilage
or blended nano1047297bers with PCL or PVA because of an acceleration in
collagenation and proliferation phases of the wound repair [21ndash23]
Thus we hypothesized that incorporation of hydrophilic drugs into
composite nano1047297bers of PLGA and GT could provide a more sustained
and prolonged release of the drug due to better hygroscopic compati-
bility of the drug and polymeric matrix
Here for the1047297rst time we aim towards the fabrication of composite
scaffolds of PLGA and GT at various ratios via blending and coaxial
electrospinning Further we investigated the controlled release of
TCH incorporated within these nano1047297bers along with the physical
characteristics (ie wettability porosity) mechanical properties and
cytocompatibility of the composite nano1047297bers which are critically im-
portant for a nano1047297brousmat to be employed as scaffolds for periodon-
tal disease treatment
2 Experimental procedure
21 Materials
PLGA with lactic acidglycolic acid (LAGA) ratio of 7525 with an
intrinsic viscosity of 072 dl gminus1 was purchased from Boehringer
Ingelheim Pharma GmbH amp Co (Ingelheim Germany) Gum tragacanth
used in this study was a high quality ribbon type collected from the
stems of Fluccosus species of Astragalus bushes grown in the central
areas of Iran TCH (purity N 95) and 111333-hexa1047298uoro-2-propanol
(HFP) was purchased from Sigma Aldrich Human dermal 1047297broblasts
(HDFs) wereobtained from American Type Culture CollectionDulbecco
modi1047297ed Eagles medium (DMEM) fetal bovine serum (FBS) penicillinstreptomycin solution and trypsin-ethylene diamine tetra acetic acid
were purchased from Gibco Invitrogen Corp USA
22 Blend and corendashshell electrospinning
Electrospinning was performed to prepare blend nano1047297bers of
PLGA-GT (PG) in three different weight ratios including 1000 7525
5050 (wt) Polymers were dissolved in HFP for making a total con-
centration of 16 (wv) For fabrication of drug containing nano1047297bers
5 (ww) TCH (based on the total weight of PLGA and GT) was added
and stirred for 30 min Prepared solution was loaded into individual
3-mL syringe attached to a 25G blunted stainless steel needle and a
high voltage of 15 kV was applied to the tip of the needle The 1047298ow
rate of the solutions was maintained at 10 mLh using a syringe pump(KDS 100 KD Scienti1047297c Holliston MA) For fabrication of core shell
nano1047297bers PLGA was dissolved in HFP to obtain 16 (wv) solution
which was used as the shell GT was dissolved in water to obtain 2
(wv) solution and stirred overnight to be used as the core solution
The polymer solutions were separately fed into 3 mL standard syringes
attached to a coaxial nuzzle The inner diameter of shell capillary was
084 mm while the smaller capillary had outer and inner diameters of
056 mm and 030 mm respectively A high voltage of 15 kV (Gamma
High Voltage Research Ormond Beach FL) was applied while the 1047298ow
rate of the shell and core was maintained at 10 mLh and 02 mLh re-
spectively and the polymer solution was drawn into 1047297bers To make
TCH incorporated core shell 1047297bers TCH was added to the core solution
(5 ww) based on the total amount of PLGA and GT considering the
concentration and 1047298aw rate of core and shell solutions Nano1047297bers
were deposited on aluminum wrapped collector at a distance of 15 cm
from the needle tip dried overnight under vacuum and used for charac-
terization drug release and cell proliferation experiments
23 Characterization of nano 1047297bers
The morphology of the electrospun nano1047297bers was studied under a
Field Emission Scanning Electron Microscope (FESEM JEOL JSM-6701-
F Japan) after sputter coating with gold (JEOL JFC-1200 1047297
ne coater Japan) at an accelerating voltage of 15 kV Diameters of the electrospun
1047297bers were analyzed from the SEM images using image analysis soft-
ware (Image J National Institutes of Health USA) Corendashshell structure
of drug loaded PLGA-GT (PG(cs)-TCH) nano1047297bers was examined using
transmission electron microscopy (TEM) (JEOL JFM-3010 Japan) At-
tenuated total re1047298ectance Fourier transform infrared (ATR-FTIR) spec-
troscopic analysis of the electrospun scaffolds was ful1047297lled using a
Nicolet Avatar 380 spectrometer (Thermo Nicolet Waltham MA) over
the range of 600ndash3800 cmminus1 at a resolution of 4 cm
The pore size of the nano1047297brous scaffolds was studied using a CFP-
1200-A capillary 1047298ow porometer (PMI New York NY) Three samples
of each type of nano1047297bers with the same thickness and a dimension of
2 times 2 c m2 were used for measuring the pore size Galwick with a surface
tension of 159 dynescm (PMI New York NY) was used as the wetting
liquid Wettability of the nano1047297bers was determined via contact angle
measurement and a sessile drop method-based video contact angle
system (VCA Optima AST Products Billerica MA) was used for this
purpose The size of the distilled water droplet was set at 10 μ L
The mechanical properties of the electrospun membranes were de-
termined by a uniaxial tensile machine (Instron5943 Canton MA)
with a load cell capacity of 10 N and cross head speed of 5 mm minminus1
All nano1047297ber tape samples were cut in the form of rectangular shape
with dimensions of 30 times 10 mm2 At 1047297rst a white window paper tem-
plate wascut andnano1047297brous tapes were glued onto thetop andbottom
areas of the window It was placed between the grips of the tensile
testing machine and after closing the grips the other sides of the win-
dow papers were cut by a scissor Tensile test was carried out for the
as obtained dry electrospun mats and the 48 h phosphate-buffered sa-
line (PBS) hydrated scaffolds A minimum of six specimens of individualscaffolds were tested
24 Nano 1047297ber degradation studies
To perform the biodegradability test the 1047297bers on cover slips were
immersed in PBS (pH of 74) and incubated for a period of 40 days at
37 degC At eachspeci1047297c time point the scaffolds were washed and subse-
quently driedin a vacuum oven for 48 h The morphology changes were
studied by FESEM
25 TCH release from electrospun nano 1047297bers
Release of TCH from electrospun nano1047297bers was measured using a
UVVIS instrument (Shimadzu 3600 UV ndashVIS-NIR Spectrophotometer)Forthisthe drug containing nano1047297brousmats wereaccuratelyweighed
placed in tightlycapped glass bottle soaked in 1 mL of PBS (pH 74) and
kept in shaking incubator at 37 degC and 150 rpm The UV absorbance of
TCH released in buffer solution was determined at λmax = 362 nm
and converted to the TCH concentration according to the calibration
curve of TCH in the same media [24] The cumulative release of TCH
against release time was further plotted Fig 1 givesthe graphical repre-
sentation of the preparation of nano1047297bers and studying release proper-
ties of them
26 Cell culture and proliferation studies
In vitro biocompatibility of electrospun mats was evaluated
using human dermal 1047297broblast (HDF) cells The proliferation test
522 M Ranjbar-Mohammadi et al Materials Science and Engineering C 58 (2016) 521ndash531
8192019 1-s20-S0928493115303222-main (1)
httpslidepdfcomreaderfull1-s20-s0928493115303222-main-1 311
was done using a colorimetric 3-(45-dimethylthiazol-2-yl)-5-(3-
carboxymethoxyphenyl)-2(4-sulfophenyl)-2H tetrazolium (MTS) assay
(CellTiter 96 AQueous One solution Promega USA) In brief 1047297broblasts
were cultured in DMEM augmented with 10 FBS and 1 antibiotic
and antimycotic solutions in a 75 cm2 cell culture 1047298ask Cells were cul-
tured in a humidi1047297ed incubator at 37 degC with 5 CO2 and the mediawere replaced every two days The nano1047297brous scaffolds were sterilized
under UV radiation for 2 h washed 3 times with PBS and then sank in
DMEM overnight before cell seeding For cell seeding the cells were de-
tached by adding 025 of trypsin containing 01 EDTA centrifuged
counted using a hemocytometer and seeded on the scaffolds placed
in a 24-well plate and tissue culture polystyrene (TCP as control) at a
density of 5000 cells per well After 1 3 and 5 days 1047297broblast seeded
scaffolds were rinsed with PBS and 20 of MTS reagent in serum-free
medium was added After incubation for 3 h aliquots were pipetted
into a 96-well plate and absorbance of the obtained dye was measured
at 492 nm using a spectrophotometric plate reader (FLUO star Optima
BMG Lab Technologies and Germany) The intensity of the obtained
color is directly proportional to the metabolic activity of the cell
population
27 Antibacterial properties
Theantimicrobialbehaviorof PG(cs) PG 7525-TCH and PG(cs)-TCH
nano1047297bers was studied by agar plate method Staphylococcus aureus
ATCC 25923 and Pseudo aeruginosa ATCC 27853 were used as Gram-
positive and Gram-negative bacteria respectively MuellerndashHinton
agar media were sterilized in an autoclave at 121 degC for 20 min under
15 lbsin2 pressures A loop of each bacterium was inoculated on 5 mL
of nutrient broth and incubated at 37 degC for 24 h then cultured in nutri-
ent agar plate The disk shape samples of nano1047297brous mat were steril-
ized by ultraviolet light for 2 h and were placed in a plate Then the
plates were held in an incubator for 24 h Images from the samples
were used for assessing the antimicrobial behavior
28 Statistical analysis
Alldata presentedare expressedas mean plusmn standard deviation(SD)
Statistical analysis was carried out using one-way analysis of variance
(ANOVA) followed by Tukey post hoc test for multiple comparisons
and signi1047297cance was considered at p le 005
3 Results
31 Physical and chemical characterization of nano 1047297bers
The SEM micrographs of the electrospun nano1047297bers are shown in
Fig 2 The optimization of the electrospinning conditions with respect
to the concentration of the polymer applied voltage 1047298ow rate and
distance between the collector and the needle tip was performed thus
producing a continuous stretch of 1047297bers At the optimized condition
uniform bead-free 1047297bers of PLGA blend PG and PG(cs) nano1047297bers
were fabricated by blend and coaxial electrospinning Addition of the
natural polysaccharide (GT) to PLGA produced compositePG nano1047297bers
with diameters much lower than those of PLGA (Table 1) The 1047297ber di-ameter of pure PLGA PG 7525 and PG 5050 without TCH was obtained
as 460 plusmn 16 296 plusmn 25 and 187 plusmn 26 nm respectively which indicates
the reduction in 1047297ber diameter of the composite scaffolds using higher
amounts of gum tragacanth in PG nano1047297bers
At the same time TCH incorporation into PLGA nano1047297bers de-
creased the 1047297ber diameter while TCH loaded PG scaffolds did not ex-
hibit signi1047297cant changes in 1047297ber diameter compared with drug free
scaffolds Fig 2 also exhibited the formation of smooth continuous
and beadless PG(cs) and PG(cs)-TCH nano1047297bers with a diameter of
399 plusmn 31 and 180 plusmn 24 nm respectively Similar to pure PLGA nano-
1047297bers the diameter of TCH loaded core shell nano1047297bers was signi1047297-
cantly lower than that of drug free PG(cs) nano1047297bers Fig 3 shows
the TEM image of drug loaded PG(cs) nano1047297bers prepared by coaxial
electrospinning The TEM micrographof the coaxially electrospun1047297bers
Fig 1 Graphical representation of the preparation of nano1047297bers and studying release properties
523M Ranjbar-Mohammadi et al Materials Science and Engineering C 58 (2016) 521 ndash531
8192019 1-s20-S0928493115303222-main (1)
httpslidepdfcomreaderfull1-s20-s0928493115303222-main-1 411
clearly shows the lsquocorersquo compartment embedded within the shell of the
polymer
The results of pore size measurements are shown in Table 1 The
pore size of the nano1047297brous mats was signi1047297cantly decreased by addi-tion of both GT and drug compared to pure PLGA and similar PG
drug-free scaffolds respectively
The ATR-FTIR spectra of the electrospun PLGA nano1047297bers (Fig 4A)
showed peaks at 1757 cmminus1 1452 cmminus1 1186 cmminus1 and 1089 cmminus1
which correspond to the carbonyl group (CndashO bond) ether group
(CndashOndashC) and methyl group (CndashH) respectively In PG blend nano1047297bersthe peaks of GT have been partially overlapped by the peaks of PLGA
itself and hence the OH peaks appeared weaker for these scaffolds
For drug loaded PLGA nano1047297bers the carbonyl peak appeared broad-
ened because of the hydrogen bonding between the hydroxyl groups
of TCH and C=O groups of PLGA Within the spectra of PLGATCH
scaffolds the stretching frequencies at 1614 and 1579 cmminus1 corre-
spond to the carbonyl groups in A and C rings of TCH respectively
(Fig 4AB) These peaks were seen for the drug loaded PG nano1047297bers
prepared by blend electrospinning but were not obviously visible for
the corendashshell PG-TCH nano1047297bers A mild shift in carbonyl group
wavelength from 1760 to 1754 cmminus1 for drug loaded PG nano1047297bers
in comparison with PG nano1047297bers might have occurred due to the
weakening of some bonds due to hydrogen bonding between drug
and PLGA or GT
Fig 2 Morphology andsize distribution of electrospunnano1047297bersP as PLGA P-TCH as PLGA-TCH PG as PLGAGT PG-TCH as PLGAGT-TCH PG(cs)as coreshell PLGAGT andPG(cs)-TCH
as core shell PLGAGT-TCH)
Table 1
Diameter and pore size of electrospun nano1047297bers
Scaffold Fiber diameter (nm) Average thickness (μ m) Pore size (μ m)
PLGA 460 plusmn 16 6120 292 plusmn 002
PLGA-TCH 288 plusmn 33 6176 095 plusmn 003
PG 7525 296 plusmn 25 6190 180 plusmn 001
PG 7525-TCH 221 plusmn 42 6134 099 plusmn 004
PG 5050 187 plusmn 26 6095 10 plusmn 001
PG 5050 -TCH 180 plusmn 24 6086 063 plusmn 002
PG(cs) 399 plusmn 31 6156 135 plusmn 002
PG(cs)-TCH 197 plusmn 42 6102 12 plusmn 003
524 M Ranjbar-Mohammadi et al Materials Science and Engineering C 58 (2016) 521ndash531
8192019 1-s20-S0928493115303222-main (1)
httpslidepdfcomreaderfull1-s20-s0928493115303222-main-1 511
The surface property (interaction with water) of the electrospun
scaffolds was determined dynamically by water contact angle measure-
mentfor a periodof 30s Asshownin Fig 5 with increasing amounts of
GT within the PG composites the hydrophilicity of the nano1047297brous
membrane increased such that PG 7525 and 5050 scaffolds showed
a contact angle value of 85 plusmn 3deg and 76 plusmn 2deg respectively after 30 s
The water contact angle of drug loaded PG nano1047297bers was signi1047297cant-
ly lower than that of drug free PG scaffolds due to the hydrophilic
properties of TCH At the same time the PG(cs) nano1047297bers were more
hydrophilic than the PLGA nano1047297bers However the hydrophilicity of
PG(cs) was lesser compared to PG nano1047297bers due to the presence of
the hydrophilic GT within the core of the nano1047297bers
32 Mechanical properties of as-spun and hydrated scaffolds
The mechanical properties of electrospunnano1047297brousscaffolds with
or without drug including their tensile strength strain at break andelastic modulus were evaluated and are shown in Fig 6 and Table 2
In dry condition the average tensile strength of PLGA nano1047297bers was
obtained as 422 plusmn 002 MPa (Fig 6A) and it exhibited a strain at
break of 11874 plusmn 117 Comparing the stressndashstrain curves of the dif-
ferent scaffolds we found that addition of GT into PLGA nano1047297bers sig-
ni1047297cantly decreased the tensile strength of the nano1047297bers and reduced
the breaking strain (Fig 6B and C) Moreover the results of our studies
showed that PG nano1047297bers had a reduced elastic modulus compared
to pure PLGA nano1047297bers (Table 2) The average tensile strength and
elongation at break of PG(cs) were 332 plusmn 003 MPa and 10283 plusmn
301 respectively which was signi1047297cantly higher than blend nano1047297-
bers (Fig 6D and Table 2) For all formulations incorporation of TCH
into nano1047297bers reduced the tensile strength and elongation at break
while the elastic modulus was increased compared to the scaffolds
without drug
The results of the tensile properties of PBS-hydrated electrospun
scaffolds after 2 days are shown in Fig 7 and Table 2 All the nano1047297bers
without drug showed reduced tensile strength and strain after 2 days
of hydration compared to the dry state except PG 5050 (Fig 7C) with
no signi1047297cant changes Moreover none of the TCH loaded nano1047297bers
Fig 3 TEM micrograph of TCH loaded PG(cs) nano1047297bers
Fig 4 (A)ATR-FTIR spectraof nano1047297bers (P as PLGA P-TCH as PLGA-TCH PG as PLGAGT PG-TCH as PLGAGT-TCH PG(cs)as core shell PLGAGT PG(cs)-TCH as coreshellPLGAGT-TCH)
525M Ranjbar-Mohammadi et al Materials Science and Engineering C 58 (2016) 521 ndash531
8192019 1-s20-S0928493115303222-main (1)
httpslidepdfcomreaderfull1-s20-s0928493115303222-main-1 611
8192019 1-s20-S0928493115303222-main (1)
httpslidepdfcomreaderfull1-s20-s0928493115303222-main-1 711
value of elastic modulus (2200plusmn 167 MPa) in wet condition compared
to other formulations (Fig 7D and Table 2)
33 Degradation behavior of nano 1047297bers
Drug diffusion can be affected by scaffolds topology and morpholo-
gy Thusthe topological and morphological changes duringdegradation
might be able to control drug release rate from the nano1047297brous scaf-
folds Fig 8 presents the SEM images of the scaffolds after in vitro deg-
radation for a period of 40 days The 1047297brous structure of PLGA and
PG(cs) scaffolds with and without TCH was partially preserved after
40 days of degradation However blend PG scaffolds with and without
drug swelled to a large extent resulting in loss of nano1047297brous morphol-
ogy within similar time scale These results are in agreement with
higher wettability of PG nano1047297bers compared to PLGA and PG(cs)
nano1047297bers
34 Drug delivery
In this paper we determined the released amounts of TCH by mea-
suringthe absorbance at 362nm using an ultraviolet visible spectropho-
tometer Thereleaseof TCHfrom variouselectrospun scaffoldsis plotted
in Fig 9A amp B PLGA nano1047297bers exhibited an initial burst release of
2320 within the 1047297rst 2 h (Fig 9B) and reached a plateau within
7 days by releasing only 35 of TCH content The burst release of TCH
from PG 7525 nano1047297bers was very similar to pure PLGA (2479)
while PG 5050 had a signi1047297cantly higher amount of TCH (4830) re-
leased in the 1047297rst 2 h followedby a veryfast release of90of drugcon-
tent within 5 days However PG 7525 composite nano1047297bers showed
a sustained TCH release up to a period of 25 days the time point that
it reached to the plateau state For the core shell nano1047297bers where
TCH was incorporated in the core along with GT the burst release was
signi1047297cantly lower (19) compared to both pure PLGA and PG blend
Table 2
Tensile properties of the electrospun nano1047297bers under dry and wet conditions
Samples Dry scaffolds Wet scaffolds
T (μ m) EM (MPa) UTS (MPa) SB () T (μ m) EM (MPa) UTS (MPa) SB ()
PLGA 5680 7600 plusmn 360 422 + 002 11874 plusmn 117 5001 6900 plusmn 180 255 plusmn 003 6409 plusmn 112
PLGA-TCH 5802 8433 plusmn 781 258 plusmn 003 1592 plusmn 212 5277 6236 plusmn 283 171 plusmn 009 1158 plusmn 178
PG 7525 5499 4334 plusmn 223 230 plusmn 002 2240 plusmn 212 5686 4273 plusmn 136 170 plusmn 008 1517 plusmn 113
PG 7525-TCH 5307 6410 plusmn 334 101 plusmn 005 1350 plusmn 691 5430 5211 plusmn 219 102 plusmn 009 1133 plusmn 501
PG 5050 5503 3295 plusmn 100 093 plusmn 003 1392 plusmn 406 5333 3290 plusmn 110 089 plusmn 008 1422 plusmn 113
PG 5050-TCH 5409 3962 plusmn 131 072 plusmn 006 883 plusmn 702 5602 3381 plusmn 187 040 plusmn 010 775 plusmn 398
PG(cs) 5204 4020 plusmn 171 332 plusmn 003 10283 plusmn 301 4903 10532 plusmn 121 215 plusmn 002 3667 plusmn 113
PG(cs)-TCH 5375 4832 plusmn 413 151 plusmn 007 1424 plusmn 451 4889 2200 plusmn 167 157 plusmn 003 3341 plusmn 315
T average thickness of nano1047297bers EM elastic modulus UTS ultimate tensile strength SB strain at break
Fig 7 Mechanical properties of PBS hydrated (A) PLGA PLGA-TCH (B) PG 7525 PG 7525-TCH (C) PG 5050 PG 5050-TCH (D) PG(cs) and PG(cs)-TCH electrospun membranes after
48 h (P as PLGA P-TCH as PLGA-TCH PG 7525 as PLGAGT7525PG 7525-TCHas PLGAGT7525-TCHPG 5050 as PLGAGT5050 PG 5050-TCHas PLGAGT5050-TCHPG(cs)as core
shell PLGAGT PG(cs)-TCH as core shell PLGAGT-TCH)
527M Ranjbar-Mohammadi et al Materials Science and Engineering C 58 (2016) 521 ndash531
8192019 1-s20-S0928493115303222-main (1)
httpslidepdfcomreaderfull1-s20-s0928493115303222-main-1 811
nano1047297bers Following burst releasePG(cs) scaffolds showed a prolonged
sustained release over the entire study period (75 days) by releasing
6810 of the total TCH content by this time
35 Proliferation of 1047297broblasts on electrospun scaffolds
The cytocompatibility of the electrospun scaffolds was evaluated by
MTS assay after culturing 1047297broblasts on the nano1047297bers over a period of
13 and 5 daysandtheresultsareshownin Fig 10 Cell proliferation on
all the scaffolds (with or without drug) was found to increase with cul-
ture time similar to thetrend observed on tissueculture plates (TCP) At
days 1 and 3 of cell culture GT contained nano1047297bers (both blended and
corendashshell) without drug exhibited improved cell viability compared
to PLGA membranes The same trend was observed for TCH incorpo-
rated nano1047297bers though the presence of TCH slightly decreased cell
growth for some of the formulations compared to drug free nano1047297bers
However after 5 days TCH-loaded PG and PG(cs) nano1047297brous mats did
not exhibit signi1047297cant increase in cell viability compared to PLGA-TCH
Fig 8 SEMimagesof degraded nano1047297bersafter40 days(P as PLGA P-TCH as PLGA-TCHPG 7525 asPLGAGT 7525PG 7525-TCH as PLGAGT7525-TCH PG 5050as PLGAGT5050 PG
5050-TCH as PLGAGT 5050-TCH PG(cs) as core shell PLGAGT PG(cs)-TCH as core shell PLGAGT-TCH)
Fig 9 Release pro1047297le of TCH from PLGA-TCH PG 7525-TCH PG 5050-TCH PG(cs)-TCH electrospun scaffolds A) Entire release time B) initial burst release
528 M Ranjbar-Mohammadi et al Materials Science and Engineering C 58 (2016) 521ndash531
8192019 1-s20-S0928493115303222-main (1)
httpslidepdfcomreaderfull1-s20-s0928493115303222-main-1 911
nano1047297bers Moreover none of the electrospun scaffolds showed signif-
icant changes in cell viability after 5 days compared to TCP This is an in-
dication of cytocompatibility of the scaffolds essential for applications
such as treatment of periodontal diseases
36 Antibacterial properties
In this work the antibacterial activity of TCH-loaded PG(cs) PG
7525-TCH and PG(cs)-TCH nano1047297bers was investigated using S aureus
and Pseudomonas aeruginosa as model bacteriaThe drug loadedsamples
showed clear bacterial inhibition rings against Gram-positive bacteria
(S aureus) which is known to be a TCH-sensitive Gram-positive spheri-
cal bacterium that causes a wide range of suppurative infections The
bacterial inhibition ring was smaller on the nano1047297bers containing
Gram-negative bacteria (P aeruginosa) (Fig 11) These observations
may be related to structural differences between two different bacteria
Gram-negative bacteria are more resistant due to the thick lipopolysac-
charide wall structure
4 Discussion
Periodontitis is a major chronic in1047298ammatory disorder that can lead
to the loss of periodontal support for the periodontal ligament which
leads to the formation of an abnormal gap between the tooth and gum
[25] If the process continues the tooth can eventually get lost For
chronic periodontitis local antimicrobial agents are used as an adjunct
to scaling root planning and restoring the periodontalhealth [25] Mul-
tiple investigations have been conducted to incorporate antibiotics into
the polymeric carriers in order to develop a DDS for treatment of peri-
odontal diseases Polymeric DDS were designed in different structures
Fig 10 Proliferation of 1047297broblasts on electrospun nano1047297bers measured by MTS assay (P as PLGA P-TCH as PLGA-TCH PG 7525 as PLGAGT7525PG 7525-TCHas PLGAGT7525-TCH
PG 5050 as PLGAGT 5050 PG 5050-TCH as PLGAGT 5050-TCH PG(cs) as core shell PLGAGT PG(cs)-TCH as core shell PLGAGT-TCH)
Fig 11 Antibacterial properties of nano1047297bers A) PG(cs) B) PG 7525-TCH and C) PG(cs)-TCH
529M Ranjbar-Mohammadi et al Materials Science and Engineering C 58 (2016) 521 ndash531
8192019 1-s20-S0928493115303222-main (1)
httpslidepdfcomreaderfull1-s20-s0928493115303222-main-1 1011
such as1047297lms microparticles and1047297bers using bothsynthetic and natural
polymers [26]
TCHis oneof the widely employed antibiotics with proven effective-
nessin acceleration of periodontal treatment [27] TCHwith low toxicity
is a broadspectrum antibiotic which can be applied for thetreatment of
diseases caused by Gram-negative and Gram-positive microorganisms
by inhibiting protein synthesis in the bacteria [28] Besides its antibiotic
property it exhibits anti-in1047298ammatory properties and has the ability
to promote the attachment of 1047297
broblasts TCH has also been reportedas an inhibitor of the activity of proteinases and hence it can be used
to treat or prevent diseases related to proteinase imbalancerheumatoid
arthritis periodontitis and osteomyelitis [29] Previous studies showed
that the long term routine use of TCH for several months resulted
in clinically favorable effects for periodontal disease [30] Controlled
release of TCH was attempted by various researchers using various
drug delivery systems such as supramolecular gels based on amphi-
philic 345-trihydroxybenzoic derivatives[31] device based on ethylene
vinyl acetate (EVA) copolymer [32] and porous calcium phosphate
polyhydroxy butyrate composites [33] for various applications
Recent advances in the1047297eld of nanotechnology enable the fabrication
of nano1047297brous constructs containing drugs such that they have the ar-
chitectural features and morphological similarities matching the native
extracellular matrix (ECM) [3435] Unique properties of nano1047297bers
such as the high surface area high loading ease of operation and cost
effectiveness make them more suitable as drug delivery vehicles How-
ever drug release characteristics (eg burst release release rate and
duration) are signi1047297cantly in1047298uenced by extent of drug encapsulation
into thenano1047297brous scaffolds whichis greatly dependent to material se-
lection as well as the drug incorporation method [3626] In general
drugs can be incorporated into nano1047297bers via various methods such as
coatings blending co-axial and emulsion electrospinning [26] Recent
developments in this direction progressed with the application of nano-
1047297bers as drug delivery systems for periodontal diseases For example
Zamani et al [26] fabricated PCL nano1047297bers containing metronidazole
benzoate where the drug release was continued for a period of 15 days
In this study we explored the incorporation of TCH into a new
bicomponent carrier PLGA-gum tragacanth (GT) via two different
technics of blend electrospinning and coaxial electrospinning GT themedicinally imported polysaccharide consists of two major fractions a
water-soluble (tragacanthic acid and small amount of arabinogalactan)
and an insolublebut water-swellable fraction named bassorinGT exhib-
ited a considerable potency for wound healing in the form of mucilage
[21] or skin regeneration capability in the form of blend nano1047297bers
with PCL or PVA [2223] Due to the mentioned structural and composi-
tional advantages natural availability antibacterial properties and low
cost we believe that TCH loaded PG and PG(cs) 1047297bers can be employed
as a proper drug delivery system for multiple applications including
treatment of periodontal diseases We aimed to explore the effect of in-
corporation method (blending vs coaxial electrospinning) on the phys-
ical characteristics of the nano1047297bers and TCH release behavior from
PG and PG(cs) nano1047297bers Moreover the biocompatibility of the drug
loaded membranes was investigatedThe SEM images (Fig 2) showed that uniformly distributed nano1047297-
bers without beads were formed from all formulations Blending GT
with PLGA decreased the diameter of nano1047297bers Incorporation of TCH
into PLGA and PG(cs) nano1047297bers also reduced the 1047297ber diameter
while addition of the drug into the blend PG nano1047297bers did not cause
further reduction in diameter of the nano1047297bers (Table 1) The possible
reason for the reduction of the diameter of the nano1047297bers is that both
GT and TCH may improve the polarity of the solution which subse-
quently increases the electrical conductivity of the solution Moreover
PG(cs) nano1047297bers exhibited reduced diameter which can be attributed
to theuse of water as the core solvent High dielectric constant of water
(801 at 25 degC) is an indication of the ability of solution to carry more
electrical charges resulting in higher elongation forces and formation
of thinner nano1047297bers under the electrical 1047297eld [37]
The results of mechanical studies showed that PG membranes ex-
hibited less tensile strength compared to PLGA (Figs 6 and 7) This
canbe relatedto theeasier slippage of polymer chainsunder loadingbe-
cause of less entanglements and weak physical interactions among the
chains of mixed polymers [38] Another reason for lower strength of
PG 1047297bers can be the low mechanical strength of GT itself Moreover
TCH could also decrease the tensile strength as well as breaking strain
of all formulations due to probable plasticizing effect of TCH molecules
for polymer chains However the breaking strain of pure PLGA was de-creased more than seven timeswhile blend PG nano1047297bers had less than
50 reduction in strain at the presence of TCH compared to the similar
membranes without drug This can be attributed to the highly branched
structure of GT which intrinsically limited the elongation of its polymer
chains under the loading resulting in alleviation of the in1047298uence of TCH
on reduction of strain at break Mechanical behavior of the nano1047297bers
under wet condition is another factor of consideration since the mem-
branes inserted into the periodontal pocket are exposed to moist condi-
tion Results of mechanical studies under wet conditions showed that
except PG 5050 nano1047297bers other TCH loaded membranes preserved
their tensile strength in wet condition Interestingly the effect of TCH
on breaking strain of PG(cs) was dependent to drywet state of the
membrane In dry state addition of TCH caused a drastic decline in
breaking strain similar to pure PLGA since smaller amount of GT existed
in PG(cs) nano1047297bers compared to blend PG nano1047297bers However there-
duction in breaking strain of PG(cs) was limited to the extent compara-
ble to blend PG nano1047297bers in wetcondition This canbe attributed to the
more pronounced role of GT in hydrated state due to swelling effect of
this natural polymer resultingin distributionand occupationof a higher
volumeof the nano1047297bers by this polymer Forthe membraneswhichare
supposed to be inserted into theperiodontalpocket it is necessaryto in-
sure that the membrane possesses enough mechanical strength and ri-
gidity to be inserted into the pocket and retain its integrity during the
release time On the other hand the membrane should remain 1047298exible
and soft enough in the wet environment to conform to the periodontal
pocket and meet patient compliance [26] Elastic modulus is a good in-
dicator of the stiffness of a material Among various TCH incorporated
composite nano1047297bers PG(cs) exhibited the highest tensile strength
in both dry and wet conditions while its wet modulus was signi1047297-cantly lower than blend nano1047297bers That means TCH loaded PG(cs)
membranes may provide a proper texture to be easily inserted into
periodontal pocket with a certain amount of back pressure and remain
comfortably in the pocket with the lowest rigiditystiffness among the
composite nano1047297bers
The release kinetics of TCH from electrospun PLGA PG 7525
PG 5050 and PG(cs) scaffolds was studied for a period of 75 days
(Fig 9) For all the formulations initial burst release was attributed to
the release of surface connected drug [39] followed by a controlled re-
lease attributed to molecular diffusion through the polymer phase In
case of blended PG nano1047297bers the presence of hydrophilic PG segments
which are randomly distributed across the diffusion path can signi1047297-
cantly facilitate water uptake and swelling of the polymeric matrix
Therefore faster diffusion of the drug molecules out of the nano1047297bersoccurred resulting in higher release rate within the 1047297rst few days and
reaching a plateau after a certain period of time As expected the
explained effect of GT on release rate was enhanced by increasing the
fraction of this polymer in the blend such that the entire amount of
TCH was released from PG 5050 in 20 days These observations are in
agreement with wettability results which con1047297rmed the promoted
wettability of the scaffolds at higher ratios of GT in the nano 1047297bers
(Fig 5) However when GT was employed as the core along with TCH
the likelihood of having drug molecules as well as GT hydrophilic
segments onnear the surface of nano1047297bers is reduced In this case the
hydrophobic PLGA shell could control the water uptake and swelling
of the hydrophilic core material resulting in lowered burst release as
well as prolonged release of TCH in a sustained fashion for 75 days
The prolonged TCH release from PG(cs) nano1047297bers validates the use of
530 M Ranjbar-Mohammadi et al Materials Science and Engineering C 58 (2016) 521ndash531
8192019 1-s20-S0928493115303222-main (1)
httpslidepdfcomreaderfull1-s20-s0928493115303222-main-1 1111
core shell structure for periodontal treatment since the elimination of
hardened bacteria in periodontal pocket requires sustained exposure
to antibiotics [40]
The cytocompatibility studies showed that GT could successfully
support cell growth on nano1047297brous membranes in both blending and
corendashshell architecture This might be attributed to the more hydro-
philic properties of GT contained membranes which improves protein
adsorption and subsequent cell attachment and proliferation [4142]
On the other hand incorporation of TCH showed to decrease cellgrowth in some of the formulations due to the inhibitory effect of this
drug on mitochondrial protein synthesis [43] However none of the
GT contained scaffolds showed signi1047297cant changes in cell viability com-
pared to the control which demonstrates good cytocompatibility of
the composite membranes Antibacterial assessment of drug loaded
PG and PG(cs) nano1047297bers showed that these scaffolds are strong
enough against of S aureus bacteria
5 Conclusion
In the present study TCH-loaded blend and core shell nano1047297bers
with smooth and bead-less morphology were successfully fabricated
from PLGA and GT for application as new and controlled drug delivery
systems The release rate of TCH in PG blend nano1047297bers increased
with the increase of GT ratio due to enhanced hydrophilicity of the
electrospun nano1047297bers Compared to PG blend nano1047297bers PG(cs) mem-
branes showed a more prolonged release of TCH for 75 days with lower
burst release of the drug within the 1047297rst 2 h Among various formula-
tions PG(cs) nano1047297bers exhibited the highest tensile strength in both
dry and wet conditions while its wet modulus was signi1047297cantly lower
than blend nano1047297bers Thus the TCH loaded PG(cs) membranes might
be strong enough to be easily inserted into periodontal pocket and sus-
tainably release the incorporated drug while affording patient compli-
ance with low rigiditystiffness of the membrane during the treatment
Thesecharacteristics along with the proven cytocompatibility and anti-
bacterial properties of TCH loaded scaffolds suggest the particular ben-
e1047297ts of composite corendashshell nano1047297bers to be used as a drug delivery
system for periodontal diseases
Acknowledgments
This study was supported by the NRF-Technion grant (WBS No
R-398-001-065-592) and the Nanoscience and Nanotechnology Initia-
tive in the National University of Singapore
References
[1] B Felice MP Prabhakaran AP Rodriacuteguez S Ramakrishna J Mater Sci Eng C 4(2014) 178ndash195
[2] P Boisseau B Loubaton C R Phys 12 (2011) 620ndash636
[3] T Allen P Cullis Science 303 (2004) 1818ndash1822[4] Y Malam M Loizidou AM Seifalian Trends Pharmacol Sci 30 (2009) 592ndash599[5] J Zhang R Misra Acta Biomater 3 (2007) 838ndash850[6] B Wang Y Wang T Yin Q Yu Chem Eng Commun 197 (2010) 1315ndash1338[7] ZX Meng XX Xu WZheng HM Zhou LLi YF ZhengX LouJ Colloids SurfB 84
(2011) 97ndash102[8] G Jin MP P rabhakaran D Kai S Ramakrishna Eur J Pharm Biopharm 85 (2013)
689ndash698[9] W QianDGYu YLi YZ LiaoX WangL WangInt JMolSci15 (2014) 774ndash786
[10] H Qi P Hu J Xu A Wang Biomacromolecules 7 (2006) 2327ndash2330[11] TP Chaturvedi R Srivastava AK Srivastava V Gupta VP Kumar Int J Pharm
Investig 2 (2012) 213ndash
217[12] K Kim YK Luu C Chang D Fang BS Hsiao B Chu M Hadjiargyrou J ControlRelease 98 (2004) 47ndash56
[13] R Kenawy GL Bowlin K Mans1047297eld J Layman DG Simpson EH Sanders GEWnek J Control Release 81 (2002) 57ndash64
[14] J Zeng L Yang Q Liang X Zhang H Guan X Xu X Chen X Jing J ControlRelease105 (2005) 43ndash51
[15] X Xu L Yang X Xu X Wang X Chen Q Liang J Zeng X Jing J Control Release108 (2005) 33ndash42
[16] HK Makadia S Siegel Polymers (Basel) 3 (2011) 1377ndash1397[17] MU Adikwu Bentham Science Publishers (2009)[18] A Rasul M Iqbal G Murtaza MK Waqas M Hanif Acta Pol Pharm 67 (2010)
517ndash522[19] B Singh V Sharma Carbohydr Polym 101 (2014) 928ndash940[20] DMW Anderson MME Bridgeman Phytochemistry 24 (1985) 2301ndash2304[21] A Moghbel AAHemmatiH Agheli I RashidiK Amraee Arch Iran Med8 (2005)
257ndash262[22] M Ranjbar-MohammadiSH BahramiMT Joghataei J Mater SciEng C 33 (2013)
4935ndash4943
[23] M Ranjbar-Mohammadi SH Bahrami J Mater Sci Eng C 48 (2015) 71ndash79[24] CL He ZM Huang XJ Han J Biomed Mater Res A 89 (2009) 80ndash95[25] S PappalardoOA Baglio C Cappello S Guarrera M De Benedittis M Petruzzi RF
Grassi Minerva Stomatol 55 (2006) 655ndash661[26] M Zamani M Morshed J Varshosaz M Jannesari Eur J Pharm Biopharm 75
(2010) 179ndash185[27] G Isik S Ince F Saglam U Onan J Clin Periodontol 24 (1997) 589ndash594[28] AN Sapadin R Fleischmajer J Am Acad Dermatol 54 (2006) 258ndash265[29] ZR Domingues ME Cortes TA Gomes HF Diniz CS Freitas JB Gomes AMC
Faria RD Sinisterra Biomaterials 25 (2004) 327ndash333[30] RA Seymour PA Heasman J Clin Periodontol 22 (1995) 22ndash35[31] L Chen J Wu L Yuwen T Shu M Xu M Zhang T Yi Langmuir 25 (2009)
8434ndash8438[32] S Kalachandra L Dongming S Offenbacher J Mater Sci Mater Med 13 (2002)
53ndash58[33] LMedvecky R StulajterovaJ BriancinChemPap 61 (2007) 477ndash484 (composites)[34] E Vatankhah MP Prabhakaran G Jin L GhasemiMobarakeh S Ramakrishna
J Biomater Appl 28 (2013) 909ndash921[35] MC Bottino V Thomas G Schmidt YK Vohra TMG Chua MJ Kowolik GM
Janowski Dent Mater 2 (2012) 703ndash721[36] M Zamani MP Prabhakaran S Ramakrishna Int J Nanomedicine 8 (2013)
2997ndash3017[37] WK Son JH Youk TS Lee WH Park Polymer 45 (2004) 2959ndash2966[38] Y Zhang H Ouyang CT Lim S Ramakrishna ZM Huang J Biomed Mater Res B
Appl Biomater 72B (2005) 156ndash165[39] DH LewisIn M Chasin RLanger (eds) NewYork MarcelDekker Inc (1990)1ndash43[40] WJ Loesche NS Grossman Clin Microbiol Rev 14 (2001) 727ndash752[41] S Fleischer A Shapira O Regev N Nseir E Zussman T Dvir Biotechnol Bioeng
111 (2014) 1246ndash1257[42] R Ravichandran R Sridhar JR Venugopal S Sundarrajan S Mukherjee S
Ramakrishna Macromol Biosci 14 (2014) 515ndash525[43] C van den Bogert G van Kernebeek L Leij AM Kroon Cancer Lett 32 (1986)
341ndash351
531M Ranjbar-Mohammadi et al Materials Science and Engineering C 58 (2016) 521 ndash531
8192019 1-s20-S0928493115303222-main (1)
httpslidepdfcomreaderfull1-s20-s0928493115303222-main-1 311
was done using a colorimetric 3-(45-dimethylthiazol-2-yl)-5-(3-
carboxymethoxyphenyl)-2(4-sulfophenyl)-2H tetrazolium (MTS) assay
(CellTiter 96 AQueous One solution Promega USA) In brief 1047297broblasts
were cultured in DMEM augmented with 10 FBS and 1 antibiotic
and antimycotic solutions in a 75 cm2 cell culture 1047298ask Cells were cul-
tured in a humidi1047297ed incubator at 37 degC with 5 CO2 and the mediawere replaced every two days The nano1047297brous scaffolds were sterilized
under UV radiation for 2 h washed 3 times with PBS and then sank in
DMEM overnight before cell seeding For cell seeding the cells were de-
tached by adding 025 of trypsin containing 01 EDTA centrifuged
counted using a hemocytometer and seeded on the scaffolds placed
in a 24-well plate and tissue culture polystyrene (TCP as control) at a
density of 5000 cells per well After 1 3 and 5 days 1047297broblast seeded
scaffolds were rinsed with PBS and 20 of MTS reagent in serum-free
medium was added After incubation for 3 h aliquots were pipetted
into a 96-well plate and absorbance of the obtained dye was measured
at 492 nm using a spectrophotometric plate reader (FLUO star Optima
BMG Lab Technologies and Germany) The intensity of the obtained
color is directly proportional to the metabolic activity of the cell
population
27 Antibacterial properties
Theantimicrobialbehaviorof PG(cs) PG 7525-TCH and PG(cs)-TCH
nano1047297bers was studied by agar plate method Staphylococcus aureus
ATCC 25923 and Pseudo aeruginosa ATCC 27853 were used as Gram-
positive and Gram-negative bacteria respectively MuellerndashHinton
agar media were sterilized in an autoclave at 121 degC for 20 min under
15 lbsin2 pressures A loop of each bacterium was inoculated on 5 mL
of nutrient broth and incubated at 37 degC for 24 h then cultured in nutri-
ent agar plate The disk shape samples of nano1047297brous mat were steril-
ized by ultraviolet light for 2 h and were placed in a plate Then the
plates were held in an incubator for 24 h Images from the samples
were used for assessing the antimicrobial behavior
28 Statistical analysis
Alldata presentedare expressedas mean plusmn standard deviation(SD)
Statistical analysis was carried out using one-way analysis of variance
(ANOVA) followed by Tukey post hoc test for multiple comparisons
and signi1047297cance was considered at p le 005
3 Results
31 Physical and chemical characterization of nano 1047297bers
The SEM micrographs of the electrospun nano1047297bers are shown in
Fig 2 The optimization of the electrospinning conditions with respect
to the concentration of the polymer applied voltage 1047298ow rate and
distance between the collector and the needle tip was performed thus
producing a continuous stretch of 1047297bers At the optimized condition
uniform bead-free 1047297bers of PLGA blend PG and PG(cs) nano1047297bers
were fabricated by blend and coaxial electrospinning Addition of the
natural polysaccharide (GT) to PLGA produced compositePG nano1047297bers
with diameters much lower than those of PLGA (Table 1) The 1047297ber di-ameter of pure PLGA PG 7525 and PG 5050 without TCH was obtained
as 460 plusmn 16 296 plusmn 25 and 187 plusmn 26 nm respectively which indicates
the reduction in 1047297ber diameter of the composite scaffolds using higher
amounts of gum tragacanth in PG nano1047297bers
At the same time TCH incorporation into PLGA nano1047297bers de-
creased the 1047297ber diameter while TCH loaded PG scaffolds did not ex-
hibit signi1047297cant changes in 1047297ber diameter compared with drug free
scaffolds Fig 2 also exhibited the formation of smooth continuous
and beadless PG(cs) and PG(cs)-TCH nano1047297bers with a diameter of
399 plusmn 31 and 180 plusmn 24 nm respectively Similar to pure PLGA nano-
1047297bers the diameter of TCH loaded core shell nano1047297bers was signi1047297-
cantly lower than that of drug free PG(cs) nano1047297bers Fig 3 shows
the TEM image of drug loaded PG(cs) nano1047297bers prepared by coaxial
electrospinning The TEM micrographof the coaxially electrospun1047297bers
Fig 1 Graphical representation of the preparation of nano1047297bers and studying release properties
523M Ranjbar-Mohammadi et al Materials Science and Engineering C 58 (2016) 521 ndash531
8192019 1-s20-S0928493115303222-main (1)
httpslidepdfcomreaderfull1-s20-s0928493115303222-main-1 411
clearly shows the lsquocorersquo compartment embedded within the shell of the
polymer
The results of pore size measurements are shown in Table 1 The
pore size of the nano1047297brous mats was signi1047297cantly decreased by addi-tion of both GT and drug compared to pure PLGA and similar PG
drug-free scaffolds respectively
The ATR-FTIR spectra of the electrospun PLGA nano1047297bers (Fig 4A)
showed peaks at 1757 cmminus1 1452 cmminus1 1186 cmminus1 and 1089 cmminus1
which correspond to the carbonyl group (CndashO bond) ether group
(CndashOndashC) and methyl group (CndashH) respectively In PG blend nano1047297bersthe peaks of GT have been partially overlapped by the peaks of PLGA
itself and hence the OH peaks appeared weaker for these scaffolds
For drug loaded PLGA nano1047297bers the carbonyl peak appeared broad-
ened because of the hydrogen bonding between the hydroxyl groups
of TCH and C=O groups of PLGA Within the spectra of PLGATCH
scaffolds the stretching frequencies at 1614 and 1579 cmminus1 corre-
spond to the carbonyl groups in A and C rings of TCH respectively
(Fig 4AB) These peaks were seen for the drug loaded PG nano1047297bers
prepared by blend electrospinning but were not obviously visible for
the corendashshell PG-TCH nano1047297bers A mild shift in carbonyl group
wavelength from 1760 to 1754 cmminus1 for drug loaded PG nano1047297bers
in comparison with PG nano1047297bers might have occurred due to the
weakening of some bonds due to hydrogen bonding between drug
and PLGA or GT
Fig 2 Morphology andsize distribution of electrospunnano1047297bersP as PLGA P-TCH as PLGA-TCH PG as PLGAGT PG-TCH as PLGAGT-TCH PG(cs)as coreshell PLGAGT andPG(cs)-TCH
as core shell PLGAGT-TCH)
Table 1
Diameter and pore size of electrospun nano1047297bers
Scaffold Fiber diameter (nm) Average thickness (μ m) Pore size (μ m)
PLGA 460 plusmn 16 6120 292 plusmn 002
PLGA-TCH 288 plusmn 33 6176 095 plusmn 003
PG 7525 296 plusmn 25 6190 180 plusmn 001
PG 7525-TCH 221 plusmn 42 6134 099 plusmn 004
PG 5050 187 plusmn 26 6095 10 plusmn 001
PG 5050 -TCH 180 plusmn 24 6086 063 plusmn 002
PG(cs) 399 plusmn 31 6156 135 plusmn 002
PG(cs)-TCH 197 plusmn 42 6102 12 plusmn 003
524 M Ranjbar-Mohammadi et al Materials Science and Engineering C 58 (2016) 521ndash531
8192019 1-s20-S0928493115303222-main (1)
httpslidepdfcomreaderfull1-s20-s0928493115303222-main-1 511
The surface property (interaction with water) of the electrospun
scaffolds was determined dynamically by water contact angle measure-
mentfor a periodof 30s Asshownin Fig 5 with increasing amounts of
GT within the PG composites the hydrophilicity of the nano1047297brous
membrane increased such that PG 7525 and 5050 scaffolds showed
a contact angle value of 85 plusmn 3deg and 76 plusmn 2deg respectively after 30 s
The water contact angle of drug loaded PG nano1047297bers was signi1047297cant-
ly lower than that of drug free PG scaffolds due to the hydrophilic
properties of TCH At the same time the PG(cs) nano1047297bers were more
hydrophilic than the PLGA nano1047297bers However the hydrophilicity of
PG(cs) was lesser compared to PG nano1047297bers due to the presence of
the hydrophilic GT within the core of the nano1047297bers
32 Mechanical properties of as-spun and hydrated scaffolds
The mechanical properties of electrospunnano1047297brousscaffolds with
or without drug including their tensile strength strain at break andelastic modulus were evaluated and are shown in Fig 6 and Table 2
In dry condition the average tensile strength of PLGA nano1047297bers was
obtained as 422 plusmn 002 MPa (Fig 6A) and it exhibited a strain at
break of 11874 plusmn 117 Comparing the stressndashstrain curves of the dif-
ferent scaffolds we found that addition of GT into PLGA nano1047297bers sig-
ni1047297cantly decreased the tensile strength of the nano1047297bers and reduced
the breaking strain (Fig 6B and C) Moreover the results of our studies
showed that PG nano1047297bers had a reduced elastic modulus compared
to pure PLGA nano1047297bers (Table 2) The average tensile strength and
elongation at break of PG(cs) were 332 plusmn 003 MPa and 10283 plusmn
301 respectively which was signi1047297cantly higher than blend nano1047297-
bers (Fig 6D and Table 2) For all formulations incorporation of TCH
into nano1047297bers reduced the tensile strength and elongation at break
while the elastic modulus was increased compared to the scaffolds
without drug
The results of the tensile properties of PBS-hydrated electrospun
scaffolds after 2 days are shown in Fig 7 and Table 2 All the nano1047297bers
without drug showed reduced tensile strength and strain after 2 days
of hydration compared to the dry state except PG 5050 (Fig 7C) with
no signi1047297cant changes Moreover none of the TCH loaded nano1047297bers
Fig 3 TEM micrograph of TCH loaded PG(cs) nano1047297bers
Fig 4 (A)ATR-FTIR spectraof nano1047297bers (P as PLGA P-TCH as PLGA-TCH PG as PLGAGT PG-TCH as PLGAGT-TCH PG(cs)as core shell PLGAGT PG(cs)-TCH as coreshellPLGAGT-TCH)
525M Ranjbar-Mohammadi et al Materials Science and Engineering C 58 (2016) 521 ndash531
8192019 1-s20-S0928493115303222-main (1)
httpslidepdfcomreaderfull1-s20-s0928493115303222-main-1 611
8192019 1-s20-S0928493115303222-main (1)
httpslidepdfcomreaderfull1-s20-s0928493115303222-main-1 711
value of elastic modulus (2200plusmn 167 MPa) in wet condition compared
to other formulations (Fig 7D and Table 2)
33 Degradation behavior of nano 1047297bers
Drug diffusion can be affected by scaffolds topology and morpholo-
gy Thusthe topological and morphological changes duringdegradation
might be able to control drug release rate from the nano1047297brous scaf-
folds Fig 8 presents the SEM images of the scaffolds after in vitro deg-
radation for a period of 40 days The 1047297brous structure of PLGA and
PG(cs) scaffolds with and without TCH was partially preserved after
40 days of degradation However blend PG scaffolds with and without
drug swelled to a large extent resulting in loss of nano1047297brous morphol-
ogy within similar time scale These results are in agreement with
higher wettability of PG nano1047297bers compared to PLGA and PG(cs)
nano1047297bers
34 Drug delivery
In this paper we determined the released amounts of TCH by mea-
suringthe absorbance at 362nm using an ultraviolet visible spectropho-
tometer Thereleaseof TCHfrom variouselectrospun scaffoldsis plotted
in Fig 9A amp B PLGA nano1047297bers exhibited an initial burst release of
2320 within the 1047297rst 2 h (Fig 9B) and reached a plateau within
7 days by releasing only 35 of TCH content The burst release of TCH
from PG 7525 nano1047297bers was very similar to pure PLGA (2479)
while PG 5050 had a signi1047297cantly higher amount of TCH (4830) re-
leased in the 1047297rst 2 h followedby a veryfast release of90of drugcon-
tent within 5 days However PG 7525 composite nano1047297bers showed
a sustained TCH release up to a period of 25 days the time point that
it reached to the plateau state For the core shell nano1047297bers where
TCH was incorporated in the core along with GT the burst release was
signi1047297cantly lower (19) compared to both pure PLGA and PG blend
Table 2
Tensile properties of the electrospun nano1047297bers under dry and wet conditions
Samples Dry scaffolds Wet scaffolds
T (μ m) EM (MPa) UTS (MPa) SB () T (μ m) EM (MPa) UTS (MPa) SB ()
PLGA 5680 7600 plusmn 360 422 + 002 11874 plusmn 117 5001 6900 plusmn 180 255 plusmn 003 6409 plusmn 112
PLGA-TCH 5802 8433 plusmn 781 258 plusmn 003 1592 plusmn 212 5277 6236 plusmn 283 171 plusmn 009 1158 plusmn 178
PG 7525 5499 4334 plusmn 223 230 plusmn 002 2240 plusmn 212 5686 4273 plusmn 136 170 plusmn 008 1517 plusmn 113
PG 7525-TCH 5307 6410 plusmn 334 101 plusmn 005 1350 plusmn 691 5430 5211 plusmn 219 102 plusmn 009 1133 plusmn 501
PG 5050 5503 3295 plusmn 100 093 plusmn 003 1392 plusmn 406 5333 3290 plusmn 110 089 plusmn 008 1422 plusmn 113
PG 5050-TCH 5409 3962 plusmn 131 072 plusmn 006 883 plusmn 702 5602 3381 plusmn 187 040 plusmn 010 775 plusmn 398
PG(cs) 5204 4020 plusmn 171 332 plusmn 003 10283 plusmn 301 4903 10532 plusmn 121 215 plusmn 002 3667 plusmn 113
PG(cs)-TCH 5375 4832 plusmn 413 151 plusmn 007 1424 plusmn 451 4889 2200 plusmn 167 157 plusmn 003 3341 plusmn 315
T average thickness of nano1047297bers EM elastic modulus UTS ultimate tensile strength SB strain at break
Fig 7 Mechanical properties of PBS hydrated (A) PLGA PLGA-TCH (B) PG 7525 PG 7525-TCH (C) PG 5050 PG 5050-TCH (D) PG(cs) and PG(cs)-TCH electrospun membranes after
48 h (P as PLGA P-TCH as PLGA-TCH PG 7525 as PLGAGT7525PG 7525-TCHas PLGAGT7525-TCHPG 5050 as PLGAGT5050 PG 5050-TCHas PLGAGT5050-TCHPG(cs)as core
shell PLGAGT PG(cs)-TCH as core shell PLGAGT-TCH)
527M Ranjbar-Mohammadi et al Materials Science and Engineering C 58 (2016) 521 ndash531
8192019 1-s20-S0928493115303222-main (1)
httpslidepdfcomreaderfull1-s20-s0928493115303222-main-1 811
nano1047297bers Following burst releasePG(cs) scaffolds showed a prolonged
sustained release over the entire study period (75 days) by releasing
6810 of the total TCH content by this time
35 Proliferation of 1047297broblasts on electrospun scaffolds
The cytocompatibility of the electrospun scaffolds was evaluated by
MTS assay after culturing 1047297broblasts on the nano1047297bers over a period of
13 and 5 daysandtheresultsareshownin Fig 10 Cell proliferation on
all the scaffolds (with or without drug) was found to increase with cul-
ture time similar to thetrend observed on tissueculture plates (TCP) At
days 1 and 3 of cell culture GT contained nano1047297bers (both blended and
corendashshell) without drug exhibited improved cell viability compared
to PLGA membranes The same trend was observed for TCH incorpo-
rated nano1047297bers though the presence of TCH slightly decreased cell
growth for some of the formulations compared to drug free nano1047297bers
However after 5 days TCH-loaded PG and PG(cs) nano1047297brous mats did
not exhibit signi1047297cant increase in cell viability compared to PLGA-TCH
Fig 8 SEMimagesof degraded nano1047297bersafter40 days(P as PLGA P-TCH as PLGA-TCHPG 7525 asPLGAGT 7525PG 7525-TCH as PLGAGT7525-TCH PG 5050as PLGAGT5050 PG
5050-TCH as PLGAGT 5050-TCH PG(cs) as core shell PLGAGT PG(cs)-TCH as core shell PLGAGT-TCH)
Fig 9 Release pro1047297le of TCH from PLGA-TCH PG 7525-TCH PG 5050-TCH PG(cs)-TCH electrospun scaffolds A) Entire release time B) initial burst release
528 M Ranjbar-Mohammadi et al Materials Science and Engineering C 58 (2016) 521ndash531
8192019 1-s20-S0928493115303222-main (1)
httpslidepdfcomreaderfull1-s20-s0928493115303222-main-1 911
nano1047297bers Moreover none of the electrospun scaffolds showed signif-
icant changes in cell viability after 5 days compared to TCP This is an in-
dication of cytocompatibility of the scaffolds essential for applications
such as treatment of periodontal diseases
36 Antibacterial properties
In this work the antibacterial activity of TCH-loaded PG(cs) PG
7525-TCH and PG(cs)-TCH nano1047297bers was investigated using S aureus
and Pseudomonas aeruginosa as model bacteriaThe drug loadedsamples
showed clear bacterial inhibition rings against Gram-positive bacteria
(S aureus) which is known to be a TCH-sensitive Gram-positive spheri-
cal bacterium that causes a wide range of suppurative infections The
bacterial inhibition ring was smaller on the nano1047297bers containing
Gram-negative bacteria (P aeruginosa) (Fig 11) These observations
may be related to structural differences between two different bacteria
Gram-negative bacteria are more resistant due to the thick lipopolysac-
charide wall structure
4 Discussion
Periodontitis is a major chronic in1047298ammatory disorder that can lead
to the loss of periodontal support for the periodontal ligament which
leads to the formation of an abnormal gap between the tooth and gum
[25] If the process continues the tooth can eventually get lost For
chronic periodontitis local antimicrobial agents are used as an adjunct
to scaling root planning and restoring the periodontalhealth [25] Mul-
tiple investigations have been conducted to incorporate antibiotics into
the polymeric carriers in order to develop a DDS for treatment of peri-
odontal diseases Polymeric DDS were designed in different structures
Fig 10 Proliferation of 1047297broblasts on electrospun nano1047297bers measured by MTS assay (P as PLGA P-TCH as PLGA-TCH PG 7525 as PLGAGT7525PG 7525-TCHas PLGAGT7525-TCH
PG 5050 as PLGAGT 5050 PG 5050-TCH as PLGAGT 5050-TCH PG(cs) as core shell PLGAGT PG(cs)-TCH as core shell PLGAGT-TCH)
Fig 11 Antibacterial properties of nano1047297bers A) PG(cs) B) PG 7525-TCH and C) PG(cs)-TCH
529M Ranjbar-Mohammadi et al Materials Science and Engineering C 58 (2016) 521 ndash531
8192019 1-s20-S0928493115303222-main (1)
httpslidepdfcomreaderfull1-s20-s0928493115303222-main-1 1011
such as1047297lms microparticles and1047297bers using bothsynthetic and natural
polymers [26]
TCHis oneof the widely employed antibiotics with proven effective-
nessin acceleration of periodontal treatment [27] TCHwith low toxicity
is a broadspectrum antibiotic which can be applied for thetreatment of
diseases caused by Gram-negative and Gram-positive microorganisms
by inhibiting protein synthesis in the bacteria [28] Besides its antibiotic
property it exhibits anti-in1047298ammatory properties and has the ability
to promote the attachment of 1047297
broblasts TCH has also been reportedas an inhibitor of the activity of proteinases and hence it can be used
to treat or prevent diseases related to proteinase imbalancerheumatoid
arthritis periodontitis and osteomyelitis [29] Previous studies showed
that the long term routine use of TCH for several months resulted
in clinically favorable effects for periodontal disease [30] Controlled
release of TCH was attempted by various researchers using various
drug delivery systems such as supramolecular gels based on amphi-
philic 345-trihydroxybenzoic derivatives[31] device based on ethylene
vinyl acetate (EVA) copolymer [32] and porous calcium phosphate
polyhydroxy butyrate composites [33] for various applications
Recent advances in the1047297eld of nanotechnology enable the fabrication
of nano1047297brous constructs containing drugs such that they have the ar-
chitectural features and morphological similarities matching the native
extracellular matrix (ECM) [3435] Unique properties of nano1047297bers
such as the high surface area high loading ease of operation and cost
effectiveness make them more suitable as drug delivery vehicles How-
ever drug release characteristics (eg burst release release rate and
duration) are signi1047297cantly in1047298uenced by extent of drug encapsulation
into thenano1047297brous scaffolds whichis greatly dependent to material se-
lection as well as the drug incorporation method [3626] In general
drugs can be incorporated into nano1047297bers via various methods such as
coatings blending co-axial and emulsion electrospinning [26] Recent
developments in this direction progressed with the application of nano-
1047297bers as drug delivery systems for periodontal diseases For example
Zamani et al [26] fabricated PCL nano1047297bers containing metronidazole
benzoate where the drug release was continued for a period of 15 days
In this study we explored the incorporation of TCH into a new
bicomponent carrier PLGA-gum tragacanth (GT) via two different
technics of blend electrospinning and coaxial electrospinning GT themedicinally imported polysaccharide consists of two major fractions a
water-soluble (tragacanthic acid and small amount of arabinogalactan)
and an insolublebut water-swellable fraction named bassorinGT exhib-
ited a considerable potency for wound healing in the form of mucilage
[21] or skin regeneration capability in the form of blend nano1047297bers
with PCL or PVA [2223] Due to the mentioned structural and composi-
tional advantages natural availability antibacterial properties and low
cost we believe that TCH loaded PG and PG(cs) 1047297bers can be employed
as a proper drug delivery system for multiple applications including
treatment of periodontal diseases We aimed to explore the effect of in-
corporation method (blending vs coaxial electrospinning) on the phys-
ical characteristics of the nano1047297bers and TCH release behavior from
PG and PG(cs) nano1047297bers Moreover the biocompatibility of the drug
loaded membranes was investigatedThe SEM images (Fig 2) showed that uniformly distributed nano1047297-
bers without beads were formed from all formulations Blending GT
with PLGA decreased the diameter of nano1047297bers Incorporation of TCH
into PLGA and PG(cs) nano1047297bers also reduced the 1047297ber diameter
while addition of the drug into the blend PG nano1047297bers did not cause
further reduction in diameter of the nano1047297bers (Table 1) The possible
reason for the reduction of the diameter of the nano1047297bers is that both
GT and TCH may improve the polarity of the solution which subse-
quently increases the electrical conductivity of the solution Moreover
PG(cs) nano1047297bers exhibited reduced diameter which can be attributed
to theuse of water as the core solvent High dielectric constant of water
(801 at 25 degC) is an indication of the ability of solution to carry more
electrical charges resulting in higher elongation forces and formation
of thinner nano1047297bers under the electrical 1047297eld [37]
The results of mechanical studies showed that PG membranes ex-
hibited less tensile strength compared to PLGA (Figs 6 and 7) This
canbe relatedto theeasier slippage of polymer chainsunder loadingbe-
cause of less entanglements and weak physical interactions among the
chains of mixed polymers [38] Another reason for lower strength of
PG 1047297bers can be the low mechanical strength of GT itself Moreover
TCH could also decrease the tensile strength as well as breaking strain
of all formulations due to probable plasticizing effect of TCH molecules
for polymer chains However the breaking strain of pure PLGA was de-creased more than seven timeswhile blend PG nano1047297bers had less than
50 reduction in strain at the presence of TCH compared to the similar
membranes without drug This can be attributed to the highly branched
structure of GT which intrinsically limited the elongation of its polymer
chains under the loading resulting in alleviation of the in1047298uence of TCH
on reduction of strain at break Mechanical behavior of the nano1047297bers
under wet condition is another factor of consideration since the mem-
branes inserted into the periodontal pocket are exposed to moist condi-
tion Results of mechanical studies under wet conditions showed that
except PG 5050 nano1047297bers other TCH loaded membranes preserved
their tensile strength in wet condition Interestingly the effect of TCH
on breaking strain of PG(cs) was dependent to drywet state of the
membrane In dry state addition of TCH caused a drastic decline in
breaking strain similar to pure PLGA since smaller amount of GT existed
in PG(cs) nano1047297bers compared to blend PG nano1047297bers However there-
duction in breaking strain of PG(cs) was limited to the extent compara-
ble to blend PG nano1047297bers in wetcondition This canbe attributed to the
more pronounced role of GT in hydrated state due to swelling effect of
this natural polymer resultingin distributionand occupationof a higher
volumeof the nano1047297bers by this polymer Forthe membraneswhichare
supposed to be inserted into theperiodontalpocket it is necessaryto in-
sure that the membrane possesses enough mechanical strength and ri-
gidity to be inserted into the pocket and retain its integrity during the
release time On the other hand the membrane should remain 1047298exible
and soft enough in the wet environment to conform to the periodontal
pocket and meet patient compliance [26] Elastic modulus is a good in-
dicator of the stiffness of a material Among various TCH incorporated
composite nano1047297bers PG(cs) exhibited the highest tensile strength
in both dry and wet conditions while its wet modulus was signi1047297-cantly lower than blend nano1047297bers That means TCH loaded PG(cs)
membranes may provide a proper texture to be easily inserted into
periodontal pocket with a certain amount of back pressure and remain
comfortably in the pocket with the lowest rigiditystiffness among the
composite nano1047297bers
The release kinetics of TCH from electrospun PLGA PG 7525
PG 5050 and PG(cs) scaffolds was studied for a period of 75 days
(Fig 9) For all the formulations initial burst release was attributed to
the release of surface connected drug [39] followed by a controlled re-
lease attributed to molecular diffusion through the polymer phase In
case of blended PG nano1047297bers the presence of hydrophilic PG segments
which are randomly distributed across the diffusion path can signi1047297-
cantly facilitate water uptake and swelling of the polymeric matrix
Therefore faster diffusion of the drug molecules out of the nano1047297bersoccurred resulting in higher release rate within the 1047297rst few days and
reaching a plateau after a certain period of time As expected the
explained effect of GT on release rate was enhanced by increasing the
fraction of this polymer in the blend such that the entire amount of
TCH was released from PG 5050 in 20 days These observations are in
agreement with wettability results which con1047297rmed the promoted
wettability of the scaffolds at higher ratios of GT in the nano 1047297bers
(Fig 5) However when GT was employed as the core along with TCH
the likelihood of having drug molecules as well as GT hydrophilic
segments onnear the surface of nano1047297bers is reduced In this case the
hydrophobic PLGA shell could control the water uptake and swelling
of the hydrophilic core material resulting in lowered burst release as
well as prolonged release of TCH in a sustained fashion for 75 days
The prolonged TCH release from PG(cs) nano1047297bers validates the use of
530 M Ranjbar-Mohammadi et al Materials Science and Engineering C 58 (2016) 521ndash531
8192019 1-s20-S0928493115303222-main (1)
httpslidepdfcomreaderfull1-s20-s0928493115303222-main-1 1111
core shell structure for periodontal treatment since the elimination of
hardened bacteria in periodontal pocket requires sustained exposure
to antibiotics [40]
The cytocompatibility studies showed that GT could successfully
support cell growth on nano1047297brous membranes in both blending and
corendashshell architecture This might be attributed to the more hydro-
philic properties of GT contained membranes which improves protein
adsorption and subsequent cell attachment and proliferation [4142]
On the other hand incorporation of TCH showed to decrease cellgrowth in some of the formulations due to the inhibitory effect of this
drug on mitochondrial protein synthesis [43] However none of the
GT contained scaffolds showed signi1047297cant changes in cell viability com-
pared to the control which demonstrates good cytocompatibility of
the composite membranes Antibacterial assessment of drug loaded
PG and PG(cs) nano1047297bers showed that these scaffolds are strong
enough against of S aureus bacteria
5 Conclusion
In the present study TCH-loaded blend and core shell nano1047297bers
with smooth and bead-less morphology were successfully fabricated
from PLGA and GT for application as new and controlled drug delivery
systems The release rate of TCH in PG blend nano1047297bers increased
with the increase of GT ratio due to enhanced hydrophilicity of the
electrospun nano1047297bers Compared to PG blend nano1047297bers PG(cs) mem-
branes showed a more prolonged release of TCH for 75 days with lower
burst release of the drug within the 1047297rst 2 h Among various formula-
tions PG(cs) nano1047297bers exhibited the highest tensile strength in both
dry and wet conditions while its wet modulus was signi1047297cantly lower
than blend nano1047297bers Thus the TCH loaded PG(cs) membranes might
be strong enough to be easily inserted into periodontal pocket and sus-
tainably release the incorporated drug while affording patient compli-
ance with low rigiditystiffness of the membrane during the treatment
Thesecharacteristics along with the proven cytocompatibility and anti-
bacterial properties of TCH loaded scaffolds suggest the particular ben-
e1047297ts of composite corendashshell nano1047297bers to be used as a drug delivery
system for periodontal diseases
Acknowledgments
This study was supported by the NRF-Technion grant (WBS No
R-398-001-065-592) and the Nanoscience and Nanotechnology Initia-
tive in the National University of Singapore
References
[1] B Felice MP Prabhakaran AP Rodriacuteguez S Ramakrishna J Mater Sci Eng C 4(2014) 178ndash195
[2] P Boisseau B Loubaton C R Phys 12 (2011) 620ndash636
[3] T Allen P Cullis Science 303 (2004) 1818ndash1822[4] Y Malam M Loizidou AM Seifalian Trends Pharmacol Sci 30 (2009) 592ndash599[5] J Zhang R Misra Acta Biomater 3 (2007) 838ndash850[6] B Wang Y Wang T Yin Q Yu Chem Eng Commun 197 (2010) 1315ndash1338[7] ZX Meng XX Xu WZheng HM Zhou LLi YF ZhengX LouJ Colloids SurfB 84
(2011) 97ndash102[8] G Jin MP P rabhakaran D Kai S Ramakrishna Eur J Pharm Biopharm 85 (2013)
689ndash698[9] W QianDGYu YLi YZ LiaoX WangL WangInt JMolSci15 (2014) 774ndash786
[10] H Qi P Hu J Xu A Wang Biomacromolecules 7 (2006) 2327ndash2330[11] TP Chaturvedi R Srivastava AK Srivastava V Gupta VP Kumar Int J Pharm
Investig 2 (2012) 213ndash
217[12] K Kim YK Luu C Chang D Fang BS Hsiao B Chu M Hadjiargyrou J ControlRelease 98 (2004) 47ndash56
[13] R Kenawy GL Bowlin K Mans1047297eld J Layman DG Simpson EH Sanders GEWnek J Control Release 81 (2002) 57ndash64
[14] J Zeng L Yang Q Liang X Zhang H Guan X Xu X Chen X Jing J ControlRelease105 (2005) 43ndash51
[15] X Xu L Yang X Xu X Wang X Chen Q Liang J Zeng X Jing J Control Release108 (2005) 33ndash42
[16] HK Makadia S Siegel Polymers (Basel) 3 (2011) 1377ndash1397[17] MU Adikwu Bentham Science Publishers (2009)[18] A Rasul M Iqbal G Murtaza MK Waqas M Hanif Acta Pol Pharm 67 (2010)
517ndash522[19] B Singh V Sharma Carbohydr Polym 101 (2014) 928ndash940[20] DMW Anderson MME Bridgeman Phytochemistry 24 (1985) 2301ndash2304[21] A Moghbel AAHemmatiH Agheli I RashidiK Amraee Arch Iran Med8 (2005)
257ndash262[22] M Ranjbar-MohammadiSH BahramiMT Joghataei J Mater SciEng C 33 (2013)
4935ndash4943
[23] M Ranjbar-Mohammadi SH Bahrami J Mater Sci Eng C 48 (2015) 71ndash79[24] CL He ZM Huang XJ Han J Biomed Mater Res A 89 (2009) 80ndash95[25] S PappalardoOA Baglio C Cappello S Guarrera M De Benedittis M Petruzzi RF
Grassi Minerva Stomatol 55 (2006) 655ndash661[26] M Zamani M Morshed J Varshosaz M Jannesari Eur J Pharm Biopharm 75
(2010) 179ndash185[27] G Isik S Ince F Saglam U Onan J Clin Periodontol 24 (1997) 589ndash594[28] AN Sapadin R Fleischmajer J Am Acad Dermatol 54 (2006) 258ndash265[29] ZR Domingues ME Cortes TA Gomes HF Diniz CS Freitas JB Gomes AMC
Faria RD Sinisterra Biomaterials 25 (2004) 327ndash333[30] RA Seymour PA Heasman J Clin Periodontol 22 (1995) 22ndash35[31] L Chen J Wu L Yuwen T Shu M Xu M Zhang T Yi Langmuir 25 (2009)
8434ndash8438[32] S Kalachandra L Dongming S Offenbacher J Mater Sci Mater Med 13 (2002)
53ndash58[33] LMedvecky R StulajterovaJ BriancinChemPap 61 (2007) 477ndash484 (composites)[34] E Vatankhah MP Prabhakaran G Jin L GhasemiMobarakeh S Ramakrishna
J Biomater Appl 28 (2013) 909ndash921[35] MC Bottino V Thomas G Schmidt YK Vohra TMG Chua MJ Kowolik GM
Janowski Dent Mater 2 (2012) 703ndash721[36] M Zamani MP Prabhakaran S Ramakrishna Int J Nanomedicine 8 (2013)
2997ndash3017[37] WK Son JH Youk TS Lee WH Park Polymer 45 (2004) 2959ndash2966[38] Y Zhang H Ouyang CT Lim S Ramakrishna ZM Huang J Biomed Mater Res B
Appl Biomater 72B (2005) 156ndash165[39] DH LewisIn M Chasin RLanger (eds) NewYork MarcelDekker Inc (1990)1ndash43[40] WJ Loesche NS Grossman Clin Microbiol Rev 14 (2001) 727ndash752[41] S Fleischer A Shapira O Regev N Nseir E Zussman T Dvir Biotechnol Bioeng
111 (2014) 1246ndash1257[42] R Ravichandran R Sridhar JR Venugopal S Sundarrajan S Mukherjee S
Ramakrishna Macromol Biosci 14 (2014) 515ndash525[43] C van den Bogert G van Kernebeek L Leij AM Kroon Cancer Lett 32 (1986)
341ndash351
531M Ranjbar-Mohammadi et al Materials Science and Engineering C 58 (2016) 521 ndash531
8192019 1-s20-S0928493115303222-main (1)
httpslidepdfcomreaderfull1-s20-s0928493115303222-main-1 411
clearly shows the lsquocorersquo compartment embedded within the shell of the
polymer
The results of pore size measurements are shown in Table 1 The
pore size of the nano1047297brous mats was signi1047297cantly decreased by addi-tion of both GT and drug compared to pure PLGA and similar PG
drug-free scaffolds respectively
The ATR-FTIR spectra of the electrospun PLGA nano1047297bers (Fig 4A)
showed peaks at 1757 cmminus1 1452 cmminus1 1186 cmminus1 and 1089 cmminus1
which correspond to the carbonyl group (CndashO bond) ether group
(CndashOndashC) and methyl group (CndashH) respectively In PG blend nano1047297bersthe peaks of GT have been partially overlapped by the peaks of PLGA
itself and hence the OH peaks appeared weaker for these scaffolds
For drug loaded PLGA nano1047297bers the carbonyl peak appeared broad-
ened because of the hydrogen bonding between the hydroxyl groups
of TCH and C=O groups of PLGA Within the spectra of PLGATCH
scaffolds the stretching frequencies at 1614 and 1579 cmminus1 corre-
spond to the carbonyl groups in A and C rings of TCH respectively
(Fig 4AB) These peaks were seen for the drug loaded PG nano1047297bers
prepared by blend electrospinning but were not obviously visible for
the corendashshell PG-TCH nano1047297bers A mild shift in carbonyl group
wavelength from 1760 to 1754 cmminus1 for drug loaded PG nano1047297bers
in comparison with PG nano1047297bers might have occurred due to the
weakening of some bonds due to hydrogen bonding between drug
and PLGA or GT
Fig 2 Morphology andsize distribution of electrospunnano1047297bersP as PLGA P-TCH as PLGA-TCH PG as PLGAGT PG-TCH as PLGAGT-TCH PG(cs)as coreshell PLGAGT andPG(cs)-TCH
as core shell PLGAGT-TCH)
Table 1
Diameter and pore size of electrospun nano1047297bers
Scaffold Fiber diameter (nm) Average thickness (μ m) Pore size (μ m)
PLGA 460 plusmn 16 6120 292 plusmn 002
PLGA-TCH 288 plusmn 33 6176 095 plusmn 003
PG 7525 296 plusmn 25 6190 180 plusmn 001
PG 7525-TCH 221 plusmn 42 6134 099 plusmn 004
PG 5050 187 plusmn 26 6095 10 plusmn 001
PG 5050 -TCH 180 plusmn 24 6086 063 plusmn 002
PG(cs) 399 plusmn 31 6156 135 plusmn 002
PG(cs)-TCH 197 plusmn 42 6102 12 plusmn 003
524 M Ranjbar-Mohammadi et al Materials Science and Engineering C 58 (2016) 521ndash531
8192019 1-s20-S0928493115303222-main (1)
httpslidepdfcomreaderfull1-s20-s0928493115303222-main-1 511
The surface property (interaction with water) of the electrospun
scaffolds was determined dynamically by water contact angle measure-
mentfor a periodof 30s Asshownin Fig 5 with increasing amounts of
GT within the PG composites the hydrophilicity of the nano1047297brous
membrane increased such that PG 7525 and 5050 scaffolds showed
a contact angle value of 85 plusmn 3deg and 76 plusmn 2deg respectively after 30 s
The water contact angle of drug loaded PG nano1047297bers was signi1047297cant-
ly lower than that of drug free PG scaffolds due to the hydrophilic
properties of TCH At the same time the PG(cs) nano1047297bers were more
hydrophilic than the PLGA nano1047297bers However the hydrophilicity of
PG(cs) was lesser compared to PG nano1047297bers due to the presence of
the hydrophilic GT within the core of the nano1047297bers
32 Mechanical properties of as-spun and hydrated scaffolds
The mechanical properties of electrospunnano1047297brousscaffolds with
or without drug including their tensile strength strain at break andelastic modulus were evaluated and are shown in Fig 6 and Table 2
In dry condition the average tensile strength of PLGA nano1047297bers was
obtained as 422 plusmn 002 MPa (Fig 6A) and it exhibited a strain at
break of 11874 plusmn 117 Comparing the stressndashstrain curves of the dif-
ferent scaffolds we found that addition of GT into PLGA nano1047297bers sig-
ni1047297cantly decreased the tensile strength of the nano1047297bers and reduced
the breaking strain (Fig 6B and C) Moreover the results of our studies
showed that PG nano1047297bers had a reduced elastic modulus compared
to pure PLGA nano1047297bers (Table 2) The average tensile strength and
elongation at break of PG(cs) were 332 plusmn 003 MPa and 10283 plusmn
301 respectively which was signi1047297cantly higher than blend nano1047297-
bers (Fig 6D and Table 2) For all formulations incorporation of TCH
into nano1047297bers reduced the tensile strength and elongation at break
while the elastic modulus was increased compared to the scaffolds
without drug
The results of the tensile properties of PBS-hydrated electrospun
scaffolds after 2 days are shown in Fig 7 and Table 2 All the nano1047297bers
without drug showed reduced tensile strength and strain after 2 days
of hydration compared to the dry state except PG 5050 (Fig 7C) with
no signi1047297cant changes Moreover none of the TCH loaded nano1047297bers
Fig 3 TEM micrograph of TCH loaded PG(cs) nano1047297bers
Fig 4 (A)ATR-FTIR spectraof nano1047297bers (P as PLGA P-TCH as PLGA-TCH PG as PLGAGT PG-TCH as PLGAGT-TCH PG(cs)as core shell PLGAGT PG(cs)-TCH as coreshellPLGAGT-TCH)
525M Ranjbar-Mohammadi et al Materials Science and Engineering C 58 (2016) 521 ndash531
8192019 1-s20-S0928493115303222-main (1)
httpslidepdfcomreaderfull1-s20-s0928493115303222-main-1 611
8192019 1-s20-S0928493115303222-main (1)
httpslidepdfcomreaderfull1-s20-s0928493115303222-main-1 711
value of elastic modulus (2200plusmn 167 MPa) in wet condition compared
to other formulations (Fig 7D and Table 2)
33 Degradation behavior of nano 1047297bers
Drug diffusion can be affected by scaffolds topology and morpholo-
gy Thusthe topological and morphological changes duringdegradation
might be able to control drug release rate from the nano1047297brous scaf-
folds Fig 8 presents the SEM images of the scaffolds after in vitro deg-
radation for a period of 40 days The 1047297brous structure of PLGA and
PG(cs) scaffolds with and without TCH was partially preserved after
40 days of degradation However blend PG scaffolds with and without
drug swelled to a large extent resulting in loss of nano1047297brous morphol-
ogy within similar time scale These results are in agreement with
higher wettability of PG nano1047297bers compared to PLGA and PG(cs)
nano1047297bers
34 Drug delivery
In this paper we determined the released amounts of TCH by mea-
suringthe absorbance at 362nm using an ultraviolet visible spectropho-
tometer Thereleaseof TCHfrom variouselectrospun scaffoldsis plotted
in Fig 9A amp B PLGA nano1047297bers exhibited an initial burst release of
2320 within the 1047297rst 2 h (Fig 9B) and reached a plateau within
7 days by releasing only 35 of TCH content The burst release of TCH
from PG 7525 nano1047297bers was very similar to pure PLGA (2479)
while PG 5050 had a signi1047297cantly higher amount of TCH (4830) re-
leased in the 1047297rst 2 h followedby a veryfast release of90of drugcon-
tent within 5 days However PG 7525 composite nano1047297bers showed
a sustained TCH release up to a period of 25 days the time point that
it reached to the plateau state For the core shell nano1047297bers where
TCH was incorporated in the core along with GT the burst release was
signi1047297cantly lower (19) compared to both pure PLGA and PG blend
Table 2
Tensile properties of the electrospun nano1047297bers under dry and wet conditions
Samples Dry scaffolds Wet scaffolds
T (μ m) EM (MPa) UTS (MPa) SB () T (μ m) EM (MPa) UTS (MPa) SB ()
PLGA 5680 7600 plusmn 360 422 + 002 11874 plusmn 117 5001 6900 plusmn 180 255 plusmn 003 6409 plusmn 112
PLGA-TCH 5802 8433 plusmn 781 258 plusmn 003 1592 plusmn 212 5277 6236 plusmn 283 171 plusmn 009 1158 plusmn 178
PG 7525 5499 4334 plusmn 223 230 plusmn 002 2240 plusmn 212 5686 4273 plusmn 136 170 plusmn 008 1517 plusmn 113
PG 7525-TCH 5307 6410 plusmn 334 101 plusmn 005 1350 plusmn 691 5430 5211 plusmn 219 102 plusmn 009 1133 plusmn 501
PG 5050 5503 3295 plusmn 100 093 plusmn 003 1392 plusmn 406 5333 3290 plusmn 110 089 plusmn 008 1422 plusmn 113
PG 5050-TCH 5409 3962 plusmn 131 072 plusmn 006 883 plusmn 702 5602 3381 plusmn 187 040 plusmn 010 775 plusmn 398
PG(cs) 5204 4020 plusmn 171 332 plusmn 003 10283 plusmn 301 4903 10532 plusmn 121 215 plusmn 002 3667 plusmn 113
PG(cs)-TCH 5375 4832 plusmn 413 151 plusmn 007 1424 plusmn 451 4889 2200 plusmn 167 157 plusmn 003 3341 plusmn 315
T average thickness of nano1047297bers EM elastic modulus UTS ultimate tensile strength SB strain at break
Fig 7 Mechanical properties of PBS hydrated (A) PLGA PLGA-TCH (B) PG 7525 PG 7525-TCH (C) PG 5050 PG 5050-TCH (D) PG(cs) and PG(cs)-TCH electrospun membranes after
48 h (P as PLGA P-TCH as PLGA-TCH PG 7525 as PLGAGT7525PG 7525-TCHas PLGAGT7525-TCHPG 5050 as PLGAGT5050 PG 5050-TCHas PLGAGT5050-TCHPG(cs)as core
shell PLGAGT PG(cs)-TCH as core shell PLGAGT-TCH)
527M Ranjbar-Mohammadi et al Materials Science and Engineering C 58 (2016) 521 ndash531
8192019 1-s20-S0928493115303222-main (1)
httpslidepdfcomreaderfull1-s20-s0928493115303222-main-1 811
nano1047297bers Following burst releasePG(cs) scaffolds showed a prolonged
sustained release over the entire study period (75 days) by releasing
6810 of the total TCH content by this time
35 Proliferation of 1047297broblasts on electrospun scaffolds
The cytocompatibility of the electrospun scaffolds was evaluated by
MTS assay after culturing 1047297broblasts on the nano1047297bers over a period of
13 and 5 daysandtheresultsareshownin Fig 10 Cell proliferation on
all the scaffolds (with or without drug) was found to increase with cul-
ture time similar to thetrend observed on tissueculture plates (TCP) At
days 1 and 3 of cell culture GT contained nano1047297bers (both blended and
corendashshell) without drug exhibited improved cell viability compared
to PLGA membranes The same trend was observed for TCH incorpo-
rated nano1047297bers though the presence of TCH slightly decreased cell
growth for some of the formulations compared to drug free nano1047297bers
However after 5 days TCH-loaded PG and PG(cs) nano1047297brous mats did
not exhibit signi1047297cant increase in cell viability compared to PLGA-TCH
Fig 8 SEMimagesof degraded nano1047297bersafter40 days(P as PLGA P-TCH as PLGA-TCHPG 7525 asPLGAGT 7525PG 7525-TCH as PLGAGT7525-TCH PG 5050as PLGAGT5050 PG
5050-TCH as PLGAGT 5050-TCH PG(cs) as core shell PLGAGT PG(cs)-TCH as core shell PLGAGT-TCH)
Fig 9 Release pro1047297le of TCH from PLGA-TCH PG 7525-TCH PG 5050-TCH PG(cs)-TCH electrospun scaffolds A) Entire release time B) initial burst release
528 M Ranjbar-Mohammadi et al Materials Science and Engineering C 58 (2016) 521ndash531
8192019 1-s20-S0928493115303222-main (1)
httpslidepdfcomreaderfull1-s20-s0928493115303222-main-1 911
nano1047297bers Moreover none of the electrospun scaffolds showed signif-
icant changes in cell viability after 5 days compared to TCP This is an in-
dication of cytocompatibility of the scaffolds essential for applications
such as treatment of periodontal diseases
36 Antibacterial properties
In this work the antibacterial activity of TCH-loaded PG(cs) PG
7525-TCH and PG(cs)-TCH nano1047297bers was investigated using S aureus
and Pseudomonas aeruginosa as model bacteriaThe drug loadedsamples
showed clear bacterial inhibition rings against Gram-positive bacteria
(S aureus) which is known to be a TCH-sensitive Gram-positive spheri-
cal bacterium that causes a wide range of suppurative infections The
bacterial inhibition ring was smaller on the nano1047297bers containing
Gram-negative bacteria (P aeruginosa) (Fig 11) These observations
may be related to structural differences between two different bacteria
Gram-negative bacteria are more resistant due to the thick lipopolysac-
charide wall structure
4 Discussion
Periodontitis is a major chronic in1047298ammatory disorder that can lead
to the loss of periodontal support for the periodontal ligament which
leads to the formation of an abnormal gap between the tooth and gum
[25] If the process continues the tooth can eventually get lost For
chronic periodontitis local antimicrobial agents are used as an adjunct
to scaling root planning and restoring the periodontalhealth [25] Mul-
tiple investigations have been conducted to incorporate antibiotics into
the polymeric carriers in order to develop a DDS for treatment of peri-
odontal diseases Polymeric DDS were designed in different structures
Fig 10 Proliferation of 1047297broblasts on electrospun nano1047297bers measured by MTS assay (P as PLGA P-TCH as PLGA-TCH PG 7525 as PLGAGT7525PG 7525-TCHas PLGAGT7525-TCH
PG 5050 as PLGAGT 5050 PG 5050-TCH as PLGAGT 5050-TCH PG(cs) as core shell PLGAGT PG(cs)-TCH as core shell PLGAGT-TCH)
Fig 11 Antibacterial properties of nano1047297bers A) PG(cs) B) PG 7525-TCH and C) PG(cs)-TCH
529M Ranjbar-Mohammadi et al Materials Science and Engineering C 58 (2016) 521 ndash531
8192019 1-s20-S0928493115303222-main (1)
httpslidepdfcomreaderfull1-s20-s0928493115303222-main-1 1011
such as1047297lms microparticles and1047297bers using bothsynthetic and natural
polymers [26]
TCHis oneof the widely employed antibiotics with proven effective-
nessin acceleration of periodontal treatment [27] TCHwith low toxicity
is a broadspectrum antibiotic which can be applied for thetreatment of
diseases caused by Gram-negative and Gram-positive microorganisms
by inhibiting protein synthesis in the bacteria [28] Besides its antibiotic
property it exhibits anti-in1047298ammatory properties and has the ability
to promote the attachment of 1047297
broblasts TCH has also been reportedas an inhibitor of the activity of proteinases and hence it can be used
to treat or prevent diseases related to proteinase imbalancerheumatoid
arthritis periodontitis and osteomyelitis [29] Previous studies showed
that the long term routine use of TCH for several months resulted
in clinically favorable effects for periodontal disease [30] Controlled
release of TCH was attempted by various researchers using various
drug delivery systems such as supramolecular gels based on amphi-
philic 345-trihydroxybenzoic derivatives[31] device based on ethylene
vinyl acetate (EVA) copolymer [32] and porous calcium phosphate
polyhydroxy butyrate composites [33] for various applications
Recent advances in the1047297eld of nanotechnology enable the fabrication
of nano1047297brous constructs containing drugs such that they have the ar-
chitectural features and morphological similarities matching the native
extracellular matrix (ECM) [3435] Unique properties of nano1047297bers
such as the high surface area high loading ease of operation and cost
effectiveness make them more suitable as drug delivery vehicles How-
ever drug release characteristics (eg burst release release rate and
duration) are signi1047297cantly in1047298uenced by extent of drug encapsulation
into thenano1047297brous scaffolds whichis greatly dependent to material se-
lection as well as the drug incorporation method [3626] In general
drugs can be incorporated into nano1047297bers via various methods such as
coatings blending co-axial and emulsion electrospinning [26] Recent
developments in this direction progressed with the application of nano-
1047297bers as drug delivery systems for periodontal diseases For example
Zamani et al [26] fabricated PCL nano1047297bers containing metronidazole
benzoate where the drug release was continued for a period of 15 days
In this study we explored the incorporation of TCH into a new
bicomponent carrier PLGA-gum tragacanth (GT) via two different
technics of blend electrospinning and coaxial electrospinning GT themedicinally imported polysaccharide consists of two major fractions a
water-soluble (tragacanthic acid and small amount of arabinogalactan)
and an insolublebut water-swellable fraction named bassorinGT exhib-
ited a considerable potency for wound healing in the form of mucilage
[21] or skin regeneration capability in the form of blend nano1047297bers
with PCL or PVA [2223] Due to the mentioned structural and composi-
tional advantages natural availability antibacterial properties and low
cost we believe that TCH loaded PG and PG(cs) 1047297bers can be employed
as a proper drug delivery system for multiple applications including
treatment of periodontal diseases We aimed to explore the effect of in-
corporation method (blending vs coaxial electrospinning) on the phys-
ical characteristics of the nano1047297bers and TCH release behavior from
PG and PG(cs) nano1047297bers Moreover the biocompatibility of the drug
loaded membranes was investigatedThe SEM images (Fig 2) showed that uniformly distributed nano1047297-
bers without beads were formed from all formulations Blending GT
with PLGA decreased the diameter of nano1047297bers Incorporation of TCH
into PLGA and PG(cs) nano1047297bers also reduced the 1047297ber diameter
while addition of the drug into the blend PG nano1047297bers did not cause
further reduction in diameter of the nano1047297bers (Table 1) The possible
reason for the reduction of the diameter of the nano1047297bers is that both
GT and TCH may improve the polarity of the solution which subse-
quently increases the electrical conductivity of the solution Moreover
PG(cs) nano1047297bers exhibited reduced diameter which can be attributed
to theuse of water as the core solvent High dielectric constant of water
(801 at 25 degC) is an indication of the ability of solution to carry more
electrical charges resulting in higher elongation forces and formation
of thinner nano1047297bers under the electrical 1047297eld [37]
The results of mechanical studies showed that PG membranes ex-
hibited less tensile strength compared to PLGA (Figs 6 and 7) This
canbe relatedto theeasier slippage of polymer chainsunder loadingbe-
cause of less entanglements and weak physical interactions among the
chains of mixed polymers [38] Another reason for lower strength of
PG 1047297bers can be the low mechanical strength of GT itself Moreover
TCH could also decrease the tensile strength as well as breaking strain
of all formulations due to probable plasticizing effect of TCH molecules
for polymer chains However the breaking strain of pure PLGA was de-creased more than seven timeswhile blend PG nano1047297bers had less than
50 reduction in strain at the presence of TCH compared to the similar
membranes without drug This can be attributed to the highly branched
structure of GT which intrinsically limited the elongation of its polymer
chains under the loading resulting in alleviation of the in1047298uence of TCH
on reduction of strain at break Mechanical behavior of the nano1047297bers
under wet condition is another factor of consideration since the mem-
branes inserted into the periodontal pocket are exposed to moist condi-
tion Results of mechanical studies under wet conditions showed that
except PG 5050 nano1047297bers other TCH loaded membranes preserved
their tensile strength in wet condition Interestingly the effect of TCH
on breaking strain of PG(cs) was dependent to drywet state of the
membrane In dry state addition of TCH caused a drastic decline in
breaking strain similar to pure PLGA since smaller amount of GT existed
in PG(cs) nano1047297bers compared to blend PG nano1047297bers However there-
duction in breaking strain of PG(cs) was limited to the extent compara-
ble to blend PG nano1047297bers in wetcondition This canbe attributed to the
more pronounced role of GT in hydrated state due to swelling effect of
this natural polymer resultingin distributionand occupationof a higher
volumeof the nano1047297bers by this polymer Forthe membraneswhichare
supposed to be inserted into theperiodontalpocket it is necessaryto in-
sure that the membrane possesses enough mechanical strength and ri-
gidity to be inserted into the pocket and retain its integrity during the
release time On the other hand the membrane should remain 1047298exible
and soft enough in the wet environment to conform to the periodontal
pocket and meet patient compliance [26] Elastic modulus is a good in-
dicator of the stiffness of a material Among various TCH incorporated
composite nano1047297bers PG(cs) exhibited the highest tensile strength
in both dry and wet conditions while its wet modulus was signi1047297-cantly lower than blend nano1047297bers That means TCH loaded PG(cs)
membranes may provide a proper texture to be easily inserted into
periodontal pocket with a certain amount of back pressure and remain
comfortably in the pocket with the lowest rigiditystiffness among the
composite nano1047297bers
The release kinetics of TCH from electrospun PLGA PG 7525
PG 5050 and PG(cs) scaffolds was studied for a period of 75 days
(Fig 9) For all the formulations initial burst release was attributed to
the release of surface connected drug [39] followed by a controlled re-
lease attributed to molecular diffusion through the polymer phase In
case of blended PG nano1047297bers the presence of hydrophilic PG segments
which are randomly distributed across the diffusion path can signi1047297-
cantly facilitate water uptake and swelling of the polymeric matrix
Therefore faster diffusion of the drug molecules out of the nano1047297bersoccurred resulting in higher release rate within the 1047297rst few days and
reaching a plateau after a certain period of time As expected the
explained effect of GT on release rate was enhanced by increasing the
fraction of this polymer in the blend such that the entire amount of
TCH was released from PG 5050 in 20 days These observations are in
agreement with wettability results which con1047297rmed the promoted
wettability of the scaffolds at higher ratios of GT in the nano 1047297bers
(Fig 5) However when GT was employed as the core along with TCH
the likelihood of having drug molecules as well as GT hydrophilic
segments onnear the surface of nano1047297bers is reduced In this case the
hydrophobic PLGA shell could control the water uptake and swelling
of the hydrophilic core material resulting in lowered burst release as
well as prolonged release of TCH in a sustained fashion for 75 days
The prolonged TCH release from PG(cs) nano1047297bers validates the use of
530 M Ranjbar-Mohammadi et al Materials Science and Engineering C 58 (2016) 521ndash531
8192019 1-s20-S0928493115303222-main (1)
httpslidepdfcomreaderfull1-s20-s0928493115303222-main-1 1111
core shell structure for periodontal treatment since the elimination of
hardened bacteria in periodontal pocket requires sustained exposure
to antibiotics [40]
The cytocompatibility studies showed that GT could successfully
support cell growth on nano1047297brous membranes in both blending and
corendashshell architecture This might be attributed to the more hydro-
philic properties of GT contained membranes which improves protein
adsorption and subsequent cell attachment and proliferation [4142]
On the other hand incorporation of TCH showed to decrease cellgrowth in some of the formulations due to the inhibitory effect of this
drug on mitochondrial protein synthesis [43] However none of the
GT contained scaffolds showed signi1047297cant changes in cell viability com-
pared to the control which demonstrates good cytocompatibility of
the composite membranes Antibacterial assessment of drug loaded
PG and PG(cs) nano1047297bers showed that these scaffolds are strong
enough against of S aureus bacteria
5 Conclusion
In the present study TCH-loaded blend and core shell nano1047297bers
with smooth and bead-less morphology were successfully fabricated
from PLGA and GT for application as new and controlled drug delivery
systems The release rate of TCH in PG blend nano1047297bers increased
with the increase of GT ratio due to enhanced hydrophilicity of the
electrospun nano1047297bers Compared to PG blend nano1047297bers PG(cs) mem-
branes showed a more prolonged release of TCH for 75 days with lower
burst release of the drug within the 1047297rst 2 h Among various formula-
tions PG(cs) nano1047297bers exhibited the highest tensile strength in both
dry and wet conditions while its wet modulus was signi1047297cantly lower
than blend nano1047297bers Thus the TCH loaded PG(cs) membranes might
be strong enough to be easily inserted into periodontal pocket and sus-
tainably release the incorporated drug while affording patient compli-
ance with low rigiditystiffness of the membrane during the treatment
Thesecharacteristics along with the proven cytocompatibility and anti-
bacterial properties of TCH loaded scaffolds suggest the particular ben-
e1047297ts of composite corendashshell nano1047297bers to be used as a drug delivery
system for periodontal diseases
Acknowledgments
This study was supported by the NRF-Technion grant (WBS No
R-398-001-065-592) and the Nanoscience and Nanotechnology Initia-
tive in the National University of Singapore
References
[1] B Felice MP Prabhakaran AP Rodriacuteguez S Ramakrishna J Mater Sci Eng C 4(2014) 178ndash195
[2] P Boisseau B Loubaton C R Phys 12 (2011) 620ndash636
[3] T Allen P Cullis Science 303 (2004) 1818ndash1822[4] Y Malam M Loizidou AM Seifalian Trends Pharmacol Sci 30 (2009) 592ndash599[5] J Zhang R Misra Acta Biomater 3 (2007) 838ndash850[6] B Wang Y Wang T Yin Q Yu Chem Eng Commun 197 (2010) 1315ndash1338[7] ZX Meng XX Xu WZheng HM Zhou LLi YF ZhengX LouJ Colloids SurfB 84
(2011) 97ndash102[8] G Jin MP P rabhakaran D Kai S Ramakrishna Eur J Pharm Biopharm 85 (2013)
689ndash698[9] W QianDGYu YLi YZ LiaoX WangL WangInt JMolSci15 (2014) 774ndash786
[10] H Qi P Hu J Xu A Wang Biomacromolecules 7 (2006) 2327ndash2330[11] TP Chaturvedi R Srivastava AK Srivastava V Gupta VP Kumar Int J Pharm
Investig 2 (2012) 213ndash
217[12] K Kim YK Luu C Chang D Fang BS Hsiao B Chu M Hadjiargyrou J ControlRelease 98 (2004) 47ndash56
[13] R Kenawy GL Bowlin K Mans1047297eld J Layman DG Simpson EH Sanders GEWnek J Control Release 81 (2002) 57ndash64
[14] J Zeng L Yang Q Liang X Zhang H Guan X Xu X Chen X Jing J ControlRelease105 (2005) 43ndash51
[15] X Xu L Yang X Xu X Wang X Chen Q Liang J Zeng X Jing J Control Release108 (2005) 33ndash42
[16] HK Makadia S Siegel Polymers (Basel) 3 (2011) 1377ndash1397[17] MU Adikwu Bentham Science Publishers (2009)[18] A Rasul M Iqbal G Murtaza MK Waqas M Hanif Acta Pol Pharm 67 (2010)
517ndash522[19] B Singh V Sharma Carbohydr Polym 101 (2014) 928ndash940[20] DMW Anderson MME Bridgeman Phytochemistry 24 (1985) 2301ndash2304[21] A Moghbel AAHemmatiH Agheli I RashidiK Amraee Arch Iran Med8 (2005)
257ndash262[22] M Ranjbar-MohammadiSH BahramiMT Joghataei J Mater SciEng C 33 (2013)
4935ndash4943
[23] M Ranjbar-Mohammadi SH Bahrami J Mater Sci Eng C 48 (2015) 71ndash79[24] CL He ZM Huang XJ Han J Biomed Mater Res A 89 (2009) 80ndash95[25] S PappalardoOA Baglio C Cappello S Guarrera M De Benedittis M Petruzzi RF
Grassi Minerva Stomatol 55 (2006) 655ndash661[26] M Zamani M Morshed J Varshosaz M Jannesari Eur J Pharm Biopharm 75
(2010) 179ndash185[27] G Isik S Ince F Saglam U Onan J Clin Periodontol 24 (1997) 589ndash594[28] AN Sapadin R Fleischmajer J Am Acad Dermatol 54 (2006) 258ndash265[29] ZR Domingues ME Cortes TA Gomes HF Diniz CS Freitas JB Gomes AMC
Faria RD Sinisterra Biomaterials 25 (2004) 327ndash333[30] RA Seymour PA Heasman J Clin Periodontol 22 (1995) 22ndash35[31] L Chen J Wu L Yuwen T Shu M Xu M Zhang T Yi Langmuir 25 (2009)
8434ndash8438[32] S Kalachandra L Dongming S Offenbacher J Mater Sci Mater Med 13 (2002)
53ndash58[33] LMedvecky R StulajterovaJ BriancinChemPap 61 (2007) 477ndash484 (composites)[34] E Vatankhah MP Prabhakaran G Jin L GhasemiMobarakeh S Ramakrishna
J Biomater Appl 28 (2013) 909ndash921[35] MC Bottino V Thomas G Schmidt YK Vohra TMG Chua MJ Kowolik GM
Janowski Dent Mater 2 (2012) 703ndash721[36] M Zamani MP Prabhakaran S Ramakrishna Int J Nanomedicine 8 (2013)
2997ndash3017[37] WK Son JH Youk TS Lee WH Park Polymer 45 (2004) 2959ndash2966[38] Y Zhang H Ouyang CT Lim S Ramakrishna ZM Huang J Biomed Mater Res B
Appl Biomater 72B (2005) 156ndash165[39] DH LewisIn M Chasin RLanger (eds) NewYork MarcelDekker Inc (1990)1ndash43[40] WJ Loesche NS Grossman Clin Microbiol Rev 14 (2001) 727ndash752[41] S Fleischer A Shapira O Regev N Nseir E Zussman T Dvir Biotechnol Bioeng
111 (2014) 1246ndash1257[42] R Ravichandran R Sridhar JR Venugopal S Sundarrajan S Mukherjee S
Ramakrishna Macromol Biosci 14 (2014) 515ndash525[43] C van den Bogert G van Kernebeek L Leij AM Kroon Cancer Lett 32 (1986)
341ndash351
531M Ranjbar-Mohammadi et al Materials Science and Engineering C 58 (2016) 521 ndash531
8192019 1-s20-S0928493115303222-main (1)
httpslidepdfcomreaderfull1-s20-s0928493115303222-main-1 511
The surface property (interaction with water) of the electrospun
scaffolds was determined dynamically by water contact angle measure-
mentfor a periodof 30s Asshownin Fig 5 with increasing amounts of
GT within the PG composites the hydrophilicity of the nano1047297brous
membrane increased such that PG 7525 and 5050 scaffolds showed
a contact angle value of 85 plusmn 3deg and 76 plusmn 2deg respectively after 30 s
The water contact angle of drug loaded PG nano1047297bers was signi1047297cant-
ly lower than that of drug free PG scaffolds due to the hydrophilic
properties of TCH At the same time the PG(cs) nano1047297bers were more
hydrophilic than the PLGA nano1047297bers However the hydrophilicity of
PG(cs) was lesser compared to PG nano1047297bers due to the presence of
the hydrophilic GT within the core of the nano1047297bers
32 Mechanical properties of as-spun and hydrated scaffolds
The mechanical properties of electrospunnano1047297brousscaffolds with
or without drug including their tensile strength strain at break andelastic modulus were evaluated and are shown in Fig 6 and Table 2
In dry condition the average tensile strength of PLGA nano1047297bers was
obtained as 422 plusmn 002 MPa (Fig 6A) and it exhibited a strain at
break of 11874 plusmn 117 Comparing the stressndashstrain curves of the dif-
ferent scaffolds we found that addition of GT into PLGA nano1047297bers sig-
ni1047297cantly decreased the tensile strength of the nano1047297bers and reduced
the breaking strain (Fig 6B and C) Moreover the results of our studies
showed that PG nano1047297bers had a reduced elastic modulus compared
to pure PLGA nano1047297bers (Table 2) The average tensile strength and
elongation at break of PG(cs) were 332 plusmn 003 MPa and 10283 plusmn
301 respectively which was signi1047297cantly higher than blend nano1047297-
bers (Fig 6D and Table 2) For all formulations incorporation of TCH
into nano1047297bers reduced the tensile strength and elongation at break
while the elastic modulus was increased compared to the scaffolds
without drug
The results of the tensile properties of PBS-hydrated electrospun
scaffolds after 2 days are shown in Fig 7 and Table 2 All the nano1047297bers
without drug showed reduced tensile strength and strain after 2 days
of hydration compared to the dry state except PG 5050 (Fig 7C) with
no signi1047297cant changes Moreover none of the TCH loaded nano1047297bers
Fig 3 TEM micrograph of TCH loaded PG(cs) nano1047297bers
Fig 4 (A)ATR-FTIR spectraof nano1047297bers (P as PLGA P-TCH as PLGA-TCH PG as PLGAGT PG-TCH as PLGAGT-TCH PG(cs)as core shell PLGAGT PG(cs)-TCH as coreshellPLGAGT-TCH)
525M Ranjbar-Mohammadi et al Materials Science and Engineering C 58 (2016) 521 ndash531
8192019 1-s20-S0928493115303222-main (1)
httpslidepdfcomreaderfull1-s20-s0928493115303222-main-1 611
8192019 1-s20-S0928493115303222-main (1)
httpslidepdfcomreaderfull1-s20-s0928493115303222-main-1 711
value of elastic modulus (2200plusmn 167 MPa) in wet condition compared
to other formulations (Fig 7D and Table 2)
33 Degradation behavior of nano 1047297bers
Drug diffusion can be affected by scaffolds topology and morpholo-
gy Thusthe topological and morphological changes duringdegradation
might be able to control drug release rate from the nano1047297brous scaf-
folds Fig 8 presents the SEM images of the scaffolds after in vitro deg-
radation for a period of 40 days The 1047297brous structure of PLGA and
PG(cs) scaffolds with and without TCH was partially preserved after
40 days of degradation However blend PG scaffolds with and without
drug swelled to a large extent resulting in loss of nano1047297brous morphol-
ogy within similar time scale These results are in agreement with
higher wettability of PG nano1047297bers compared to PLGA and PG(cs)
nano1047297bers
34 Drug delivery
In this paper we determined the released amounts of TCH by mea-
suringthe absorbance at 362nm using an ultraviolet visible spectropho-
tometer Thereleaseof TCHfrom variouselectrospun scaffoldsis plotted
in Fig 9A amp B PLGA nano1047297bers exhibited an initial burst release of
2320 within the 1047297rst 2 h (Fig 9B) and reached a plateau within
7 days by releasing only 35 of TCH content The burst release of TCH
from PG 7525 nano1047297bers was very similar to pure PLGA (2479)
while PG 5050 had a signi1047297cantly higher amount of TCH (4830) re-
leased in the 1047297rst 2 h followedby a veryfast release of90of drugcon-
tent within 5 days However PG 7525 composite nano1047297bers showed
a sustained TCH release up to a period of 25 days the time point that
it reached to the plateau state For the core shell nano1047297bers where
TCH was incorporated in the core along with GT the burst release was
signi1047297cantly lower (19) compared to both pure PLGA and PG blend
Table 2
Tensile properties of the electrospun nano1047297bers under dry and wet conditions
Samples Dry scaffolds Wet scaffolds
T (μ m) EM (MPa) UTS (MPa) SB () T (μ m) EM (MPa) UTS (MPa) SB ()
PLGA 5680 7600 plusmn 360 422 + 002 11874 plusmn 117 5001 6900 plusmn 180 255 plusmn 003 6409 plusmn 112
PLGA-TCH 5802 8433 plusmn 781 258 plusmn 003 1592 plusmn 212 5277 6236 plusmn 283 171 plusmn 009 1158 plusmn 178
PG 7525 5499 4334 plusmn 223 230 plusmn 002 2240 plusmn 212 5686 4273 plusmn 136 170 plusmn 008 1517 plusmn 113
PG 7525-TCH 5307 6410 plusmn 334 101 plusmn 005 1350 plusmn 691 5430 5211 plusmn 219 102 plusmn 009 1133 plusmn 501
PG 5050 5503 3295 plusmn 100 093 plusmn 003 1392 plusmn 406 5333 3290 plusmn 110 089 plusmn 008 1422 plusmn 113
PG 5050-TCH 5409 3962 plusmn 131 072 plusmn 006 883 plusmn 702 5602 3381 plusmn 187 040 plusmn 010 775 plusmn 398
PG(cs) 5204 4020 plusmn 171 332 plusmn 003 10283 plusmn 301 4903 10532 plusmn 121 215 plusmn 002 3667 plusmn 113
PG(cs)-TCH 5375 4832 plusmn 413 151 plusmn 007 1424 plusmn 451 4889 2200 plusmn 167 157 plusmn 003 3341 plusmn 315
T average thickness of nano1047297bers EM elastic modulus UTS ultimate tensile strength SB strain at break
Fig 7 Mechanical properties of PBS hydrated (A) PLGA PLGA-TCH (B) PG 7525 PG 7525-TCH (C) PG 5050 PG 5050-TCH (D) PG(cs) and PG(cs)-TCH electrospun membranes after
48 h (P as PLGA P-TCH as PLGA-TCH PG 7525 as PLGAGT7525PG 7525-TCHas PLGAGT7525-TCHPG 5050 as PLGAGT5050 PG 5050-TCHas PLGAGT5050-TCHPG(cs)as core
shell PLGAGT PG(cs)-TCH as core shell PLGAGT-TCH)
527M Ranjbar-Mohammadi et al Materials Science and Engineering C 58 (2016) 521 ndash531
8192019 1-s20-S0928493115303222-main (1)
httpslidepdfcomreaderfull1-s20-s0928493115303222-main-1 811
nano1047297bers Following burst releasePG(cs) scaffolds showed a prolonged
sustained release over the entire study period (75 days) by releasing
6810 of the total TCH content by this time
35 Proliferation of 1047297broblasts on electrospun scaffolds
The cytocompatibility of the electrospun scaffolds was evaluated by
MTS assay after culturing 1047297broblasts on the nano1047297bers over a period of
13 and 5 daysandtheresultsareshownin Fig 10 Cell proliferation on
all the scaffolds (with or without drug) was found to increase with cul-
ture time similar to thetrend observed on tissueculture plates (TCP) At
days 1 and 3 of cell culture GT contained nano1047297bers (both blended and
corendashshell) without drug exhibited improved cell viability compared
to PLGA membranes The same trend was observed for TCH incorpo-
rated nano1047297bers though the presence of TCH slightly decreased cell
growth for some of the formulations compared to drug free nano1047297bers
However after 5 days TCH-loaded PG and PG(cs) nano1047297brous mats did
not exhibit signi1047297cant increase in cell viability compared to PLGA-TCH
Fig 8 SEMimagesof degraded nano1047297bersafter40 days(P as PLGA P-TCH as PLGA-TCHPG 7525 asPLGAGT 7525PG 7525-TCH as PLGAGT7525-TCH PG 5050as PLGAGT5050 PG
5050-TCH as PLGAGT 5050-TCH PG(cs) as core shell PLGAGT PG(cs)-TCH as core shell PLGAGT-TCH)
Fig 9 Release pro1047297le of TCH from PLGA-TCH PG 7525-TCH PG 5050-TCH PG(cs)-TCH electrospun scaffolds A) Entire release time B) initial burst release
528 M Ranjbar-Mohammadi et al Materials Science and Engineering C 58 (2016) 521ndash531
8192019 1-s20-S0928493115303222-main (1)
httpslidepdfcomreaderfull1-s20-s0928493115303222-main-1 911
nano1047297bers Moreover none of the electrospun scaffolds showed signif-
icant changes in cell viability after 5 days compared to TCP This is an in-
dication of cytocompatibility of the scaffolds essential for applications
such as treatment of periodontal diseases
36 Antibacterial properties
In this work the antibacterial activity of TCH-loaded PG(cs) PG
7525-TCH and PG(cs)-TCH nano1047297bers was investigated using S aureus
and Pseudomonas aeruginosa as model bacteriaThe drug loadedsamples
showed clear bacterial inhibition rings against Gram-positive bacteria
(S aureus) which is known to be a TCH-sensitive Gram-positive spheri-
cal bacterium that causes a wide range of suppurative infections The
bacterial inhibition ring was smaller on the nano1047297bers containing
Gram-negative bacteria (P aeruginosa) (Fig 11) These observations
may be related to structural differences between two different bacteria
Gram-negative bacteria are more resistant due to the thick lipopolysac-
charide wall structure
4 Discussion
Periodontitis is a major chronic in1047298ammatory disorder that can lead
to the loss of periodontal support for the periodontal ligament which
leads to the formation of an abnormal gap between the tooth and gum
[25] If the process continues the tooth can eventually get lost For
chronic periodontitis local antimicrobial agents are used as an adjunct
to scaling root planning and restoring the periodontalhealth [25] Mul-
tiple investigations have been conducted to incorporate antibiotics into
the polymeric carriers in order to develop a DDS for treatment of peri-
odontal diseases Polymeric DDS were designed in different structures
Fig 10 Proliferation of 1047297broblasts on electrospun nano1047297bers measured by MTS assay (P as PLGA P-TCH as PLGA-TCH PG 7525 as PLGAGT7525PG 7525-TCHas PLGAGT7525-TCH
PG 5050 as PLGAGT 5050 PG 5050-TCH as PLGAGT 5050-TCH PG(cs) as core shell PLGAGT PG(cs)-TCH as core shell PLGAGT-TCH)
Fig 11 Antibacterial properties of nano1047297bers A) PG(cs) B) PG 7525-TCH and C) PG(cs)-TCH
529M Ranjbar-Mohammadi et al Materials Science and Engineering C 58 (2016) 521 ndash531
8192019 1-s20-S0928493115303222-main (1)
httpslidepdfcomreaderfull1-s20-s0928493115303222-main-1 1011
such as1047297lms microparticles and1047297bers using bothsynthetic and natural
polymers [26]
TCHis oneof the widely employed antibiotics with proven effective-
nessin acceleration of periodontal treatment [27] TCHwith low toxicity
is a broadspectrum antibiotic which can be applied for thetreatment of
diseases caused by Gram-negative and Gram-positive microorganisms
by inhibiting protein synthesis in the bacteria [28] Besides its antibiotic
property it exhibits anti-in1047298ammatory properties and has the ability
to promote the attachment of 1047297
broblasts TCH has also been reportedas an inhibitor of the activity of proteinases and hence it can be used
to treat or prevent diseases related to proteinase imbalancerheumatoid
arthritis periodontitis and osteomyelitis [29] Previous studies showed
that the long term routine use of TCH for several months resulted
in clinically favorable effects for periodontal disease [30] Controlled
release of TCH was attempted by various researchers using various
drug delivery systems such as supramolecular gels based on amphi-
philic 345-trihydroxybenzoic derivatives[31] device based on ethylene
vinyl acetate (EVA) copolymer [32] and porous calcium phosphate
polyhydroxy butyrate composites [33] for various applications
Recent advances in the1047297eld of nanotechnology enable the fabrication
of nano1047297brous constructs containing drugs such that they have the ar-
chitectural features and morphological similarities matching the native
extracellular matrix (ECM) [3435] Unique properties of nano1047297bers
such as the high surface area high loading ease of operation and cost
effectiveness make them more suitable as drug delivery vehicles How-
ever drug release characteristics (eg burst release release rate and
duration) are signi1047297cantly in1047298uenced by extent of drug encapsulation
into thenano1047297brous scaffolds whichis greatly dependent to material se-
lection as well as the drug incorporation method [3626] In general
drugs can be incorporated into nano1047297bers via various methods such as
coatings blending co-axial and emulsion electrospinning [26] Recent
developments in this direction progressed with the application of nano-
1047297bers as drug delivery systems for periodontal diseases For example
Zamani et al [26] fabricated PCL nano1047297bers containing metronidazole
benzoate where the drug release was continued for a period of 15 days
In this study we explored the incorporation of TCH into a new
bicomponent carrier PLGA-gum tragacanth (GT) via two different
technics of blend electrospinning and coaxial electrospinning GT themedicinally imported polysaccharide consists of two major fractions a
water-soluble (tragacanthic acid and small amount of arabinogalactan)
and an insolublebut water-swellable fraction named bassorinGT exhib-
ited a considerable potency for wound healing in the form of mucilage
[21] or skin regeneration capability in the form of blend nano1047297bers
with PCL or PVA [2223] Due to the mentioned structural and composi-
tional advantages natural availability antibacterial properties and low
cost we believe that TCH loaded PG and PG(cs) 1047297bers can be employed
as a proper drug delivery system for multiple applications including
treatment of periodontal diseases We aimed to explore the effect of in-
corporation method (blending vs coaxial electrospinning) on the phys-
ical characteristics of the nano1047297bers and TCH release behavior from
PG and PG(cs) nano1047297bers Moreover the biocompatibility of the drug
loaded membranes was investigatedThe SEM images (Fig 2) showed that uniformly distributed nano1047297-
bers without beads were formed from all formulations Blending GT
with PLGA decreased the diameter of nano1047297bers Incorporation of TCH
into PLGA and PG(cs) nano1047297bers also reduced the 1047297ber diameter
while addition of the drug into the blend PG nano1047297bers did not cause
further reduction in diameter of the nano1047297bers (Table 1) The possible
reason for the reduction of the diameter of the nano1047297bers is that both
GT and TCH may improve the polarity of the solution which subse-
quently increases the electrical conductivity of the solution Moreover
PG(cs) nano1047297bers exhibited reduced diameter which can be attributed
to theuse of water as the core solvent High dielectric constant of water
(801 at 25 degC) is an indication of the ability of solution to carry more
electrical charges resulting in higher elongation forces and formation
of thinner nano1047297bers under the electrical 1047297eld [37]
The results of mechanical studies showed that PG membranes ex-
hibited less tensile strength compared to PLGA (Figs 6 and 7) This
canbe relatedto theeasier slippage of polymer chainsunder loadingbe-
cause of less entanglements and weak physical interactions among the
chains of mixed polymers [38] Another reason for lower strength of
PG 1047297bers can be the low mechanical strength of GT itself Moreover
TCH could also decrease the tensile strength as well as breaking strain
of all formulations due to probable plasticizing effect of TCH molecules
for polymer chains However the breaking strain of pure PLGA was de-creased more than seven timeswhile blend PG nano1047297bers had less than
50 reduction in strain at the presence of TCH compared to the similar
membranes without drug This can be attributed to the highly branched
structure of GT which intrinsically limited the elongation of its polymer
chains under the loading resulting in alleviation of the in1047298uence of TCH
on reduction of strain at break Mechanical behavior of the nano1047297bers
under wet condition is another factor of consideration since the mem-
branes inserted into the periodontal pocket are exposed to moist condi-
tion Results of mechanical studies under wet conditions showed that
except PG 5050 nano1047297bers other TCH loaded membranes preserved
their tensile strength in wet condition Interestingly the effect of TCH
on breaking strain of PG(cs) was dependent to drywet state of the
membrane In dry state addition of TCH caused a drastic decline in
breaking strain similar to pure PLGA since smaller amount of GT existed
in PG(cs) nano1047297bers compared to blend PG nano1047297bers However there-
duction in breaking strain of PG(cs) was limited to the extent compara-
ble to blend PG nano1047297bers in wetcondition This canbe attributed to the
more pronounced role of GT in hydrated state due to swelling effect of
this natural polymer resultingin distributionand occupationof a higher
volumeof the nano1047297bers by this polymer Forthe membraneswhichare
supposed to be inserted into theperiodontalpocket it is necessaryto in-
sure that the membrane possesses enough mechanical strength and ri-
gidity to be inserted into the pocket and retain its integrity during the
release time On the other hand the membrane should remain 1047298exible
and soft enough in the wet environment to conform to the periodontal
pocket and meet patient compliance [26] Elastic modulus is a good in-
dicator of the stiffness of a material Among various TCH incorporated
composite nano1047297bers PG(cs) exhibited the highest tensile strength
in both dry and wet conditions while its wet modulus was signi1047297-cantly lower than blend nano1047297bers That means TCH loaded PG(cs)
membranes may provide a proper texture to be easily inserted into
periodontal pocket with a certain amount of back pressure and remain
comfortably in the pocket with the lowest rigiditystiffness among the
composite nano1047297bers
The release kinetics of TCH from electrospun PLGA PG 7525
PG 5050 and PG(cs) scaffolds was studied for a period of 75 days
(Fig 9) For all the formulations initial burst release was attributed to
the release of surface connected drug [39] followed by a controlled re-
lease attributed to molecular diffusion through the polymer phase In
case of blended PG nano1047297bers the presence of hydrophilic PG segments
which are randomly distributed across the diffusion path can signi1047297-
cantly facilitate water uptake and swelling of the polymeric matrix
Therefore faster diffusion of the drug molecules out of the nano1047297bersoccurred resulting in higher release rate within the 1047297rst few days and
reaching a plateau after a certain period of time As expected the
explained effect of GT on release rate was enhanced by increasing the
fraction of this polymer in the blend such that the entire amount of
TCH was released from PG 5050 in 20 days These observations are in
agreement with wettability results which con1047297rmed the promoted
wettability of the scaffolds at higher ratios of GT in the nano 1047297bers
(Fig 5) However when GT was employed as the core along with TCH
the likelihood of having drug molecules as well as GT hydrophilic
segments onnear the surface of nano1047297bers is reduced In this case the
hydrophobic PLGA shell could control the water uptake and swelling
of the hydrophilic core material resulting in lowered burst release as
well as prolonged release of TCH in a sustained fashion for 75 days
The prolonged TCH release from PG(cs) nano1047297bers validates the use of
530 M Ranjbar-Mohammadi et al Materials Science and Engineering C 58 (2016) 521ndash531
8192019 1-s20-S0928493115303222-main (1)
httpslidepdfcomreaderfull1-s20-s0928493115303222-main-1 1111
core shell structure for periodontal treatment since the elimination of
hardened bacteria in periodontal pocket requires sustained exposure
to antibiotics [40]
The cytocompatibility studies showed that GT could successfully
support cell growth on nano1047297brous membranes in both blending and
corendashshell architecture This might be attributed to the more hydro-
philic properties of GT contained membranes which improves protein
adsorption and subsequent cell attachment and proliferation [4142]
On the other hand incorporation of TCH showed to decrease cellgrowth in some of the formulations due to the inhibitory effect of this
drug on mitochondrial protein synthesis [43] However none of the
GT contained scaffolds showed signi1047297cant changes in cell viability com-
pared to the control which demonstrates good cytocompatibility of
the composite membranes Antibacterial assessment of drug loaded
PG and PG(cs) nano1047297bers showed that these scaffolds are strong
enough against of S aureus bacteria
5 Conclusion
In the present study TCH-loaded blend and core shell nano1047297bers
with smooth and bead-less morphology were successfully fabricated
from PLGA and GT for application as new and controlled drug delivery
systems The release rate of TCH in PG blend nano1047297bers increased
with the increase of GT ratio due to enhanced hydrophilicity of the
electrospun nano1047297bers Compared to PG blend nano1047297bers PG(cs) mem-
branes showed a more prolonged release of TCH for 75 days with lower
burst release of the drug within the 1047297rst 2 h Among various formula-
tions PG(cs) nano1047297bers exhibited the highest tensile strength in both
dry and wet conditions while its wet modulus was signi1047297cantly lower
than blend nano1047297bers Thus the TCH loaded PG(cs) membranes might
be strong enough to be easily inserted into periodontal pocket and sus-
tainably release the incorporated drug while affording patient compli-
ance with low rigiditystiffness of the membrane during the treatment
Thesecharacteristics along with the proven cytocompatibility and anti-
bacterial properties of TCH loaded scaffolds suggest the particular ben-
e1047297ts of composite corendashshell nano1047297bers to be used as a drug delivery
system for periodontal diseases
Acknowledgments
This study was supported by the NRF-Technion grant (WBS No
R-398-001-065-592) and the Nanoscience and Nanotechnology Initia-
tive in the National University of Singapore
References
[1] B Felice MP Prabhakaran AP Rodriacuteguez S Ramakrishna J Mater Sci Eng C 4(2014) 178ndash195
[2] P Boisseau B Loubaton C R Phys 12 (2011) 620ndash636
[3] T Allen P Cullis Science 303 (2004) 1818ndash1822[4] Y Malam M Loizidou AM Seifalian Trends Pharmacol Sci 30 (2009) 592ndash599[5] J Zhang R Misra Acta Biomater 3 (2007) 838ndash850[6] B Wang Y Wang T Yin Q Yu Chem Eng Commun 197 (2010) 1315ndash1338[7] ZX Meng XX Xu WZheng HM Zhou LLi YF ZhengX LouJ Colloids SurfB 84
(2011) 97ndash102[8] G Jin MP P rabhakaran D Kai S Ramakrishna Eur J Pharm Biopharm 85 (2013)
689ndash698[9] W QianDGYu YLi YZ LiaoX WangL WangInt JMolSci15 (2014) 774ndash786
[10] H Qi P Hu J Xu A Wang Biomacromolecules 7 (2006) 2327ndash2330[11] TP Chaturvedi R Srivastava AK Srivastava V Gupta VP Kumar Int J Pharm
Investig 2 (2012) 213ndash
217[12] K Kim YK Luu C Chang D Fang BS Hsiao B Chu M Hadjiargyrou J ControlRelease 98 (2004) 47ndash56
[13] R Kenawy GL Bowlin K Mans1047297eld J Layman DG Simpson EH Sanders GEWnek J Control Release 81 (2002) 57ndash64
[14] J Zeng L Yang Q Liang X Zhang H Guan X Xu X Chen X Jing J ControlRelease105 (2005) 43ndash51
[15] X Xu L Yang X Xu X Wang X Chen Q Liang J Zeng X Jing J Control Release108 (2005) 33ndash42
[16] HK Makadia S Siegel Polymers (Basel) 3 (2011) 1377ndash1397[17] MU Adikwu Bentham Science Publishers (2009)[18] A Rasul M Iqbal G Murtaza MK Waqas M Hanif Acta Pol Pharm 67 (2010)
517ndash522[19] B Singh V Sharma Carbohydr Polym 101 (2014) 928ndash940[20] DMW Anderson MME Bridgeman Phytochemistry 24 (1985) 2301ndash2304[21] A Moghbel AAHemmatiH Agheli I RashidiK Amraee Arch Iran Med8 (2005)
257ndash262[22] M Ranjbar-MohammadiSH BahramiMT Joghataei J Mater SciEng C 33 (2013)
4935ndash4943
[23] M Ranjbar-Mohammadi SH Bahrami J Mater Sci Eng C 48 (2015) 71ndash79[24] CL He ZM Huang XJ Han J Biomed Mater Res A 89 (2009) 80ndash95[25] S PappalardoOA Baglio C Cappello S Guarrera M De Benedittis M Petruzzi RF
Grassi Minerva Stomatol 55 (2006) 655ndash661[26] M Zamani M Morshed J Varshosaz M Jannesari Eur J Pharm Biopharm 75
(2010) 179ndash185[27] G Isik S Ince F Saglam U Onan J Clin Periodontol 24 (1997) 589ndash594[28] AN Sapadin R Fleischmajer J Am Acad Dermatol 54 (2006) 258ndash265[29] ZR Domingues ME Cortes TA Gomes HF Diniz CS Freitas JB Gomes AMC
Faria RD Sinisterra Biomaterials 25 (2004) 327ndash333[30] RA Seymour PA Heasman J Clin Periodontol 22 (1995) 22ndash35[31] L Chen J Wu L Yuwen T Shu M Xu M Zhang T Yi Langmuir 25 (2009)
8434ndash8438[32] S Kalachandra L Dongming S Offenbacher J Mater Sci Mater Med 13 (2002)
53ndash58[33] LMedvecky R StulajterovaJ BriancinChemPap 61 (2007) 477ndash484 (composites)[34] E Vatankhah MP Prabhakaran G Jin L GhasemiMobarakeh S Ramakrishna
J Biomater Appl 28 (2013) 909ndash921[35] MC Bottino V Thomas G Schmidt YK Vohra TMG Chua MJ Kowolik GM
Janowski Dent Mater 2 (2012) 703ndash721[36] M Zamani MP Prabhakaran S Ramakrishna Int J Nanomedicine 8 (2013)
2997ndash3017[37] WK Son JH Youk TS Lee WH Park Polymer 45 (2004) 2959ndash2966[38] Y Zhang H Ouyang CT Lim S Ramakrishna ZM Huang J Biomed Mater Res B
Appl Biomater 72B (2005) 156ndash165[39] DH LewisIn M Chasin RLanger (eds) NewYork MarcelDekker Inc (1990)1ndash43[40] WJ Loesche NS Grossman Clin Microbiol Rev 14 (2001) 727ndash752[41] S Fleischer A Shapira O Regev N Nseir E Zussman T Dvir Biotechnol Bioeng
111 (2014) 1246ndash1257[42] R Ravichandran R Sridhar JR Venugopal S Sundarrajan S Mukherjee S
Ramakrishna Macromol Biosci 14 (2014) 515ndash525[43] C van den Bogert G van Kernebeek L Leij AM Kroon Cancer Lett 32 (1986)
341ndash351
531M Ranjbar-Mohammadi et al Materials Science and Engineering C 58 (2016) 521 ndash531
8192019 1-s20-S0928493115303222-main (1)
httpslidepdfcomreaderfull1-s20-s0928493115303222-main-1 611
8192019 1-s20-S0928493115303222-main (1)
httpslidepdfcomreaderfull1-s20-s0928493115303222-main-1 711
value of elastic modulus (2200plusmn 167 MPa) in wet condition compared
to other formulations (Fig 7D and Table 2)
33 Degradation behavior of nano 1047297bers
Drug diffusion can be affected by scaffolds topology and morpholo-
gy Thusthe topological and morphological changes duringdegradation
might be able to control drug release rate from the nano1047297brous scaf-
folds Fig 8 presents the SEM images of the scaffolds after in vitro deg-
radation for a period of 40 days The 1047297brous structure of PLGA and
PG(cs) scaffolds with and without TCH was partially preserved after
40 days of degradation However blend PG scaffolds with and without
drug swelled to a large extent resulting in loss of nano1047297brous morphol-
ogy within similar time scale These results are in agreement with
higher wettability of PG nano1047297bers compared to PLGA and PG(cs)
nano1047297bers
34 Drug delivery
In this paper we determined the released amounts of TCH by mea-
suringthe absorbance at 362nm using an ultraviolet visible spectropho-
tometer Thereleaseof TCHfrom variouselectrospun scaffoldsis plotted
in Fig 9A amp B PLGA nano1047297bers exhibited an initial burst release of
2320 within the 1047297rst 2 h (Fig 9B) and reached a plateau within
7 days by releasing only 35 of TCH content The burst release of TCH
from PG 7525 nano1047297bers was very similar to pure PLGA (2479)
while PG 5050 had a signi1047297cantly higher amount of TCH (4830) re-
leased in the 1047297rst 2 h followedby a veryfast release of90of drugcon-
tent within 5 days However PG 7525 composite nano1047297bers showed
a sustained TCH release up to a period of 25 days the time point that
it reached to the plateau state For the core shell nano1047297bers where
TCH was incorporated in the core along with GT the burst release was
signi1047297cantly lower (19) compared to both pure PLGA and PG blend
Table 2
Tensile properties of the electrospun nano1047297bers under dry and wet conditions
Samples Dry scaffolds Wet scaffolds
T (μ m) EM (MPa) UTS (MPa) SB () T (μ m) EM (MPa) UTS (MPa) SB ()
PLGA 5680 7600 plusmn 360 422 + 002 11874 plusmn 117 5001 6900 plusmn 180 255 plusmn 003 6409 plusmn 112
PLGA-TCH 5802 8433 plusmn 781 258 plusmn 003 1592 plusmn 212 5277 6236 plusmn 283 171 plusmn 009 1158 plusmn 178
PG 7525 5499 4334 plusmn 223 230 plusmn 002 2240 plusmn 212 5686 4273 plusmn 136 170 plusmn 008 1517 plusmn 113
PG 7525-TCH 5307 6410 plusmn 334 101 plusmn 005 1350 plusmn 691 5430 5211 plusmn 219 102 plusmn 009 1133 plusmn 501
PG 5050 5503 3295 plusmn 100 093 plusmn 003 1392 plusmn 406 5333 3290 plusmn 110 089 plusmn 008 1422 plusmn 113
PG 5050-TCH 5409 3962 plusmn 131 072 plusmn 006 883 plusmn 702 5602 3381 plusmn 187 040 plusmn 010 775 plusmn 398
PG(cs) 5204 4020 plusmn 171 332 plusmn 003 10283 plusmn 301 4903 10532 plusmn 121 215 plusmn 002 3667 plusmn 113
PG(cs)-TCH 5375 4832 plusmn 413 151 plusmn 007 1424 plusmn 451 4889 2200 plusmn 167 157 plusmn 003 3341 plusmn 315
T average thickness of nano1047297bers EM elastic modulus UTS ultimate tensile strength SB strain at break
Fig 7 Mechanical properties of PBS hydrated (A) PLGA PLGA-TCH (B) PG 7525 PG 7525-TCH (C) PG 5050 PG 5050-TCH (D) PG(cs) and PG(cs)-TCH electrospun membranes after
48 h (P as PLGA P-TCH as PLGA-TCH PG 7525 as PLGAGT7525PG 7525-TCHas PLGAGT7525-TCHPG 5050 as PLGAGT5050 PG 5050-TCHas PLGAGT5050-TCHPG(cs)as core
shell PLGAGT PG(cs)-TCH as core shell PLGAGT-TCH)
527M Ranjbar-Mohammadi et al Materials Science and Engineering C 58 (2016) 521 ndash531
8192019 1-s20-S0928493115303222-main (1)
httpslidepdfcomreaderfull1-s20-s0928493115303222-main-1 811
nano1047297bers Following burst releasePG(cs) scaffolds showed a prolonged
sustained release over the entire study period (75 days) by releasing
6810 of the total TCH content by this time
35 Proliferation of 1047297broblasts on electrospun scaffolds
The cytocompatibility of the electrospun scaffolds was evaluated by
MTS assay after culturing 1047297broblasts on the nano1047297bers over a period of
13 and 5 daysandtheresultsareshownin Fig 10 Cell proliferation on
all the scaffolds (with or without drug) was found to increase with cul-
ture time similar to thetrend observed on tissueculture plates (TCP) At
days 1 and 3 of cell culture GT contained nano1047297bers (both blended and
corendashshell) without drug exhibited improved cell viability compared
to PLGA membranes The same trend was observed for TCH incorpo-
rated nano1047297bers though the presence of TCH slightly decreased cell
growth for some of the formulations compared to drug free nano1047297bers
However after 5 days TCH-loaded PG and PG(cs) nano1047297brous mats did
not exhibit signi1047297cant increase in cell viability compared to PLGA-TCH
Fig 8 SEMimagesof degraded nano1047297bersafter40 days(P as PLGA P-TCH as PLGA-TCHPG 7525 asPLGAGT 7525PG 7525-TCH as PLGAGT7525-TCH PG 5050as PLGAGT5050 PG
5050-TCH as PLGAGT 5050-TCH PG(cs) as core shell PLGAGT PG(cs)-TCH as core shell PLGAGT-TCH)
Fig 9 Release pro1047297le of TCH from PLGA-TCH PG 7525-TCH PG 5050-TCH PG(cs)-TCH electrospun scaffolds A) Entire release time B) initial burst release
528 M Ranjbar-Mohammadi et al Materials Science and Engineering C 58 (2016) 521ndash531
8192019 1-s20-S0928493115303222-main (1)
httpslidepdfcomreaderfull1-s20-s0928493115303222-main-1 911
nano1047297bers Moreover none of the electrospun scaffolds showed signif-
icant changes in cell viability after 5 days compared to TCP This is an in-
dication of cytocompatibility of the scaffolds essential for applications
such as treatment of periodontal diseases
36 Antibacterial properties
In this work the antibacterial activity of TCH-loaded PG(cs) PG
7525-TCH and PG(cs)-TCH nano1047297bers was investigated using S aureus
and Pseudomonas aeruginosa as model bacteriaThe drug loadedsamples
showed clear bacterial inhibition rings against Gram-positive bacteria
(S aureus) which is known to be a TCH-sensitive Gram-positive spheri-
cal bacterium that causes a wide range of suppurative infections The
bacterial inhibition ring was smaller on the nano1047297bers containing
Gram-negative bacteria (P aeruginosa) (Fig 11) These observations
may be related to structural differences between two different bacteria
Gram-negative bacteria are more resistant due to the thick lipopolysac-
charide wall structure
4 Discussion
Periodontitis is a major chronic in1047298ammatory disorder that can lead
to the loss of periodontal support for the periodontal ligament which
leads to the formation of an abnormal gap between the tooth and gum
[25] If the process continues the tooth can eventually get lost For
chronic periodontitis local antimicrobial agents are used as an adjunct
to scaling root planning and restoring the periodontalhealth [25] Mul-
tiple investigations have been conducted to incorporate antibiotics into
the polymeric carriers in order to develop a DDS for treatment of peri-
odontal diseases Polymeric DDS were designed in different structures
Fig 10 Proliferation of 1047297broblasts on electrospun nano1047297bers measured by MTS assay (P as PLGA P-TCH as PLGA-TCH PG 7525 as PLGAGT7525PG 7525-TCHas PLGAGT7525-TCH
PG 5050 as PLGAGT 5050 PG 5050-TCH as PLGAGT 5050-TCH PG(cs) as core shell PLGAGT PG(cs)-TCH as core shell PLGAGT-TCH)
Fig 11 Antibacterial properties of nano1047297bers A) PG(cs) B) PG 7525-TCH and C) PG(cs)-TCH
529M Ranjbar-Mohammadi et al Materials Science and Engineering C 58 (2016) 521 ndash531
8192019 1-s20-S0928493115303222-main (1)
httpslidepdfcomreaderfull1-s20-s0928493115303222-main-1 1011
such as1047297lms microparticles and1047297bers using bothsynthetic and natural
polymers [26]
TCHis oneof the widely employed antibiotics with proven effective-
nessin acceleration of periodontal treatment [27] TCHwith low toxicity
is a broadspectrum antibiotic which can be applied for thetreatment of
diseases caused by Gram-negative and Gram-positive microorganisms
by inhibiting protein synthesis in the bacteria [28] Besides its antibiotic
property it exhibits anti-in1047298ammatory properties and has the ability
to promote the attachment of 1047297
broblasts TCH has also been reportedas an inhibitor of the activity of proteinases and hence it can be used
to treat or prevent diseases related to proteinase imbalancerheumatoid
arthritis periodontitis and osteomyelitis [29] Previous studies showed
that the long term routine use of TCH for several months resulted
in clinically favorable effects for periodontal disease [30] Controlled
release of TCH was attempted by various researchers using various
drug delivery systems such as supramolecular gels based on amphi-
philic 345-trihydroxybenzoic derivatives[31] device based on ethylene
vinyl acetate (EVA) copolymer [32] and porous calcium phosphate
polyhydroxy butyrate composites [33] for various applications
Recent advances in the1047297eld of nanotechnology enable the fabrication
of nano1047297brous constructs containing drugs such that they have the ar-
chitectural features and morphological similarities matching the native
extracellular matrix (ECM) [3435] Unique properties of nano1047297bers
such as the high surface area high loading ease of operation and cost
effectiveness make them more suitable as drug delivery vehicles How-
ever drug release characteristics (eg burst release release rate and
duration) are signi1047297cantly in1047298uenced by extent of drug encapsulation
into thenano1047297brous scaffolds whichis greatly dependent to material se-
lection as well as the drug incorporation method [3626] In general
drugs can be incorporated into nano1047297bers via various methods such as
coatings blending co-axial and emulsion electrospinning [26] Recent
developments in this direction progressed with the application of nano-
1047297bers as drug delivery systems for periodontal diseases For example
Zamani et al [26] fabricated PCL nano1047297bers containing metronidazole
benzoate where the drug release was continued for a period of 15 days
In this study we explored the incorporation of TCH into a new
bicomponent carrier PLGA-gum tragacanth (GT) via two different
technics of blend electrospinning and coaxial electrospinning GT themedicinally imported polysaccharide consists of two major fractions a
water-soluble (tragacanthic acid and small amount of arabinogalactan)
and an insolublebut water-swellable fraction named bassorinGT exhib-
ited a considerable potency for wound healing in the form of mucilage
[21] or skin regeneration capability in the form of blend nano1047297bers
with PCL or PVA [2223] Due to the mentioned structural and composi-
tional advantages natural availability antibacterial properties and low
cost we believe that TCH loaded PG and PG(cs) 1047297bers can be employed
as a proper drug delivery system for multiple applications including
treatment of periodontal diseases We aimed to explore the effect of in-
corporation method (blending vs coaxial electrospinning) on the phys-
ical characteristics of the nano1047297bers and TCH release behavior from
PG and PG(cs) nano1047297bers Moreover the biocompatibility of the drug
loaded membranes was investigatedThe SEM images (Fig 2) showed that uniformly distributed nano1047297-
bers without beads were formed from all formulations Blending GT
with PLGA decreased the diameter of nano1047297bers Incorporation of TCH
into PLGA and PG(cs) nano1047297bers also reduced the 1047297ber diameter
while addition of the drug into the blend PG nano1047297bers did not cause
further reduction in diameter of the nano1047297bers (Table 1) The possible
reason for the reduction of the diameter of the nano1047297bers is that both
GT and TCH may improve the polarity of the solution which subse-
quently increases the electrical conductivity of the solution Moreover
PG(cs) nano1047297bers exhibited reduced diameter which can be attributed
to theuse of water as the core solvent High dielectric constant of water
(801 at 25 degC) is an indication of the ability of solution to carry more
electrical charges resulting in higher elongation forces and formation
of thinner nano1047297bers under the electrical 1047297eld [37]
The results of mechanical studies showed that PG membranes ex-
hibited less tensile strength compared to PLGA (Figs 6 and 7) This
canbe relatedto theeasier slippage of polymer chainsunder loadingbe-
cause of less entanglements and weak physical interactions among the
chains of mixed polymers [38] Another reason for lower strength of
PG 1047297bers can be the low mechanical strength of GT itself Moreover
TCH could also decrease the tensile strength as well as breaking strain
of all formulations due to probable plasticizing effect of TCH molecules
for polymer chains However the breaking strain of pure PLGA was de-creased more than seven timeswhile blend PG nano1047297bers had less than
50 reduction in strain at the presence of TCH compared to the similar
membranes without drug This can be attributed to the highly branched
structure of GT which intrinsically limited the elongation of its polymer
chains under the loading resulting in alleviation of the in1047298uence of TCH
on reduction of strain at break Mechanical behavior of the nano1047297bers
under wet condition is another factor of consideration since the mem-
branes inserted into the periodontal pocket are exposed to moist condi-
tion Results of mechanical studies under wet conditions showed that
except PG 5050 nano1047297bers other TCH loaded membranes preserved
their tensile strength in wet condition Interestingly the effect of TCH
on breaking strain of PG(cs) was dependent to drywet state of the
membrane In dry state addition of TCH caused a drastic decline in
breaking strain similar to pure PLGA since smaller amount of GT existed
in PG(cs) nano1047297bers compared to blend PG nano1047297bers However there-
duction in breaking strain of PG(cs) was limited to the extent compara-
ble to blend PG nano1047297bers in wetcondition This canbe attributed to the
more pronounced role of GT in hydrated state due to swelling effect of
this natural polymer resultingin distributionand occupationof a higher
volumeof the nano1047297bers by this polymer Forthe membraneswhichare
supposed to be inserted into theperiodontalpocket it is necessaryto in-
sure that the membrane possesses enough mechanical strength and ri-
gidity to be inserted into the pocket and retain its integrity during the
release time On the other hand the membrane should remain 1047298exible
and soft enough in the wet environment to conform to the periodontal
pocket and meet patient compliance [26] Elastic modulus is a good in-
dicator of the stiffness of a material Among various TCH incorporated
composite nano1047297bers PG(cs) exhibited the highest tensile strength
in both dry and wet conditions while its wet modulus was signi1047297-cantly lower than blend nano1047297bers That means TCH loaded PG(cs)
membranes may provide a proper texture to be easily inserted into
periodontal pocket with a certain amount of back pressure and remain
comfortably in the pocket with the lowest rigiditystiffness among the
composite nano1047297bers
The release kinetics of TCH from electrospun PLGA PG 7525
PG 5050 and PG(cs) scaffolds was studied for a period of 75 days
(Fig 9) For all the formulations initial burst release was attributed to
the release of surface connected drug [39] followed by a controlled re-
lease attributed to molecular diffusion through the polymer phase In
case of blended PG nano1047297bers the presence of hydrophilic PG segments
which are randomly distributed across the diffusion path can signi1047297-
cantly facilitate water uptake and swelling of the polymeric matrix
Therefore faster diffusion of the drug molecules out of the nano1047297bersoccurred resulting in higher release rate within the 1047297rst few days and
reaching a plateau after a certain period of time As expected the
explained effect of GT on release rate was enhanced by increasing the
fraction of this polymer in the blend such that the entire amount of
TCH was released from PG 5050 in 20 days These observations are in
agreement with wettability results which con1047297rmed the promoted
wettability of the scaffolds at higher ratios of GT in the nano 1047297bers
(Fig 5) However when GT was employed as the core along with TCH
the likelihood of having drug molecules as well as GT hydrophilic
segments onnear the surface of nano1047297bers is reduced In this case the
hydrophobic PLGA shell could control the water uptake and swelling
of the hydrophilic core material resulting in lowered burst release as
well as prolonged release of TCH in a sustained fashion for 75 days
The prolonged TCH release from PG(cs) nano1047297bers validates the use of
530 M Ranjbar-Mohammadi et al Materials Science and Engineering C 58 (2016) 521ndash531
8192019 1-s20-S0928493115303222-main (1)
httpslidepdfcomreaderfull1-s20-s0928493115303222-main-1 1111
core shell structure for periodontal treatment since the elimination of
hardened bacteria in periodontal pocket requires sustained exposure
to antibiotics [40]
The cytocompatibility studies showed that GT could successfully
support cell growth on nano1047297brous membranes in both blending and
corendashshell architecture This might be attributed to the more hydro-
philic properties of GT contained membranes which improves protein
adsorption and subsequent cell attachment and proliferation [4142]
On the other hand incorporation of TCH showed to decrease cellgrowth in some of the formulations due to the inhibitory effect of this
drug on mitochondrial protein synthesis [43] However none of the
GT contained scaffolds showed signi1047297cant changes in cell viability com-
pared to the control which demonstrates good cytocompatibility of
the composite membranes Antibacterial assessment of drug loaded
PG and PG(cs) nano1047297bers showed that these scaffolds are strong
enough against of S aureus bacteria
5 Conclusion
In the present study TCH-loaded blend and core shell nano1047297bers
with smooth and bead-less morphology were successfully fabricated
from PLGA and GT for application as new and controlled drug delivery
systems The release rate of TCH in PG blend nano1047297bers increased
with the increase of GT ratio due to enhanced hydrophilicity of the
electrospun nano1047297bers Compared to PG blend nano1047297bers PG(cs) mem-
branes showed a more prolonged release of TCH for 75 days with lower
burst release of the drug within the 1047297rst 2 h Among various formula-
tions PG(cs) nano1047297bers exhibited the highest tensile strength in both
dry and wet conditions while its wet modulus was signi1047297cantly lower
than blend nano1047297bers Thus the TCH loaded PG(cs) membranes might
be strong enough to be easily inserted into periodontal pocket and sus-
tainably release the incorporated drug while affording patient compli-
ance with low rigiditystiffness of the membrane during the treatment
Thesecharacteristics along with the proven cytocompatibility and anti-
bacterial properties of TCH loaded scaffolds suggest the particular ben-
e1047297ts of composite corendashshell nano1047297bers to be used as a drug delivery
system for periodontal diseases
Acknowledgments
This study was supported by the NRF-Technion grant (WBS No
R-398-001-065-592) and the Nanoscience and Nanotechnology Initia-
tive in the National University of Singapore
References
[1] B Felice MP Prabhakaran AP Rodriacuteguez S Ramakrishna J Mater Sci Eng C 4(2014) 178ndash195
[2] P Boisseau B Loubaton C R Phys 12 (2011) 620ndash636
[3] T Allen P Cullis Science 303 (2004) 1818ndash1822[4] Y Malam M Loizidou AM Seifalian Trends Pharmacol Sci 30 (2009) 592ndash599[5] J Zhang R Misra Acta Biomater 3 (2007) 838ndash850[6] B Wang Y Wang T Yin Q Yu Chem Eng Commun 197 (2010) 1315ndash1338[7] ZX Meng XX Xu WZheng HM Zhou LLi YF ZhengX LouJ Colloids SurfB 84
(2011) 97ndash102[8] G Jin MP P rabhakaran D Kai S Ramakrishna Eur J Pharm Biopharm 85 (2013)
689ndash698[9] W QianDGYu YLi YZ LiaoX WangL WangInt JMolSci15 (2014) 774ndash786
[10] H Qi P Hu J Xu A Wang Biomacromolecules 7 (2006) 2327ndash2330[11] TP Chaturvedi R Srivastava AK Srivastava V Gupta VP Kumar Int J Pharm
Investig 2 (2012) 213ndash
217[12] K Kim YK Luu C Chang D Fang BS Hsiao B Chu M Hadjiargyrou J ControlRelease 98 (2004) 47ndash56
[13] R Kenawy GL Bowlin K Mans1047297eld J Layman DG Simpson EH Sanders GEWnek J Control Release 81 (2002) 57ndash64
[14] J Zeng L Yang Q Liang X Zhang H Guan X Xu X Chen X Jing J ControlRelease105 (2005) 43ndash51
[15] X Xu L Yang X Xu X Wang X Chen Q Liang J Zeng X Jing J Control Release108 (2005) 33ndash42
[16] HK Makadia S Siegel Polymers (Basel) 3 (2011) 1377ndash1397[17] MU Adikwu Bentham Science Publishers (2009)[18] A Rasul M Iqbal G Murtaza MK Waqas M Hanif Acta Pol Pharm 67 (2010)
517ndash522[19] B Singh V Sharma Carbohydr Polym 101 (2014) 928ndash940[20] DMW Anderson MME Bridgeman Phytochemistry 24 (1985) 2301ndash2304[21] A Moghbel AAHemmatiH Agheli I RashidiK Amraee Arch Iran Med8 (2005)
257ndash262[22] M Ranjbar-MohammadiSH BahramiMT Joghataei J Mater SciEng C 33 (2013)
4935ndash4943
[23] M Ranjbar-Mohammadi SH Bahrami J Mater Sci Eng C 48 (2015) 71ndash79[24] CL He ZM Huang XJ Han J Biomed Mater Res A 89 (2009) 80ndash95[25] S PappalardoOA Baglio C Cappello S Guarrera M De Benedittis M Petruzzi RF
Grassi Minerva Stomatol 55 (2006) 655ndash661[26] M Zamani M Morshed J Varshosaz M Jannesari Eur J Pharm Biopharm 75
(2010) 179ndash185[27] G Isik S Ince F Saglam U Onan J Clin Periodontol 24 (1997) 589ndash594[28] AN Sapadin R Fleischmajer J Am Acad Dermatol 54 (2006) 258ndash265[29] ZR Domingues ME Cortes TA Gomes HF Diniz CS Freitas JB Gomes AMC
Faria RD Sinisterra Biomaterials 25 (2004) 327ndash333[30] RA Seymour PA Heasman J Clin Periodontol 22 (1995) 22ndash35[31] L Chen J Wu L Yuwen T Shu M Xu M Zhang T Yi Langmuir 25 (2009)
8434ndash8438[32] S Kalachandra L Dongming S Offenbacher J Mater Sci Mater Med 13 (2002)
53ndash58[33] LMedvecky R StulajterovaJ BriancinChemPap 61 (2007) 477ndash484 (composites)[34] E Vatankhah MP Prabhakaran G Jin L GhasemiMobarakeh S Ramakrishna
J Biomater Appl 28 (2013) 909ndash921[35] MC Bottino V Thomas G Schmidt YK Vohra TMG Chua MJ Kowolik GM
Janowski Dent Mater 2 (2012) 703ndash721[36] M Zamani MP Prabhakaran S Ramakrishna Int J Nanomedicine 8 (2013)
2997ndash3017[37] WK Son JH Youk TS Lee WH Park Polymer 45 (2004) 2959ndash2966[38] Y Zhang H Ouyang CT Lim S Ramakrishna ZM Huang J Biomed Mater Res B
Appl Biomater 72B (2005) 156ndash165[39] DH LewisIn M Chasin RLanger (eds) NewYork MarcelDekker Inc (1990)1ndash43[40] WJ Loesche NS Grossman Clin Microbiol Rev 14 (2001) 727ndash752[41] S Fleischer A Shapira O Regev N Nseir E Zussman T Dvir Biotechnol Bioeng
111 (2014) 1246ndash1257[42] R Ravichandran R Sridhar JR Venugopal S Sundarrajan S Mukherjee S
Ramakrishna Macromol Biosci 14 (2014) 515ndash525[43] C van den Bogert G van Kernebeek L Leij AM Kroon Cancer Lett 32 (1986)
341ndash351
531M Ranjbar-Mohammadi et al Materials Science and Engineering C 58 (2016) 521 ndash531
8192019 1-s20-S0928493115303222-main (1)
httpslidepdfcomreaderfull1-s20-s0928493115303222-main-1 711
value of elastic modulus (2200plusmn 167 MPa) in wet condition compared
to other formulations (Fig 7D and Table 2)
33 Degradation behavior of nano 1047297bers
Drug diffusion can be affected by scaffolds topology and morpholo-
gy Thusthe topological and morphological changes duringdegradation
might be able to control drug release rate from the nano1047297brous scaf-
folds Fig 8 presents the SEM images of the scaffolds after in vitro deg-
radation for a period of 40 days The 1047297brous structure of PLGA and
PG(cs) scaffolds with and without TCH was partially preserved after
40 days of degradation However blend PG scaffolds with and without
drug swelled to a large extent resulting in loss of nano1047297brous morphol-
ogy within similar time scale These results are in agreement with
higher wettability of PG nano1047297bers compared to PLGA and PG(cs)
nano1047297bers
34 Drug delivery
In this paper we determined the released amounts of TCH by mea-
suringthe absorbance at 362nm using an ultraviolet visible spectropho-
tometer Thereleaseof TCHfrom variouselectrospun scaffoldsis plotted
in Fig 9A amp B PLGA nano1047297bers exhibited an initial burst release of
2320 within the 1047297rst 2 h (Fig 9B) and reached a plateau within
7 days by releasing only 35 of TCH content The burst release of TCH
from PG 7525 nano1047297bers was very similar to pure PLGA (2479)
while PG 5050 had a signi1047297cantly higher amount of TCH (4830) re-
leased in the 1047297rst 2 h followedby a veryfast release of90of drugcon-
tent within 5 days However PG 7525 composite nano1047297bers showed
a sustained TCH release up to a period of 25 days the time point that
it reached to the plateau state For the core shell nano1047297bers where
TCH was incorporated in the core along with GT the burst release was
signi1047297cantly lower (19) compared to both pure PLGA and PG blend
Table 2
Tensile properties of the electrospun nano1047297bers under dry and wet conditions
Samples Dry scaffolds Wet scaffolds
T (μ m) EM (MPa) UTS (MPa) SB () T (μ m) EM (MPa) UTS (MPa) SB ()
PLGA 5680 7600 plusmn 360 422 + 002 11874 plusmn 117 5001 6900 plusmn 180 255 plusmn 003 6409 plusmn 112
PLGA-TCH 5802 8433 plusmn 781 258 plusmn 003 1592 plusmn 212 5277 6236 plusmn 283 171 plusmn 009 1158 plusmn 178
PG 7525 5499 4334 plusmn 223 230 plusmn 002 2240 plusmn 212 5686 4273 plusmn 136 170 plusmn 008 1517 plusmn 113
PG 7525-TCH 5307 6410 plusmn 334 101 plusmn 005 1350 plusmn 691 5430 5211 plusmn 219 102 plusmn 009 1133 plusmn 501
PG 5050 5503 3295 plusmn 100 093 plusmn 003 1392 plusmn 406 5333 3290 plusmn 110 089 plusmn 008 1422 plusmn 113
PG 5050-TCH 5409 3962 plusmn 131 072 plusmn 006 883 plusmn 702 5602 3381 plusmn 187 040 plusmn 010 775 plusmn 398
PG(cs) 5204 4020 plusmn 171 332 plusmn 003 10283 plusmn 301 4903 10532 plusmn 121 215 plusmn 002 3667 plusmn 113
PG(cs)-TCH 5375 4832 plusmn 413 151 plusmn 007 1424 plusmn 451 4889 2200 plusmn 167 157 plusmn 003 3341 plusmn 315
T average thickness of nano1047297bers EM elastic modulus UTS ultimate tensile strength SB strain at break
Fig 7 Mechanical properties of PBS hydrated (A) PLGA PLGA-TCH (B) PG 7525 PG 7525-TCH (C) PG 5050 PG 5050-TCH (D) PG(cs) and PG(cs)-TCH electrospun membranes after
48 h (P as PLGA P-TCH as PLGA-TCH PG 7525 as PLGAGT7525PG 7525-TCHas PLGAGT7525-TCHPG 5050 as PLGAGT5050 PG 5050-TCHas PLGAGT5050-TCHPG(cs)as core
shell PLGAGT PG(cs)-TCH as core shell PLGAGT-TCH)
527M Ranjbar-Mohammadi et al Materials Science and Engineering C 58 (2016) 521 ndash531
8192019 1-s20-S0928493115303222-main (1)
httpslidepdfcomreaderfull1-s20-s0928493115303222-main-1 811
nano1047297bers Following burst releasePG(cs) scaffolds showed a prolonged
sustained release over the entire study period (75 days) by releasing
6810 of the total TCH content by this time
35 Proliferation of 1047297broblasts on electrospun scaffolds
The cytocompatibility of the electrospun scaffolds was evaluated by
MTS assay after culturing 1047297broblasts on the nano1047297bers over a period of
13 and 5 daysandtheresultsareshownin Fig 10 Cell proliferation on
all the scaffolds (with or without drug) was found to increase with cul-
ture time similar to thetrend observed on tissueculture plates (TCP) At
days 1 and 3 of cell culture GT contained nano1047297bers (both blended and
corendashshell) without drug exhibited improved cell viability compared
to PLGA membranes The same trend was observed for TCH incorpo-
rated nano1047297bers though the presence of TCH slightly decreased cell
growth for some of the formulations compared to drug free nano1047297bers
However after 5 days TCH-loaded PG and PG(cs) nano1047297brous mats did
not exhibit signi1047297cant increase in cell viability compared to PLGA-TCH
Fig 8 SEMimagesof degraded nano1047297bersafter40 days(P as PLGA P-TCH as PLGA-TCHPG 7525 asPLGAGT 7525PG 7525-TCH as PLGAGT7525-TCH PG 5050as PLGAGT5050 PG
5050-TCH as PLGAGT 5050-TCH PG(cs) as core shell PLGAGT PG(cs)-TCH as core shell PLGAGT-TCH)
Fig 9 Release pro1047297le of TCH from PLGA-TCH PG 7525-TCH PG 5050-TCH PG(cs)-TCH electrospun scaffolds A) Entire release time B) initial burst release
528 M Ranjbar-Mohammadi et al Materials Science and Engineering C 58 (2016) 521ndash531
8192019 1-s20-S0928493115303222-main (1)
httpslidepdfcomreaderfull1-s20-s0928493115303222-main-1 911
nano1047297bers Moreover none of the electrospun scaffolds showed signif-
icant changes in cell viability after 5 days compared to TCP This is an in-
dication of cytocompatibility of the scaffolds essential for applications
such as treatment of periodontal diseases
36 Antibacterial properties
In this work the antibacterial activity of TCH-loaded PG(cs) PG
7525-TCH and PG(cs)-TCH nano1047297bers was investigated using S aureus
and Pseudomonas aeruginosa as model bacteriaThe drug loadedsamples
showed clear bacterial inhibition rings against Gram-positive bacteria
(S aureus) which is known to be a TCH-sensitive Gram-positive spheri-
cal bacterium that causes a wide range of suppurative infections The
bacterial inhibition ring was smaller on the nano1047297bers containing
Gram-negative bacteria (P aeruginosa) (Fig 11) These observations
may be related to structural differences between two different bacteria
Gram-negative bacteria are more resistant due to the thick lipopolysac-
charide wall structure
4 Discussion
Periodontitis is a major chronic in1047298ammatory disorder that can lead
to the loss of periodontal support for the periodontal ligament which
leads to the formation of an abnormal gap between the tooth and gum
[25] If the process continues the tooth can eventually get lost For
chronic periodontitis local antimicrobial agents are used as an adjunct
to scaling root planning and restoring the periodontalhealth [25] Mul-
tiple investigations have been conducted to incorporate antibiotics into
the polymeric carriers in order to develop a DDS for treatment of peri-
odontal diseases Polymeric DDS were designed in different structures
Fig 10 Proliferation of 1047297broblasts on electrospun nano1047297bers measured by MTS assay (P as PLGA P-TCH as PLGA-TCH PG 7525 as PLGAGT7525PG 7525-TCHas PLGAGT7525-TCH
PG 5050 as PLGAGT 5050 PG 5050-TCH as PLGAGT 5050-TCH PG(cs) as core shell PLGAGT PG(cs)-TCH as core shell PLGAGT-TCH)
Fig 11 Antibacterial properties of nano1047297bers A) PG(cs) B) PG 7525-TCH and C) PG(cs)-TCH
529M Ranjbar-Mohammadi et al Materials Science and Engineering C 58 (2016) 521 ndash531
8192019 1-s20-S0928493115303222-main (1)
httpslidepdfcomreaderfull1-s20-s0928493115303222-main-1 1011
such as1047297lms microparticles and1047297bers using bothsynthetic and natural
polymers [26]
TCHis oneof the widely employed antibiotics with proven effective-
nessin acceleration of periodontal treatment [27] TCHwith low toxicity
is a broadspectrum antibiotic which can be applied for thetreatment of
diseases caused by Gram-negative and Gram-positive microorganisms
by inhibiting protein synthesis in the bacteria [28] Besides its antibiotic
property it exhibits anti-in1047298ammatory properties and has the ability
to promote the attachment of 1047297
broblasts TCH has also been reportedas an inhibitor of the activity of proteinases and hence it can be used
to treat or prevent diseases related to proteinase imbalancerheumatoid
arthritis periodontitis and osteomyelitis [29] Previous studies showed
that the long term routine use of TCH for several months resulted
in clinically favorable effects for periodontal disease [30] Controlled
release of TCH was attempted by various researchers using various
drug delivery systems such as supramolecular gels based on amphi-
philic 345-trihydroxybenzoic derivatives[31] device based on ethylene
vinyl acetate (EVA) copolymer [32] and porous calcium phosphate
polyhydroxy butyrate composites [33] for various applications
Recent advances in the1047297eld of nanotechnology enable the fabrication
of nano1047297brous constructs containing drugs such that they have the ar-
chitectural features and morphological similarities matching the native
extracellular matrix (ECM) [3435] Unique properties of nano1047297bers
such as the high surface area high loading ease of operation and cost
effectiveness make them more suitable as drug delivery vehicles How-
ever drug release characteristics (eg burst release release rate and
duration) are signi1047297cantly in1047298uenced by extent of drug encapsulation
into thenano1047297brous scaffolds whichis greatly dependent to material se-
lection as well as the drug incorporation method [3626] In general
drugs can be incorporated into nano1047297bers via various methods such as
coatings blending co-axial and emulsion electrospinning [26] Recent
developments in this direction progressed with the application of nano-
1047297bers as drug delivery systems for periodontal diseases For example
Zamani et al [26] fabricated PCL nano1047297bers containing metronidazole
benzoate where the drug release was continued for a period of 15 days
In this study we explored the incorporation of TCH into a new
bicomponent carrier PLGA-gum tragacanth (GT) via two different
technics of blend electrospinning and coaxial electrospinning GT themedicinally imported polysaccharide consists of two major fractions a
water-soluble (tragacanthic acid and small amount of arabinogalactan)
and an insolublebut water-swellable fraction named bassorinGT exhib-
ited a considerable potency for wound healing in the form of mucilage
[21] or skin regeneration capability in the form of blend nano1047297bers
with PCL or PVA [2223] Due to the mentioned structural and composi-
tional advantages natural availability antibacterial properties and low
cost we believe that TCH loaded PG and PG(cs) 1047297bers can be employed
as a proper drug delivery system for multiple applications including
treatment of periodontal diseases We aimed to explore the effect of in-
corporation method (blending vs coaxial electrospinning) on the phys-
ical characteristics of the nano1047297bers and TCH release behavior from
PG and PG(cs) nano1047297bers Moreover the biocompatibility of the drug
loaded membranes was investigatedThe SEM images (Fig 2) showed that uniformly distributed nano1047297-
bers without beads were formed from all formulations Blending GT
with PLGA decreased the diameter of nano1047297bers Incorporation of TCH
into PLGA and PG(cs) nano1047297bers also reduced the 1047297ber diameter
while addition of the drug into the blend PG nano1047297bers did not cause
further reduction in diameter of the nano1047297bers (Table 1) The possible
reason for the reduction of the diameter of the nano1047297bers is that both
GT and TCH may improve the polarity of the solution which subse-
quently increases the electrical conductivity of the solution Moreover
PG(cs) nano1047297bers exhibited reduced diameter which can be attributed
to theuse of water as the core solvent High dielectric constant of water
(801 at 25 degC) is an indication of the ability of solution to carry more
electrical charges resulting in higher elongation forces and formation
of thinner nano1047297bers under the electrical 1047297eld [37]
The results of mechanical studies showed that PG membranes ex-
hibited less tensile strength compared to PLGA (Figs 6 and 7) This
canbe relatedto theeasier slippage of polymer chainsunder loadingbe-
cause of less entanglements and weak physical interactions among the
chains of mixed polymers [38] Another reason for lower strength of
PG 1047297bers can be the low mechanical strength of GT itself Moreover
TCH could also decrease the tensile strength as well as breaking strain
of all formulations due to probable plasticizing effect of TCH molecules
for polymer chains However the breaking strain of pure PLGA was de-creased more than seven timeswhile blend PG nano1047297bers had less than
50 reduction in strain at the presence of TCH compared to the similar
membranes without drug This can be attributed to the highly branched
structure of GT which intrinsically limited the elongation of its polymer
chains under the loading resulting in alleviation of the in1047298uence of TCH
on reduction of strain at break Mechanical behavior of the nano1047297bers
under wet condition is another factor of consideration since the mem-
branes inserted into the periodontal pocket are exposed to moist condi-
tion Results of mechanical studies under wet conditions showed that
except PG 5050 nano1047297bers other TCH loaded membranes preserved
their tensile strength in wet condition Interestingly the effect of TCH
on breaking strain of PG(cs) was dependent to drywet state of the
membrane In dry state addition of TCH caused a drastic decline in
breaking strain similar to pure PLGA since smaller amount of GT existed
in PG(cs) nano1047297bers compared to blend PG nano1047297bers However there-
duction in breaking strain of PG(cs) was limited to the extent compara-
ble to blend PG nano1047297bers in wetcondition This canbe attributed to the
more pronounced role of GT in hydrated state due to swelling effect of
this natural polymer resultingin distributionand occupationof a higher
volumeof the nano1047297bers by this polymer Forthe membraneswhichare
supposed to be inserted into theperiodontalpocket it is necessaryto in-
sure that the membrane possesses enough mechanical strength and ri-
gidity to be inserted into the pocket and retain its integrity during the
release time On the other hand the membrane should remain 1047298exible
and soft enough in the wet environment to conform to the periodontal
pocket and meet patient compliance [26] Elastic modulus is a good in-
dicator of the stiffness of a material Among various TCH incorporated
composite nano1047297bers PG(cs) exhibited the highest tensile strength
in both dry and wet conditions while its wet modulus was signi1047297-cantly lower than blend nano1047297bers That means TCH loaded PG(cs)
membranes may provide a proper texture to be easily inserted into
periodontal pocket with a certain amount of back pressure and remain
comfortably in the pocket with the lowest rigiditystiffness among the
composite nano1047297bers
The release kinetics of TCH from electrospun PLGA PG 7525
PG 5050 and PG(cs) scaffolds was studied for a period of 75 days
(Fig 9) For all the formulations initial burst release was attributed to
the release of surface connected drug [39] followed by a controlled re-
lease attributed to molecular diffusion through the polymer phase In
case of blended PG nano1047297bers the presence of hydrophilic PG segments
which are randomly distributed across the diffusion path can signi1047297-
cantly facilitate water uptake and swelling of the polymeric matrix
Therefore faster diffusion of the drug molecules out of the nano1047297bersoccurred resulting in higher release rate within the 1047297rst few days and
reaching a plateau after a certain period of time As expected the
explained effect of GT on release rate was enhanced by increasing the
fraction of this polymer in the blend such that the entire amount of
TCH was released from PG 5050 in 20 days These observations are in
agreement with wettability results which con1047297rmed the promoted
wettability of the scaffolds at higher ratios of GT in the nano 1047297bers
(Fig 5) However when GT was employed as the core along with TCH
the likelihood of having drug molecules as well as GT hydrophilic
segments onnear the surface of nano1047297bers is reduced In this case the
hydrophobic PLGA shell could control the water uptake and swelling
of the hydrophilic core material resulting in lowered burst release as
well as prolonged release of TCH in a sustained fashion for 75 days
The prolonged TCH release from PG(cs) nano1047297bers validates the use of
530 M Ranjbar-Mohammadi et al Materials Science and Engineering C 58 (2016) 521ndash531
8192019 1-s20-S0928493115303222-main (1)
httpslidepdfcomreaderfull1-s20-s0928493115303222-main-1 1111
core shell structure for periodontal treatment since the elimination of
hardened bacteria in periodontal pocket requires sustained exposure
to antibiotics [40]
The cytocompatibility studies showed that GT could successfully
support cell growth on nano1047297brous membranes in both blending and
corendashshell architecture This might be attributed to the more hydro-
philic properties of GT contained membranes which improves protein
adsorption and subsequent cell attachment and proliferation [4142]
On the other hand incorporation of TCH showed to decrease cellgrowth in some of the formulations due to the inhibitory effect of this
drug on mitochondrial protein synthesis [43] However none of the
GT contained scaffolds showed signi1047297cant changes in cell viability com-
pared to the control which demonstrates good cytocompatibility of
the composite membranes Antibacterial assessment of drug loaded
PG and PG(cs) nano1047297bers showed that these scaffolds are strong
enough against of S aureus bacteria
5 Conclusion
In the present study TCH-loaded blend and core shell nano1047297bers
with smooth and bead-less morphology were successfully fabricated
from PLGA and GT for application as new and controlled drug delivery
systems The release rate of TCH in PG blend nano1047297bers increased
with the increase of GT ratio due to enhanced hydrophilicity of the
electrospun nano1047297bers Compared to PG blend nano1047297bers PG(cs) mem-
branes showed a more prolonged release of TCH for 75 days with lower
burst release of the drug within the 1047297rst 2 h Among various formula-
tions PG(cs) nano1047297bers exhibited the highest tensile strength in both
dry and wet conditions while its wet modulus was signi1047297cantly lower
than blend nano1047297bers Thus the TCH loaded PG(cs) membranes might
be strong enough to be easily inserted into periodontal pocket and sus-
tainably release the incorporated drug while affording patient compli-
ance with low rigiditystiffness of the membrane during the treatment
Thesecharacteristics along with the proven cytocompatibility and anti-
bacterial properties of TCH loaded scaffolds suggest the particular ben-
e1047297ts of composite corendashshell nano1047297bers to be used as a drug delivery
system for periodontal diseases
Acknowledgments
This study was supported by the NRF-Technion grant (WBS No
R-398-001-065-592) and the Nanoscience and Nanotechnology Initia-
tive in the National University of Singapore
References
[1] B Felice MP Prabhakaran AP Rodriacuteguez S Ramakrishna J Mater Sci Eng C 4(2014) 178ndash195
[2] P Boisseau B Loubaton C R Phys 12 (2011) 620ndash636
[3] T Allen P Cullis Science 303 (2004) 1818ndash1822[4] Y Malam M Loizidou AM Seifalian Trends Pharmacol Sci 30 (2009) 592ndash599[5] J Zhang R Misra Acta Biomater 3 (2007) 838ndash850[6] B Wang Y Wang T Yin Q Yu Chem Eng Commun 197 (2010) 1315ndash1338[7] ZX Meng XX Xu WZheng HM Zhou LLi YF ZhengX LouJ Colloids SurfB 84
(2011) 97ndash102[8] G Jin MP P rabhakaran D Kai S Ramakrishna Eur J Pharm Biopharm 85 (2013)
689ndash698[9] W QianDGYu YLi YZ LiaoX WangL WangInt JMolSci15 (2014) 774ndash786
[10] H Qi P Hu J Xu A Wang Biomacromolecules 7 (2006) 2327ndash2330[11] TP Chaturvedi R Srivastava AK Srivastava V Gupta VP Kumar Int J Pharm
Investig 2 (2012) 213ndash
217[12] K Kim YK Luu C Chang D Fang BS Hsiao B Chu M Hadjiargyrou J ControlRelease 98 (2004) 47ndash56
[13] R Kenawy GL Bowlin K Mans1047297eld J Layman DG Simpson EH Sanders GEWnek J Control Release 81 (2002) 57ndash64
[14] J Zeng L Yang Q Liang X Zhang H Guan X Xu X Chen X Jing J ControlRelease105 (2005) 43ndash51
[15] X Xu L Yang X Xu X Wang X Chen Q Liang J Zeng X Jing J Control Release108 (2005) 33ndash42
[16] HK Makadia S Siegel Polymers (Basel) 3 (2011) 1377ndash1397[17] MU Adikwu Bentham Science Publishers (2009)[18] A Rasul M Iqbal G Murtaza MK Waqas M Hanif Acta Pol Pharm 67 (2010)
517ndash522[19] B Singh V Sharma Carbohydr Polym 101 (2014) 928ndash940[20] DMW Anderson MME Bridgeman Phytochemistry 24 (1985) 2301ndash2304[21] A Moghbel AAHemmatiH Agheli I RashidiK Amraee Arch Iran Med8 (2005)
257ndash262[22] M Ranjbar-MohammadiSH BahramiMT Joghataei J Mater SciEng C 33 (2013)
4935ndash4943
[23] M Ranjbar-Mohammadi SH Bahrami J Mater Sci Eng C 48 (2015) 71ndash79[24] CL He ZM Huang XJ Han J Biomed Mater Res A 89 (2009) 80ndash95[25] S PappalardoOA Baglio C Cappello S Guarrera M De Benedittis M Petruzzi RF
Grassi Minerva Stomatol 55 (2006) 655ndash661[26] M Zamani M Morshed J Varshosaz M Jannesari Eur J Pharm Biopharm 75
(2010) 179ndash185[27] G Isik S Ince F Saglam U Onan J Clin Periodontol 24 (1997) 589ndash594[28] AN Sapadin R Fleischmajer J Am Acad Dermatol 54 (2006) 258ndash265[29] ZR Domingues ME Cortes TA Gomes HF Diniz CS Freitas JB Gomes AMC
Faria RD Sinisterra Biomaterials 25 (2004) 327ndash333[30] RA Seymour PA Heasman J Clin Periodontol 22 (1995) 22ndash35[31] L Chen J Wu L Yuwen T Shu M Xu M Zhang T Yi Langmuir 25 (2009)
8434ndash8438[32] S Kalachandra L Dongming S Offenbacher J Mater Sci Mater Med 13 (2002)
53ndash58[33] LMedvecky R StulajterovaJ BriancinChemPap 61 (2007) 477ndash484 (composites)[34] E Vatankhah MP Prabhakaran G Jin L GhasemiMobarakeh S Ramakrishna
J Biomater Appl 28 (2013) 909ndash921[35] MC Bottino V Thomas G Schmidt YK Vohra TMG Chua MJ Kowolik GM
Janowski Dent Mater 2 (2012) 703ndash721[36] M Zamani MP Prabhakaran S Ramakrishna Int J Nanomedicine 8 (2013)
2997ndash3017[37] WK Son JH Youk TS Lee WH Park Polymer 45 (2004) 2959ndash2966[38] Y Zhang H Ouyang CT Lim S Ramakrishna ZM Huang J Biomed Mater Res B
Appl Biomater 72B (2005) 156ndash165[39] DH LewisIn M Chasin RLanger (eds) NewYork MarcelDekker Inc (1990)1ndash43[40] WJ Loesche NS Grossman Clin Microbiol Rev 14 (2001) 727ndash752[41] S Fleischer A Shapira O Regev N Nseir E Zussman T Dvir Biotechnol Bioeng
111 (2014) 1246ndash1257[42] R Ravichandran R Sridhar JR Venugopal S Sundarrajan S Mukherjee S
Ramakrishna Macromol Biosci 14 (2014) 515ndash525[43] C van den Bogert G van Kernebeek L Leij AM Kroon Cancer Lett 32 (1986)
341ndash351
531M Ranjbar-Mohammadi et al Materials Science and Engineering C 58 (2016) 521 ndash531
8192019 1-s20-S0928493115303222-main (1)
httpslidepdfcomreaderfull1-s20-s0928493115303222-main-1 811
nano1047297bers Following burst releasePG(cs) scaffolds showed a prolonged
sustained release over the entire study period (75 days) by releasing
6810 of the total TCH content by this time
35 Proliferation of 1047297broblasts on electrospun scaffolds
The cytocompatibility of the electrospun scaffolds was evaluated by
MTS assay after culturing 1047297broblasts on the nano1047297bers over a period of
13 and 5 daysandtheresultsareshownin Fig 10 Cell proliferation on
all the scaffolds (with or without drug) was found to increase with cul-
ture time similar to thetrend observed on tissueculture plates (TCP) At
days 1 and 3 of cell culture GT contained nano1047297bers (both blended and
corendashshell) without drug exhibited improved cell viability compared
to PLGA membranes The same trend was observed for TCH incorpo-
rated nano1047297bers though the presence of TCH slightly decreased cell
growth for some of the formulations compared to drug free nano1047297bers
However after 5 days TCH-loaded PG and PG(cs) nano1047297brous mats did
not exhibit signi1047297cant increase in cell viability compared to PLGA-TCH
Fig 8 SEMimagesof degraded nano1047297bersafter40 days(P as PLGA P-TCH as PLGA-TCHPG 7525 asPLGAGT 7525PG 7525-TCH as PLGAGT7525-TCH PG 5050as PLGAGT5050 PG
5050-TCH as PLGAGT 5050-TCH PG(cs) as core shell PLGAGT PG(cs)-TCH as core shell PLGAGT-TCH)
Fig 9 Release pro1047297le of TCH from PLGA-TCH PG 7525-TCH PG 5050-TCH PG(cs)-TCH electrospun scaffolds A) Entire release time B) initial burst release
528 M Ranjbar-Mohammadi et al Materials Science and Engineering C 58 (2016) 521ndash531
8192019 1-s20-S0928493115303222-main (1)
httpslidepdfcomreaderfull1-s20-s0928493115303222-main-1 911
nano1047297bers Moreover none of the electrospun scaffolds showed signif-
icant changes in cell viability after 5 days compared to TCP This is an in-
dication of cytocompatibility of the scaffolds essential for applications
such as treatment of periodontal diseases
36 Antibacterial properties
In this work the antibacterial activity of TCH-loaded PG(cs) PG
7525-TCH and PG(cs)-TCH nano1047297bers was investigated using S aureus
and Pseudomonas aeruginosa as model bacteriaThe drug loadedsamples
showed clear bacterial inhibition rings against Gram-positive bacteria
(S aureus) which is known to be a TCH-sensitive Gram-positive spheri-
cal bacterium that causes a wide range of suppurative infections The
bacterial inhibition ring was smaller on the nano1047297bers containing
Gram-negative bacteria (P aeruginosa) (Fig 11) These observations
may be related to structural differences between two different bacteria
Gram-negative bacteria are more resistant due to the thick lipopolysac-
charide wall structure
4 Discussion
Periodontitis is a major chronic in1047298ammatory disorder that can lead
to the loss of periodontal support for the periodontal ligament which
leads to the formation of an abnormal gap between the tooth and gum
[25] If the process continues the tooth can eventually get lost For
chronic periodontitis local antimicrobial agents are used as an adjunct
to scaling root planning and restoring the periodontalhealth [25] Mul-
tiple investigations have been conducted to incorporate antibiotics into
the polymeric carriers in order to develop a DDS for treatment of peri-
odontal diseases Polymeric DDS were designed in different structures
Fig 10 Proliferation of 1047297broblasts on electrospun nano1047297bers measured by MTS assay (P as PLGA P-TCH as PLGA-TCH PG 7525 as PLGAGT7525PG 7525-TCHas PLGAGT7525-TCH
PG 5050 as PLGAGT 5050 PG 5050-TCH as PLGAGT 5050-TCH PG(cs) as core shell PLGAGT PG(cs)-TCH as core shell PLGAGT-TCH)
Fig 11 Antibacterial properties of nano1047297bers A) PG(cs) B) PG 7525-TCH and C) PG(cs)-TCH
529M Ranjbar-Mohammadi et al Materials Science and Engineering C 58 (2016) 521 ndash531
8192019 1-s20-S0928493115303222-main (1)
httpslidepdfcomreaderfull1-s20-s0928493115303222-main-1 1011
such as1047297lms microparticles and1047297bers using bothsynthetic and natural
polymers [26]
TCHis oneof the widely employed antibiotics with proven effective-
nessin acceleration of periodontal treatment [27] TCHwith low toxicity
is a broadspectrum antibiotic which can be applied for thetreatment of
diseases caused by Gram-negative and Gram-positive microorganisms
by inhibiting protein synthesis in the bacteria [28] Besides its antibiotic
property it exhibits anti-in1047298ammatory properties and has the ability
to promote the attachment of 1047297
broblasts TCH has also been reportedas an inhibitor of the activity of proteinases and hence it can be used
to treat or prevent diseases related to proteinase imbalancerheumatoid
arthritis periodontitis and osteomyelitis [29] Previous studies showed
that the long term routine use of TCH for several months resulted
in clinically favorable effects for periodontal disease [30] Controlled
release of TCH was attempted by various researchers using various
drug delivery systems such as supramolecular gels based on amphi-
philic 345-trihydroxybenzoic derivatives[31] device based on ethylene
vinyl acetate (EVA) copolymer [32] and porous calcium phosphate
polyhydroxy butyrate composites [33] for various applications
Recent advances in the1047297eld of nanotechnology enable the fabrication
of nano1047297brous constructs containing drugs such that they have the ar-
chitectural features and morphological similarities matching the native
extracellular matrix (ECM) [3435] Unique properties of nano1047297bers
such as the high surface area high loading ease of operation and cost
effectiveness make them more suitable as drug delivery vehicles How-
ever drug release characteristics (eg burst release release rate and
duration) are signi1047297cantly in1047298uenced by extent of drug encapsulation
into thenano1047297brous scaffolds whichis greatly dependent to material se-
lection as well as the drug incorporation method [3626] In general
drugs can be incorporated into nano1047297bers via various methods such as
coatings blending co-axial and emulsion electrospinning [26] Recent
developments in this direction progressed with the application of nano-
1047297bers as drug delivery systems for periodontal diseases For example
Zamani et al [26] fabricated PCL nano1047297bers containing metronidazole
benzoate where the drug release was continued for a period of 15 days
In this study we explored the incorporation of TCH into a new
bicomponent carrier PLGA-gum tragacanth (GT) via two different
technics of blend electrospinning and coaxial electrospinning GT themedicinally imported polysaccharide consists of two major fractions a
water-soluble (tragacanthic acid and small amount of arabinogalactan)
and an insolublebut water-swellable fraction named bassorinGT exhib-
ited a considerable potency for wound healing in the form of mucilage
[21] or skin regeneration capability in the form of blend nano1047297bers
with PCL or PVA [2223] Due to the mentioned structural and composi-
tional advantages natural availability antibacterial properties and low
cost we believe that TCH loaded PG and PG(cs) 1047297bers can be employed
as a proper drug delivery system for multiple applications including
treatment of periodontal diseases We aimed to explore the effect of in-
corporation method (blending vs coaxial electrospinning) on the phys-
ical characteristics of the nano1047297bers and TCH release behavior from
PG and PG(cs) nano1047297bers Moreover the biocompatibility of the drug
loaded membranes was investigatedThe SEM images (Fig 2) showed that uniformly distributed nano1047297-
bers without beads were formed from all formulations Blending GT
with PLGA decreased the diameter of nano1047297bers Incorporation of TCH
into PLGA and PG(cs) nano1047297bers also reduced the 1047297ber diameter
while addition of the drug into the blend PG nano1047297bers did not cause
further reduction in diameter of the nano1047297bers (Table 1) The possible
reason for the reduction of the diameter of the nano1047297bers is that both
GT and TCH may improve the polarity of the solution which subse-
quently increases the electrical conductivity of the solution Moreover
PG(cs) nano1047297bers exhibited reduced diameter which can be attributed
to theuse of water as the core solvent High dielectric constant of water
(801 at 25 degC) is an indication of the ability of solution to carry more
electrical charges resulting in higher elongation forces and formation
of thinner nano1047297bers under the electrical 1047297eld [37]
The results of mechanical studies showed that PG membranes ex-
hibited less tensile strength compared to PLGA (Figs 6 and 7) This
canbe relatedto theeasier slippage of polymer chainsunder loadingbe-
cause of less entanglements and weak physical interactions among the
chains of mixed polymers [38] Another reason for lower strength of
PG 1047297bers can be the low mechanical strength of GT itself Moreover
TCH could also decrease the tensile strength as well as breaking strain
of all formulations due to probable plasticizing effect of TCH molecules
for polymer chains However the breaking strain of pure PLGA was de-creased more than seven timeswhile blend PG nano1047297bers had less than
50 reduction in strain at the presence of TCH compared to the similar
membranes without drug This can be attributed to the highly branched
structure of GT which intrinsically limited the elongation of its polymer
chains under the loading resulting in alleviation of the in1047298uence of TCH
on reduction of strain at break Mechanical behavior of the nano1047297bers
under wet condition is another factor of consideration since the mem-
branes inserted into the periodontal pocket are exposed to moist condi-
tion Results of mechanical studies under wet conditions showed that
except PG 5050 nano1047297bers other TCH loaded membranes preserved
their tensile strength in wet condition Interestingly the effect of TCH
on breaking strain of PG(cs) was dependent to drywet state of the
membrane In dry state addition of TCH caused a drastic decline in
breaking strain similar to pure PLGA since smaller amount of GT existed
in PG(cs) nano1047297bers compared to blend PG nano1047297bers However there-
duction in breaking strain of PG(cs) was limited to the extent compara-
ble to blend PG nano1047297bers in wetcondition This canbe attributed to the
more pronounced role of GT in hydrated state due to swelling effect of
this natural polymer resultingin distributionand occupationof a higher
volumeof the nano1047297bers by this polymer Forthe membraneswhichare
supposed to be inserted into theperiodontalpocket it is necessaryto in-
sure that the membrane possesses enough mechanical strength and ri-
gidity to be inserted into the pocket and retain its integrity during the
release time On the other hand the membrane should remain 1047298exible
and soft enough in the wet environment to conform to the periodontal
pocket and meet patient compliance [26] Elastic modulus is a good in-
dicator of the stiffness of a material Among various TCH incorporated
composite nano1047297bers PG(cs) exhibited the highest tensile strength
in both dry and wet conditions while its wet modulus was signi1047297-cantly lower than blend nano1047297bers That means TCH loaded PG(cs)
membranes may provide a proper texture to be easily inserted into
periodontal pocket with a certain amount of back pressure and remain
comfortably in the pocket with the lowest rigiditystiffness among the
composite nano1047297bers
The release kinetics of TCH from electrospun PLGA PG 7525
PG 5050 and PG(cs) scaffolds was studied for a period of 75 days
(Fig 9) For all the formulations initial burst release was attributed to
the release of surface connected drug [39] followed by a controlled re-
lease attributed to molecular diffusion through the polymer phase In
case of blended PG nano1047297bers the presence of hydrophilic PG segments
which are randomly distributed across the diffusion path can signi1047297-
cantly facilitate water uptake and swelling of the polymeric matrix
Therefore faster diffusion of the drug molecules out of the nano1047297bersoccurred resulting in higher release rate within the 1047297rst few days and
reaching a plateau after a certain period of time As expected the
explained effect of GT on release rate was enhanced by increasing the
fraction of this polymer in the blend such that the entire amount of
TCH was released from PG 5050 in 20 days These observations are in
agreement with wettability results which con1047297rmed the promoted
wettability of the scaffolds at higher ratios of GT in the nano 1047297bers
(Fig 5) However when GT was employed as the core along with TCH
the likelihood of having drug molecules as well as GT hydrophilic
segments onnear the surface of nano1047297bers is reduced In this case the
hydrophobic PLGA shell could control the water uptake and swelling
of the hydrophilic core material resulting in lowered burst release as
well as prolonged release of TCH in a sustained fashion for 75 days
The prolonged TCH release from PG(cs) nano1047297bers validates the use of
530 M Ranjbar-Mohammadi et al Materials Science and Engineering C 58 (2016) 521ndash531
8192019 1-s20-S0928493115303222-main (1)
httpslidepdfcomreaderfull1-s20-s0928493115303222-main-1 1111
core shell structure for periodontal treatment since the elimination of
hardened bacteria in periodontal pocket requires sustained exposure
to antibiotics [40]
The cytocompatibility studies showed that GT could successfully
support cell growth on nano1047297brous membranes in both blending and
corendashshell architecture This might be attributed to the more hydro-
philic properties of GT contained membranes which improves protein
adsorption and subsequent cell attachment and proliferation [4142]
On the other hand incorporation of TCH showed to decrease cellgrowth in some of the formulations due to the inhibitory effect of this
drug on mitochondrial protein synthesis [43] However none of the
GT contained scaffolds showed signi1047297cant changes in cell viability com-
pared to the control which demonstrates good cytocompatibility of
the composite membranes Antibacterial assessment of drug loaded
PG and PG(cs) nano1047297bers showed that these scaffolds are strong
enough against of S aureus bacteria
5 Conclusion
In the present study TCH-loaded blend and core shell nano1047297bers
with smooth and bead-less morphology were successfully fabricated
from PLGA and GT for application as new and controlled drug delivery
systems The release rate of TCH in PG blend nano1047297bers increased
with the increase of GT ratio due to enhanced hydrophilicity of the
electrospun nano1047297bers Compared to PG blend nano1047297bers PG(cs) mem-
branes showed a more prolonged release of TCH for 75 days with lower
burst release of the drug within the 1047297rst 2 h Among various formula-
tions PG(cs) nano1047297bers exhibited the highest tensile strength in both
dry and wet conditions while its wet modulus was signi1047297cantly lower
than blend nano1047297bers Thus the TCH loaded PG(cs) membranes might
be strong enough to be easily inserted into periodontal pocket and sus-
tainably release the incorporated drug while affording patient compli-
ance with low rigiditystiffness of the membrane during the treatment
Thesecharacteristics along with the proven cytocompatibility and anti-
bacterial properties of TCH loaded scaffolds suggest the particular ben-
e1047297ts of composite corendashshell nano1047297bers to be used as a drug delivery
system for periodontal diseases
Acknowledgments
This study was supported by the NRF-Technion grant (WBS No
R-398-001-065-592) and the Nanoscience and Nanotechnology Initia-
tive in the National University of Singapore
References
[1] B Felice MP Prabhakaran AP Rodriacuteguez S Ramakrishna J Mater Sci Eng C 4(2014) 178ndash195
[2] P Boisseau B Loubaton C R Phys 12 (2011) 620ndash636
[3] T Allen P Cullis Science 303 (2004) 1818ndash1822[4] Y Malam M Loizidou AM Seifalian Trends Pharmacol Sci 30 (2009) 592ndash599[5] J Zhang R Misra Acta Biomater 3 (2007) 838ndash850[6] B Wang Y Wang T Yin Q Yu Chem Eng Commun 197 (2010) 1315ndash1338[7] ZX Meng XX Xu WZheng HM Zhou LLi YF ZhengX LouJ Colloids SurfB 84
(2011) 97ndash102[8] G Jin MP P rabhakaran D Kai S Ramakrishna Eur J Pharm Biopharm 85 (2013)
689ndash698[9] W QianDGYu YLi YZ LiaoX WangL WangInt JMolSci15 (2014) 774ndash786
[10] H Qi P Hu J Xu A Wang Biomacromolecules 7 (2006) 2327ndash2330[11] TP Chaturvedi R Srivastava AK Srivastava V Gupta VP Kumar Int J Pharm
Investig 2 (2012) 213ndash
217[12] K Kim YK Luu C Chang D Fang BS Hsiao B Chu M Hadjiargyrou J ControlRelease 98 (2004) 47ndash56
[13] R Kenawy GL Bowlin K Mans1047297eld J Layman DG Simpson EH Sanders GEWnek J Control Release 81 (2002) 57ndash64
[14] J Zeng L Yang Q Liang X Zhang H Guan X Xu X Chen X Jing J ControlRelease105 (2005) 43ndash51
[15] X Xu L Yang X Xu X Wang X Chen Q Liang J Zeng X Jing J Control Release108 (2005) 33ndash42
[16] HK Makadia S Siegel Polymers (Basel) 3 (2011) 1377ndash1397[17] MU Adikwu Bentham Science Publishers (2009)[18] A Rasul M Iqbal G Murtaza MK Waqas M Hanif Acta Pol Pharm 67 (2010)
517ndash522[19] B Singh V Sharma Carbohydr Polym 101 (2014) 928ndash940[20] DMW Anderson MME Bridgeman Phytochemistry 24 (1985) 2301ndash2304[21] A Moghbel AAHemmatiH Agheli I RashidiK Amraee Arch Iran Med8 (2005)
257ndash262[22] M Ranjbar-MohammadiSH BahramiMT Joghataei J Mater SciEng C 33 (2013)
4935ndash4943
[23] M Ranjbar-Mohammadi SH Bahrami J Mater Sci Eng C 48 (2015) 71ndash79[24] CL He ZM Huang XJ Han J Biomed Mater Res A 89 (2009) 80ndash95[25] S PappalardoOA Baglio C Cappello S Guarrera M De Benedittis M Petruzzi RF
Grassi Minerva Stomatol 55 (2006) 655ndash661[26] M Zamani M Morshed J Varshosaz M Jannesari Eur J Pharm Biopharm 75
(2010) 179ndash185[27] G Isik S Ince F Saglam U Onan J Clin Periodontol 24 (1997) 589ndash594[28] AN Sapadin R Fleischmajer J Am Acad Dermatol 54 (2006) 258ndash265[29] ZR Domingues ME Cortes TA Gomes HF Diniz CS Freitas JB Gomes AMC
Faria RD Sinisterra Biomaterials 25 (2004) 327ndash333[30] RA Seymour PA Heasman J Clin Periodontol 22 (1995) 22ndash35[31] L Chen J Wu L Yuwen T Shu M Xu M Zhang T Yi Langmuir 25 (2009)
8434ndash8438[32] S Kalachandra L Dongming S Offenbacher J Mater Sci Mater Med 13 (2002)
53ndash58[33] LMedvecky R StulajterovaJ BriancinChemPap 61 (2007) 477ndash484 (composites)[34] E Vatankhah MP Prabhakaran G Jin L GhasemiMobarakeh S Ramakrishna
J Biomater Appl 28 (2013) 909ndash921[35] MC Bottino V Thomas G Schmidt YK Vohra TMG Chua MJ Kowolik GM
Janowski Dent Mater 2 (2012) 703ndash721[36] M Zamani MP Prabhakaran S Ramakrishna Int J Nanomedicine 8 (2013)
2997ndash3017[37] WK Son JH Youk TS Lee WH Park Polymer 45 (2004) 2959ndash2966[38] Y Zhang H Ouyang CT Lim S Ramakrishna ZM Huang J Biomed Mater Res B
Appl Biomater 72B (2005) 156ndash165[39] DH LewisIn M Chasin RLanger (eds) NewYork MarcelDekker Inc (1990)1ndash43[40] WJ Loesche NS Grossman Clin Microbiol Rev 14 (2001) 727ndash752[41] S Fleischer A Shapira O Regev N Nseir E Zussman T Dvir Biotechnol Bioeng
111 (2014) 1246ndash1257[42] R Ravichandran R Sridhar JR Venugopal S Sundarrajan S Mukherjee S
Ramakrishna Macromol Biosci 14 (2014) 515ndash525[43] C van den Bogert G van Kernebeek L Leij AM Kroon Cancer Lett 32 (1986)
341ndash351
531M Ranjbar-Mohammadi et al Materials Science and Engineering C 58 (2016) 521 ndash531
8192019 1-s20-S0928493115303222-main (1)
httpslidepdfcomreaderfull1-s20-s0928493115303222-main-1 911
nano1047297bers Moreover none of the electrospun scaffolds showed signif-
icant changes in cell viability after 5 days compared to TCP This is an in-
dication of cytocompatibility of the scaffolds essential for applications
such as treatment of periodontal diseases
36 Antibacterial properties
In this work the antibacterial activity of TCH-loaded PG(cs) PG
7525-TCH and PG(cs)-TCH nano1047297bers was investigated using S aureus
and Pseudomonas aeruginosa as model bacteriaThe drug loadedsamples
showed clear bacterial inhibition rings against Gram-positive bacteria
(S aureus) which is known to be a TCH-sensitive Gram-positive spheri-
cal bacterium that causes a wide range of suppurative infections The
bacterial inhibition ring was smaller on the nano1047297bers containing
Gram-negative bacteria (P aeruginosa) (Fig 11) These observations
may be related to structural differences between two different bacteria
Gram-negative bacteria are more resistant due to the thick lipopolysac-
charide wall structure
4 Discussion
Periodontitis is a major chronic in1047298ammatory disorder that can lead
to the loss of periodontal support for the periodontal ligament which
leads to the formation of an abnormal gap between the tooth and gum
[25] If the process continues the tooth can eventually get lost For
chronic periodontitis local antimicrobial agents are used as an adjunct
to scaling root planning and restoring the periodontalhealth [25] Mul-
tiple investigations have been conducted to incorporate antibiotics into
the polymeric carriers in order to develop a DDS for treatment of peri-
odontal diseases Polymeric DDS were designed in different structures
Fig 10 Proliferation of 1047297broblasts on electrospun nano1047297bers measured by MTS assay (P as PLGA P-TCH as PLGA-TCH PG 7525 as PLGAGT7525PG 7525-TCHas PLGAGT7525-TCH
PG 5050 as PLGAGT 5050 PG 5050-TCH as PLGAGT 5050-TCH PG(cs) as core shell PLGAGT PG(cs)-TCH as core shell PLGAGT-TCH)
Fig 11 Antibacterial properties of nano1047297bers A) PG(cs) B) PG 7525-TCH and C) PG(cs)-TCH
529M Ranjbar-Mohammadi et al Materials Science and Engineering C 58 (2016) 521 ndash531
8192019 1-s20-S0928493115303222-main (1)
httpslidepdfcomreaderfull1-s20-s0928493115303222-main-1 1011
such as1047297lms microparticles and1047297bers using bothsynthetic and natural
polymers [26]
TCHis oneof the widely employed antibiotics with proven effective-
nessin acceleration of periodontal treatment [27] TCHwith low toxicity
is a broadspectrum antibiotic which can be applied for thetreatment of
diseases caused by Gram-negative and Gram-positive microorganisms
by inhibiting protein synthesis in the bacteria [28] Besides its antibiotic
property it exhibits anti-in1047298ammatory properties and has the ability
to promote the attachment of 1047297
broblasts TCH has also been reportedas an inhibitor of the activity of proteinases and hence it can be used
to treat or prevent diseases related to proteinase imbalancerheumatoid
arthritis periodontitis and osteomyelitis [29] Previous studies showed
that the long term routine use of TCH for several months resulted
in clinically favorable effects for periodontal disease [30] Controlled
release of TCH was attempted by various researchers using various
drug delivery systems such as supramolecular gels based on amphi-
philic 345-trihydroxybenzoic derivatives[31] device based on ethylene
vinyl acetate (EVA) copolymer [32] and porous calcium phosphate
polyhydroxy butyrate composites [33] for various applications
Recent advances in the1047297eld of nanotechnology enable the fabrication
of nano1047297brous constructs containing drugs such that they have the ar-
chitectural features and morphological similarities matching the native
extracellular matrix (ECM) [3435] Unique properties of nano1047297bers
such as the high surface area high loading ease of operation and cost
effectiveness make them more suitable as drug delivery vehicles How-
ever drug release characteristics (eg burst release release rate and
duration) are signi1047297cantly in1047298uenced by extent of drug encapsulation
into thenano1047297brous scaffolds whichis greatly dependent to material se-
lection as well as the drug incorporation method [3626] In general
drugs can be incorporated into nano1047297bers via various methods such as
coatings blending co-axial and emulsion electrospinning [26] Recent
developments in this direction progressed with the application of nano-
1047297bers as drug delivery systems for periodontal diseases For example
Zamani et al [26] fabricated PCL nano1047297bers containing metronidazole
benzoate where the drug release was continued for a period of 15 days
In this study we explored the incorporation of TCH into a new
bicomponent carrier PLGA-gum tragacanth (GT) via two different
technics of blend electrospinning and coaxial electrospinning GT themedicinally imported polysaccharide consists of two major fractions a
water-soluble (tragacanthic acid and small amount of arabinogalactan)
and an insolublebut water-swellable fraction named bassorinGT exhib-
ited a considerable potency for wound healing in the form of mucilage
[21] or skin regeneration capability in the form of blend nano1047297bers
with PCL or PVA [2223] Due to the mentioned structural and composi-
tional advantages natural availability antibacterial properties and low
cost we believe that TCH loaded PG and PG(cs) 1047297bers can be employed
as a proper drug delivery system for multiple applications including
treatment of periodontal diseases We aimed to explore the effect of in-
corporation method (blending vs coaxial electrospinning) on the phys-
ical characteristics of the nano1047297bers and TCH release behavior from
PG and PG(cs) nano1047297bers Moreover the biocompatibility of the drug
loaded membranes was investigatedThe SEM images (Fig 2) showed that uniformly distributed nano1047297-
bers without beads were formed from all formulations Blending GT
with PLGA decreased the diameter of nano1047297bers Incorporation of TCH
into PLGA and PG(cs) nano1047297bers also reduced the 1047297ber diameter
while addition of the drug into the blend PG nano1047297bers did not cause
further reduction in diameter of the nano1047297bers (Table 1) The possible
reason for the reduction of the diameter of the nano1047297bers is that both
GT and TCH may improve the polarity of the solution which subse-
quently increases the electrical conductivity of the solution Moreover
PG(cs) nano1047297bers exhibited reduced diameter which can be attributed
to theuse of water as the core solvent High dielectric constant of water
(801 at 25 degC) is an indication of the ability of solution to carry more
electrical charges resulting in higher elongation forces and formation
of thinner nano1047297bers under the electrical 1047297eld [37]
The results of mechanical studies showed that PG membranes ex-
hibited less tensile strength compared to PLGA (Figs 6 and 7) This
canbe relatedto theeasier slippage of polymer chainsunder loadingbe-
cause of less entanglements and weak physical interactions among the
chains of mixed polymers [38] Another reason for lower strength of
PG 1047297bers can be the low mechanical strength of GT itself Moreover
TCH could also decrease the tensile strength as well as breaking strain
of all formulations due to probable plasticizing effect of TCH molecules
for polymer chains However the breaking strain of pure PLGA was de-creased more than seven timeswhile blend PG nano1047297bers had less than
50 reduction in strain at the presence of TCH compared to the similar
membranes without drug This can be attributed to the highly branched
structure of GT which intrinsically limited the elongation of its polymer
chains under the loading resulting in alleviation of the in1047298uence of TCH
on reduction of strain at break Mechanical behavior of the nano1047297bers
under wet condition is another factor of consideration since the mem-
branes inserted into the periodontal pocket are exposed to moist condi-
tion Results of mechanical studies under wet conditions showed that
except PG 5050 nano1047297bers other TCH loaded membranes preserved
their tensile strength in wet condition Interestingly the effect of TCH
on breaking strain of PG(cs) was dependent to drywet state of the
membrane In dry state addition of TCH caused a drastic decline in
breaking strain similar to pure PLGA since smaller amount of GT existed
in PG(cs) nano1047297bers compared to blend PG nano1047297bers However there-
duction in breaking strain of PG(cs) was limited to the extent compara-
ble to blend PG nano1047297bers in wetcondition This canbe attributed to the
more pronounced role of GT in hydrated state due to swelling effect of
this natural polymer resultingin distributionand occupationof a higher
volumeof the nano1047297bers by this polymer Forthe membraneswhichare
supposed to be inserted into theperiodontalpocket it is necessaryto in-
sure that the membrane possesses enough mechanical strength and ri-
gidity to be inserted into the pocket and retain its integrity during the
release time On the other hand the membrane should remain 1047298exible
and soft enough in the wet environment to conform to the periodontal
pocket and meet patient compliance [26] Elastic modulus is a good in-
dicator of the stiffness of a material Among various TCH incorporated
composite nano1047297bers PG(cs) exhibited the highest tensile strength
in both dry and wet conditions while its wet modulus was signi1047297-cantly lower than blend nano1047297bers That means TCH loaded PG(cs)
membranes may provide a proper texture to be easily inserted into
periodontal pocket with a certain amount of back pressure and remain
comfortably in the pocket with the lowest rigiditystiffness among the
composite nano1047297bers
The release kinetics of TCH from electrospun PLGA PG 7525
PG 5050 and PG(cs) scaffolds was studied for a period of 75 days
(Fig 9) For all the formulations initial burst release was attributed to
the release of surface connected drug [39] followed by a controlled re-
lease attributed to molecular diffusion through the polymer phase In
case of blended PG nano1047297bers the presence of hydrophilic PG segments
which are randomly distributed across the diffusion path can signi1047297-
cantly facilitate water uptake and swelling of the polymeric matrix
Therefore faster diffusion of the drug molecules out of the nano1047297bersoccurred resulting in higher release rate within the 1047297rst few days and
reaching a plateau after a certain period of time As expected the
explained effect of GT on release rate was enhanced by increasing the
fraction of this polymer in the blend such that the entire amount of
TCH was released from PG 5050 in 20 days These observations are in
agreement with wettability results which con1047297rmed the promoted
wettability of the scaffolds at higher ratios of GT in the nano 1047297bers
(Fig 5) However when GT was employed as the core along with TCH
the likelihood of having drug molecules as well as GT hydrophilic
segments onnear the surface of nano1047297bers is reduced In this case the
hydrophobic PLGA shell could control the water uptake and swelling
of the hydrophilic core material resulting in lowered burst release as
well as prolonged release of TCH in a sustained fashion for 75 days
The prolonged TCH release from PG(cs) nano1047297bers validates the use of
530 M Ranjbar-Mohammadi et al Materials Science and Engineering C 58 (2016) 521ndash531
8192019 1-s20-S0928493115303222-main (1)
httpslidepdfcomreaderfull1-s20-s0928493115303222-main-1 1111
core shell structure for periodontal treatment since the elimination of
hardened bacteria in periodontal pocket requires sustained exposure
to antibiotics [40]
The cytocompatibility studies showed that GT could successfully
support cell growth on nano1047297brous membranes in both blending and
corendashshell architecture This might be attributed to the more hydro-
philic properties of GT contained membranes which improves protein
adsorption and subsequent cell attachment and proliferation [4142]
On the other hand incorporation of TCH showed to decrease cellgrowth in some of the formulations due to the inhibitory effect of this
drug on mitochondrial protein synthesis [43] However none of the
GT contained scaffolds showed signi1047297cant changes in cell viability com-
pared to the control which demonstrates good cytocompatibility of
the composite membranes Antibacterial assessment of drug loaded
PG and PG(cs) nano1047297bers showed that these scaffolds are strong
enough against of S aureus bacteria
5 Conclusion
In the present study TCH-loaded blend and core shell nano1047297bers
with smooth and bead-less morphology were successfully fabricated
from PLGA and GT for application as new and controlled drug delivery
systems The release rate of TCH in PG blend nano1047297bers increased
with the increase of GT ratio due to enhanced hydrophilicity of the
electrospun nano1047297bers Compared to PG blend nano1047297bers PG(cs) mem-
branes showed a more prolonged release of TCH for 75 days with lower
burst release of the drug within the 1047297rst 2 h Among various formula-
tions PG(cs) nano1047297bers exhibited the highest tensile strength in both
dry and wet conditions while its wet modulus was signi1047297cantly lower
than blend nano1047297bers Thus the TCH loaded PG(cs) membranes might
be strong enough to be easily inserted into periodontal pocket and sus-
tainably release the incorporated drug while affording patient compli-
ance with low rigiditystiffness of the membrane during the treatment
Thesecharacteristics along with the proven cytocompatibility and anti-
bacterial properties of TCH loaded scaffolds suggest the particular ben-
e1047297ts of composite corendashshell nano1047297bers to be used as a drug delivery
system for periodontal diseases
Acknowledgments
This study was supported by the NRF-Technion grant (WBS No
R-398-001-065-592) and the Nanoscience and Nanotechnology Initia-
tive in the National University of Singapore
References
[1] B Felice MP Prabhakaran AP Rodriacuteguez S Ramakrishna J Mater Sci Eng C 4(2014) 178ndash195
[2] P Boisseau B Loubaton C R Phys 12 (2011) 620ndash636
[3] T Allen P Cullis Science 303 (2004) 1818ndash1822[4] Y Malam M Loizidou AM Seifalian Trends Pharmacol Sci 30 (2009) 592ndash599[5] J Zhang R Misra Acta Biomater 3 (2007) 838ndash850[6] B Wang Y Wang T Yin Q Yu Chem Eng Commun 197 (2010) 1315ndash1338[7] ZX Meng XX Xu WZheng HM Zhou LLi YF ZhengX LouJ Colloids SurfB 84
(2011) 97ndash102[8] G Jin MP P rabhakaran D Kai S Ramakrishna Eur J Pharm Biopharm 85 (2013)
689ndash698[9] W QianDGYu YLi YZ LiaoX WangL WangInt JMolSci15 (2014) 774ndash786
[10] H Qi P Hu J Xu A Wang Biomacromolecules 7 (2006) 2327ndash2330[11] TP Chaturvedi R Srivastava AK Srivastava V Gupta VP Kumar Int J Pharm
Investig 2 (2012) 213ndash
217[12] K Kim YK Luu C Chang D Fang BS Hsiao B Chu M Hadjiargyrou J ControlRelease 98 (2004) 47ndash56
[13] R Kenawy GL Bowlin K Mans1047297eld J Layman DG Simpson EH Sanders GEWnek J Control Release 81 (2002) 57ndash64
[14] J Zeng L Yang Q Liang X Zhang H Guan X Xu X Chen X Jing J ControlRelease105 (2005) 43ndash51
[15] X Xu L Yang X Xu X Wang X Chen Q Liang J Zeng X Jing J Control Release108 (2005) 33ndash42
[16] HK Makadia S Siegel Polymers (Basel) 3 (2011) 1377ndash1397[17] MU Adikwu Bentham Science Publishers (2009)[18] A Rasul M Iqbal G Murtaza MK Waqas M Hanif Acta Pol Pharm 67 (2010)
517ndash522[19] B Singh V Sharma Carbohydr Polym 101 (2014) 928ndash940[20] DMW Anderson MME Bridgeman Phytochemistry 24 (1985) 2301ndash2304[21] A Moghbel AAHemmatiH Agheli I RashidiK Amraee Arch Iran Med8 (2005)
257ndash262[22] M Ranjbar-MohammadiSH BahramiMT Joghataei J Mater SciEng C 33 (2013)
4935ndash4943
[23] M Ranjbar-Mohammadi SH Bahrami J Mater Sci Eng C 48 (2015) 71ndash79[24] CL He ZM Huang XJ Han J Biomed Mater Res A 89 (2009) 80ndash95[25] S PappalardoOA Baglio C Cappello S Guarrera M De Benedittis M Petruzzi RF
Grassi Minerva Stomatol 55 (2006) 655ndash661[26] M Zamani M Morshed J Varshosaz M Jannesari Eur J Pharm Biopharm 75
(2010) 179ndash185[27] G Isik S Ince F Saglam U Onan J Clin Periodontol 24 (1997) 589ndash594[28] AN Sapadin R Fleischmajer J Am Acad Dermatol 54 (2006) 258ndash265[29] ZR Domingues ME Cortes TA Gomes HF Diniz CS Freitas JB Gomes AMC
Faria RD Sinisterra Biomaterials 25 (2004) 327ndash333[30] RA Seymour PA Heasman J Clin Periodontol 22 (1995) 22ndash35[31] L Chen J Wu L Yuwen T Shu M Xu M Zhang T Yi Langmuir 25 (2009)
8434ndash8438[32] S Kalachandra L Dongming S Offenbacher J Mater Sci Mater Med 13 (2002)
53ndash58[33] LMedvecky R StulajterovaJ BriancinChemPap 61 (2007) 477ndash484 (composites)[34] E Vatankhah MP Prabhakaran G Jin L GhasemiMobarakeh S Ramakrishna
J Biomater Appl 28 (2013) 909ndash921[35] MC Bottino V Thomas G Schmidt YK Vohra TMG Chua MJ Kowolik GM
Janowski Dent Mater 2 (2012) 703ndash721[36] M Zamani MP Prabhakaran S Ramakrishna Int J Nanomedicine 8 (2013)
2997ndash3017[37] WK Son JH Youk TS Lee WH Park Polymer 45 (2004) 2959ndash2966[38] Y Zhang H Ouyang CT Lim S Ramakrishna ZM Huang J Biomed Mater Res B
Appl Biomater 72B (2005) 156ndash165[39] DH LewisIn M Chasin RLanger (eds) NewYork MarcelDekker Inc (1990)1ndash43[40] WJ Loesche NS Grossman Clin Microbiol Rev 14 (2001) 727ndash752[41] S Fleischer A Shapira O Regev N Nseir E Zussman T Dvir Biotechnol Bioeng
111 (2014) 1246ndash1257[42] R Ravichandran R Sridhar JR Venugopal S Sundarrajan S Mukherjee S
Ramakrishna Macromol Biosci 14 (2014) 515ndash525[43] C van den Bogert G van Kernebeek L Leij AM Kroon Cancer Lett 32 (1986)
341ndash351
531M Ranjbar-Mohammadi et al Materials Science and Engineering C 58 (2016) 521 ndash531
8192019 1-s20-S0928493115303222-main (1)
httpslidepdfcomreaderfull1-s20-s0928493115303222-main-1 1011
such as1047297lms microparticles and1047297bers using bothsynthetic and natural
polymers [26]
TCHis oneof the widely employed antibiotics with proven effective-
nessin acceleration of periodontal treatment [27] TCHwith low toxicity
is a broadspectrum antibiotic which can be applied for thetreatment of
diseases caused by Gram-negative and Gram-positive microorganisms
by inhibiting protein synthesis in the bacteria [28] Besides its antibiotic
property it exhibits anti-in1047298ammatory properties and has the ability
to promote the attachment of 1047297
broblasts TCH has also been reportedas an inhibitor of the activity of proteinases and hence it can be used
to treat or prevent diseases related to proteinase imbalancerheumatoid
arthritis periodontitis and osteomyelitis [29] Previous studies showed
that the long term routine use of TCH for several months resulted
in clinically favorable effects for periodontal disease [30] Controlled
release of TCH was attempted by various researchers using various
drug delivery systems such as supramolecular gels based on amphi-
philic 345-trihydroxybenzoic derivatives[31] device based on ethylene
vinyl acetate (EVA) copolymer [32] and porous calcium phosphate
polyhydroxy butyrate composites [33] for various applications
Recent advances in the1047297eld of nanotechnology enable the fabrication
of nano1047297brous constructs containing drugs such that they have the ar-
chitectural features and morphological similarities matching the native
extracellular matrix (ECM) [3435] Unique properties of nano1047297bers
such as the high surface area high loading ease of operation and cost
effectiveness make them more suitable as drug delivery vehicles How-
ever drug release characteristics (eg burst release release rate and
duration) are signi1047297cantly in1047298uenced by extent of drug encapsulation
into thenano1047297brous scaffolds whichis greatly dependent to material se-
lection as well as the drug incorporation method [3626] In general
drugs can be incorporated into nano1047297bers via various methods such as
coatings blending co-axial and emulsion electrospinning [26] Recent
developments in this direction progressed with the application of nano-
1047297bers as drug delivery systems for periodontal diseases For example
Zamani et al [26] fabricated PCL nano1047297bers containing metronidazole
benzoate where the drug release was continued for a period of 15 days
In this study we explored the incorporation of TCH into a new
bicomponent carrier PLGA-gum tragacanth (GT) via two different
technics of blend electrospinning and coaxial electrospinning GT themedicinally imported polysaccharide consists of two major fractions a
water-soluble (tragacanthic acid and small amount of arabinogalactan)
and an insolublebut water-swellable fraction named bassorinGT exhib-
ited a considerable potency for wound healing in the form of mucilage
[21] or skin regeneration capability in the form of blend nano1047297bers
with PCL or PVA [2223] Due to the mentioned structural and composi-
tional advantages natural availability antibacterial properties and low
cost we believe that TCH loaded PG and PG(cs) 1047297bers can be employed
as a proper drug delivery system for multiple applications including
treatment of periodontal diseases We aimed to explore the effect of in-
corporation method (blending vs coaxial electrospinning) on the phys-
ical characteristics of the nano1047297bers and TCH release behavior from
PG and PG(cs) nano1047297bers Moreover the biocompatibility of the drug
loaded membranes was investigatedThe SEM images (Fig 2) showed that uniformly distributed nano1047297-
bers without beads were formed from all formulations Blending GT
with PLGA decreased the diameter of nano1047297bers Incorporation of TCH
into PLGA and PG(cs) nano1047297bers also reduced the 1047297ber diameter
while addition of the drug into the blend PG nano1047297bers did not cause
further reduction in diameter of the nano1047297bers (Table 1) The possible
reason for the reduction of the diameter of the nano1047297bers is that both
GT and TCH may improve the polarity of the solution which subse-
quently increases the electrical conductivity of the solution Moreover
PG(cs) nano1047297bers exhibited reduced diameter which can be attributed
to theuse of water as the core solvent High dielectric constant of water
(801 at 25 degC) is an indication of the ability of solution to carry more
electrical charges resulting in higher elongation forces and formation
of thinner nano1047297bers under the electrical 1047297eld [37]
The results of mechanical studies showed that PG membranes ex-
hibited less tensile strength compared to PLGA (Figs 6 and 7) This
canbe relatedto theeasier slippage of polymer chainsunder loadingbe-
cause of less entanglements and weak physical interactions among the
chains of mixed polymers [38] Another reason for lower strength of
PG 1047297bers can be the low mechanical strength of GT itself Moreover
TCH could also decrease the tensile strength as well as breaking strain
of all formulations due to probable plasticizing effect of TCH molecules
for polymer chains However the breaking strain of pure PLGA was de-creased more than seven timeswhile blend PG nano1047297bers had less than
50 reduction in strain at the presence of TCH compared to the similar
membranes without drug This can be attributed to the highly branched
structure of GT which intrinsically limited the elongation of its polymer
chains under the loading resulting in alleviation of the in1047298uence of TCH
on reduction of strain at break Mechanical behavior of the nano1047297bers
under wet condition is another factor of consideration since the mem-
branes inserted into the periodontal pocket are exposed to moist condi-
tion Results of mechanical studies under wet conditions showed that
except PG 5050 nano1047297bers other TCH loaded membranes preserved
their tensile strength in wet condition Interestingly the effect of TCH
on breaking strain of PG(cs) was dependent to drywet state of the
membrane In dry state addition of TCH caused a drastic decline in
breaking strain similar to pure PLGA since smaller amount of GT existed
in PG(cs) nano1047297bers compared to blend PG nano1047297bers However there-
duction in breaking strain of PG(cs) was limited to the extent compara-
ble to blend PG nano1047297bers in wetcondition This canbe attributed to the
more pronounced role of GT in hydrated state due to swelling effect of
this natural polymer resultingin distributionand occupationof a higher
volumeof the nano1047297bers by this polymer Forthe membraneswhichare
supposed to be inserted into theperiodontalpocket it is necessaryto in-
sure that the membrane possesses enough mechanical strength and ri-
gidity to be inserted into the pocket and retain its integrity during the
release time On the other hand the membrane should remain 1047298exible
and soft enough in the wet environment to conform to the periodontal
pocket and meet patient compliance [26] Elastic modulus is a good in-
dicator of the stiffness of a material Among various TCH incorporated
composite nano1047297bers PG(cs) exhibited the highest tensile strength
in both dry and wet conditions while its wet modulus was signi1047297-cantly lower than blend nano1047297bers That means TCH loaded PG(cs)
membranes may provide a proper texture to be easily inserted into
periodontal pocket with a certain amount of back pressure and remain
comfortably in the pocket with the lowest rigiditystiffness among the
composite nano1047297bers
The release kinetics of TCH from electrospun PLGA PG 7525
PG 5050 and PG(cs) scaffolds was studied for a period of 75 days
(Fig 9) For all the formulations initial burst release was attributed to
the release of surface connected drug [39] followed by a controlled re-
lease attributed to molecular diffusion through the polymer phase In
case of blended PG nano1047297bers the presence of hydrophilic PG segments
which are randomly distributed across the diffusion path can signi1047297-
cantly facilitate water uptake and swelling of the polymeric matrix
Therefore faster diffusion of the drug molecules out of the nano1047297bersoccurred resulting in higher release rate within the 1047297rst few days and
reaching a plateau after a certain period of time As expected the
explained effect of GT on release rate was enhanced by increasing the
fraction of this polymer in the blend such that the entire amount of
TCH was released from PG 5050 in 20 days These observations are in
agreement with wettability results which con1047297rmed the promoted
wettability of the scaffolds at higher ratios of GT in the nano 1047297bers
(Fig 5) However when GT was employed as the core along with TCH
the likelihood of having drug molecules as well as GT hydrophilic
segments onnear the surface of nano1047297bers is reduced In this case the
hydrophobic PLGA shell could control the water uptake and swelling
of the hydrophilic core material resulting in lowered burst release as
well as prolonged release of TCH in a sustained fashion for 75 days
The prolonged TCH release from PG(cs) nano1047297bers validates the use of
530 M Ranjbar-Mohammadi et al Materials Science and Engineering C 58 (2016) 521ndash531
8192019 1-s20-S0928493115303222-main (1)
httpslidepdfcomreaderfull1-s20-s0928493115303222-main-1 1111
core shell structure for periodontal treatment since the elimination of
hardened bacteria in periodontal pocket requires sustained exposure
to antibiotics [40]
The cytocompatibility studies showed that GT could successfully
support cell growth on nano1047297brous membranes in both blending and
corendashshell architecture This might be attributed to the more hydro-
philic properties of GT contained membranes which improves protein
adsorption and subsequent cell attachment and proliferation [4142]
On the other hand incorporation of TCH showed to decrease cellgrowth in some of the formulations due to the inhibitory effect of this
drug on mitochondrial protein synthesis [43] However none of the
GT contained scaffolds showed signi1047297cant changes in cell viability com-
pared to the control which demonstrates good cytocompatibility of
the composite membranes Antibacterial assessment of drug loaded
PG and PG(cs) nano1047297bers showed that these scaffolds are strong
enough against of S aureus bacteria
5 Conclusion
In the present study TCH-loaded blend and core shell nano1047297bers
with smooth and bead-less morphology were successfully fabricated
from PLGA and GT for application as new and controlled drug delivery
systems The release rate of TCH in PG blend nano1047297bers increased
with the increase of GT ratio due to enhanced hydrophilicity of the
electrospun nano1047297bers Compared to PG blend nano1047297bers PG(cs) mem-
branes showed a more prolonged release of TCH for 75 days with lower
burst release of the drug within the 1047297rst 2 h Among various formula-
tions PG(cs) nano1047297bers exhibited the highest tensile strength in both
dry and wet conditions while its wet modulus was signi1047297cantly lower
than blend nano1047297bers Thus the TCH loaded PG(cs) membranes might
be strong enough to be easily inserted into periodontal pocket and sus-
tainably release the incorporated drug while affording patient compli-
ance with low rigiditystiffness of the membrane during the treatment
Thesecharacteristics along with the proven cytocompatibility and anti-
bacterial properties of TCH loaded scaffolds suggest the particular ben-
e1047297ts of composite corendashshell nano1047297bers to be used as a drug delivery
system for periodontal diseases
Acknowledgments
This study was supported by the NRF-Technion grant (WBS No
R-398-001-065-592) and the Nanoscience and Nanotechnology Initia-
tive in the National University of Singapore
References
[1] B Felice MP Prabhakaran AP Rodriacuteguez S Ramakrishna J Mater Sci Eng C 4(2014) 178ndash195
[2] P Boisseau B Loubaton C R Phys 12 (2011) 620ndash636
[3] T Allen P Cullis Science 303 (2004) 1818ndash1822[4] Y Malam M Loizidou AM Seifalian Trends Pharmacol Sci 30 (2009) 592ndash599[5] J Zhang R Misra Acta Biomater 3 (2007) 838ndash850[6] B Wang Y Wang T Yin Q Yu Chem Eng Commun 197 (2010) 1315ndash1338[7] ZX Meng XX Xu WZheng HM Zhou LLi YF ZhengX LouJ Colloids SurfB 84
(2011) 97ndash102[8] G Jin MP P rabhakaran D Kai S Ramakrishna Eur J Pharm Biopharm 85 (2013)
689ndash698[9] W QianDGYu YLi YZ LiaoX WangL WangInt JMolSci15 (2014) 774ndash786
[10] H Qi P Hu J Xu A Wang Biomacromolecules 7 (2006) 2327ndash2330[11] TP Chaturvedi R Srivastava AK Srivastava V Gupta VP Kumar Int J Pharm
Investig 2 (2012) 213ndash
217[12] K Kim YK Luu C Chang D Fang BS Hsiao B Chu M Hadjiargyrou J ControlRelease 98 (2004) 47ndash56
[13] R Kenawy GL Bowlin K Mans1047297eld J Layman DG Simpson EH Sanders GEWnek J Control Release 81 (2002) 57ndash64
[14] J Zeng L Yang Q Liang X Zhang H Guan X Xu X Chen X Jing J ControlRelease105 (2005) 43ndash51
[15] X Xu L Yang X Xu X Wang X Chen Q Liang J Zeng X Jing J Control Release108 (2005) 33ndash42
[16] HK Makadia S Siegel Polymers (Basel) 3 (2011) 1377ndash1397[17] MU Adikwu Bentham Science Publishers (2009)[18] A Rasul M Iqbal G Murtaza MK Waqas M Hanif Acta Pol Pharm 67 (2010)
517ndash522[19] B Singh V Sharma Carbohydr Polym 101 (2014) 928ndash940[20] DMW Anderson MME Bridgeman Phytochemistry 24 (1985) 2301ndash2304[21] A Moghbel AAHemmatiH Agheli I RashidiK Amraee Arch Iran Med8 (2005)
257ndash262[22] M Ranjbar-MohammadiSH BahramiMT Joghataei J Mater SciEng C 33 (2013)
4935ndash4943
[23] M Ranjbar-Mohammadi SH Bahrami J Mater Sci Eng C 48 (2015) 71ndash79[24] CL He ZM Huang XJ Han J Biomed Mater Res A 89 (2009) 80ndash95[25] S PappalardoOA Baglio C Cappello S Guarrera M De Benedittis M Petruzzi RF
Grassi Minerva Stomatol 55 (2006) 655ndash661[26] M Zamani M Morshed J Varshosaz M Jannesari Eur J Pharm Biopharm 75
(2010) 179ndash185[27] G Isik S Ince F Saglam U Onan J Clin Periodontol 24 (1997) 589ndash594[28] AN Sapadin R Fleischmajer J Am Acad Dermatol 54 (2006) 258ndash265[29] ZR Domingues ME Cortes TA Gomes HF Diniz CS Freitas JB Gomes AMC
Faria RD Sinisterra Biomaterials 25 (2004) 327ndash333[30] RA Seymour PA Heasman J Clin Periodontol 22 (1995) 22ndash35[31] L Chen J Wu L Yuwen T Shu M Xu M Zhang T Yi Langmuir 25 (2009)
8434ndash8438[32] S Kalachandra L Dongming S Offenbacher J Mater Sci Mater Med 13 (2002)
53ndash58[33] LMedvecky R StulajterovaJ BriancinChemPap 61 (2007) 477ndash484 (composites)[34] E Vatankhah MP Prabhakaran G Jin L GhasemiMobarakeh S Ramakrishna
J Biomater Appl 28 (2013) 909ndash921[35] MC Bottino V Thomas G Schmidt YK Vohra TMG Chua MJ Kowolik GM
Janowski Dent Mater 2 (2012) 703ndash721[36] M Zamani MP Prabhakaran S Ramakrishna Int J Nanomedicine 8 (2013)
2997ndash3017[37] WK Son JH Youk TS Lee WH Park Polymer 45 (2004) 2959ndash2966[38] Y Zhang H Ouyang CT Lim S Ramakrishna ZM Huang J Biomed Mater Res B
Appl Biomater 72B (2005) 156ndash165[39] DH LewisIn M Chasin RLanger (eds) NewYork MarcelDekker Inc (1990)1ndash43[40] WJ Loesche NS Grossman Clin Microbiol Rev 14 (2001) 727ndash752[41] S Fleischer A Shapira O Regev N Nseir E Zussman T Dvir Biotechnol Bioeng
111 (2014) 1246ndash1257[42] R Ravichandran R Sridhar JR Venugopal S Sundarrajan S Mukherjee S
Ramakrishna Macromol Biosci 14 (2014) 515ndash525[43] C van den Bogert G van Kernebeek L Leij AM Kroon Cancer Lett 32 (1986)
341ndash351
531M Ranjbar-Mohammadi et al Materials Science and Engineering C 58 (2016) 521 ndash531
8192019 1-s20-S0928493115303222-main (1)
httpslidepdfcomreaderfull1-s20-s0928493115303222-main-1 1111
core shell structure for periodontal treatment since the elimination of
hardened bacteria in periodontal pocket requires sustained exposure
to antibiotics [40]
The cytocompatibility studies showed that GT could successfully
support cell growth on nano1047297brous membranes in both blending and
corendashshell architecture This might be attributed to the more hydro-
philic properties of GT contained membranes which improves protein
adsorption and subsequent cell attachment and proliferation [4142]
On the other hand incorporation of TCH showed to decrease cellgrowth in some of the formulations due to the inhibitory effect of this
drug on mitochondrial protein synthesis [43] However none of the
GT contained scaffolds showed signi1047297cant changes in cell viability com-
pared to the control which demonstrates good cytocompatibility of
the composite membranes Antibacterial assessment of drug loaded
PG and PG(cs) nano1047297bers showed that these scaffolds are strong
enough against of S aureus bacteria
5 Conclusion
In the present study TCH-loaded blend and core shell nano1047297bers
with smooth and bead-less morphology were successfully fabricated
from PLGA and GT for application as new and controlled drug delivery
systems The release rate of TCH in PG blend nano1047297bers increased
with the increase of GT ratio due to enhanced hydrophilicity of the
electrospun nano1047297bers Compared to PG blend nano1047297bers PG(cs) mem-
branes showed a more prolonged release of TCH for 75 days with lower
burst release of the drug within the 1047297rst 2 h Among various formula-
tions PG(cs) nano1047297bers exhibited the highest tensile strength in both
dry and wet conditions while its wet modulus was signi1047297cantly lower
than blend nano1047297bers Thus the TCH loaded PG(cs) membranes might
be strong enough to be easily inserted into periodontal pocket and sus-
tainably release the incorporated drug while affording patient compli-
ance with low rigiditystiffness of the membrane during the treatment
Thesecharacteristics along with the proven cytocompatibility and anti-
bacterial properties of TCH loaded scaffolds suggest the particular ben-
e1047297ts of composite corendashshell nano1047297bers to be used as a drug delivery
system for periodontal diseases
Acknowledgments
This study was supported by the NRF-Technion grant (WBS No
R-398-001-065-592) and the Nanoscience and Nanotechnology Initia-
tive in the National University of Singapore
References
[1] B Felice MP Prabhakaran AP Rodriacuteguez S Ramakrishna J Mater Sci Eng C 4(2014) 178ndash195
[2] P Boisseau B Loubaton C R Phys 12 (2011) 620ndash636
[3] T Allen P Cullis Science 303 (2004) 1818ndash1822[4] Y Malam M Loizidou AM Seifalian Trends Pharmacol Sci 30 (2009) 592ndash599[5] J Zhang R Misra Acta Biomater 3 (2007) 838ndash850[6] B Wang Y Wang T Yin Q Yu Chem Eng Commun 197 (2010) 1315ndash1338[7] ZX Meng XX Xu WZheng HM Zhou LLi YF ZhengX LouJ Colloids SurfB 84
(2011) 97ndash102[8] G Jin MP P rabhakaran D Kai S Ramakrishna Eur J Pharm Biopharm 85 (2013)
689ndash698[9] W QianDGYu YLi YZ LiaoX WangL WangInt JMolSci15 (2014) 774ndash786
[10] H Qi P Hu J Xu A Wang Biomacromolecules 7 (2006) 2327ndash2330[11] TP Chaturvedi R Srivastava AK Srivastava V Gupta VP Kumar Int J Pharm
Investig 2 (2012) 213ndash
217[12] K Kim YK Luu C Chang D Fang BS Hsiao B Chu M Hadjiargyrou J ControlRelease 98 (2004) 47ndash56
[13] R Kenawy GL Bowlin K Mans1047297eld J Layman DG Simpson EH Sanders GEWnek J Control Release 81 (2002) 57ndash64
[14] J Zeng L Yang Q Liang X Zhang H Guan X Xu X Chen X Jing J ControlRelease105 (2005) 43ndash51
[15] X Xu L Yang X Xu X Wang X Chen Q Liang J Zeng X Jing J Control Release108 (2005) 33ndash42
[16] HK Makadia S Siegel Polymers (Basel) 3 (2011) 1377ndash1397[17] MU Adikwu Bentham Science Publishers (2009)[18] A Rasul M Iqbal G Murtaza MK Waqas M Hanif Acta Pol Pharm 67 (2010)
517ndash522[19] B Singh V Sharma Carbohydr Polym 101 (2014) 928ndash940[20] DMW Anderson MME Bridgeman Phytochemistry 24 (1985) 2301ndash2304[21] A Moghbel AAHemmatiH Agheli I RashidiK Amraee Arch Iran Med8 (2005)
257ndash262[22] M Ranjbar-MohammadiSH BahramiMT Joghataei J Mater SciEng C 33 (2013)
4935ndash4943
[23] M Ranjbar-Mohammadi SH Bahrami J Mater Sci Eng C 48 (2015) 71ndash79[24] CL He ZM Huang XJ Han J Biomed Mater Res A 89 (2009) 80ndash95[25] S PappalardoOA Baglio C Cappello S Guarrera M De Benedittis M Petruzzi RF
Grassi Minerva Stomatol 55 (2006) 655ndash661[26] M Zamani M Morshed J Varshosaz M Jannesari Eur J Pharm Biopharm 75
(2010) 179ndash185[27] G Isik S Ince F Saglam U Onan J Clin Periodontol 24 (1997) 589ndash594[28] AN Sapadin R Fleischmajer J Am Acad Dermatol 54 (2006) 258ndash265[29] ZR Domingues ME Cortes TA Gomes HF Diniz CS Freitas JB Gomes AMC
Faria RD Sinisterra Biomaterials 25 (2004) 327ndash333[30] RA Seymour PA Heasman J Clin Periodontol 22 (1995) 22ndash35[31] L Chen J Wu L Yuwen T Shu M Xu M Zhang T Yi Langmuir 25 (2009)
8434ndash8438[32] S Kalachandra L Dongming S Offenbacher J Mater Sci Mater Med 13 (2002)
53ndash58[33] LMedvecky R StulajterovaJ BriancinChemPap 61 (2007) 477ndash484 (composites)[34] E Vatankhah MP Prabhakaran G Jin L GhasemiMobarakeh S Ramakrishna
J Biomater Appl 28 (2013) 909ndash921[35] MC Bottino V Thomas G Schmidt YK Vohra TMG Chua MJ Kowolik GM
Janowski Dent Mater 2 (2012) 703ndash721[36] M Zamani MP Prabhakaran S Ramakrishna Int J Nanomedicine 8 (2013)
2997ndash3017[37] WK Son JH Youk TS Lee WH Park Polymer 45 (2004) 2959ndash2966[38] Y Zhang H Ouyang CT Lim S Ramakrishna ZM Huang J Biomed Mater Res B
Appl Biomater 72B (2005) 156ndash165[39] DH LewisIn M Chasin RLanger (eds) NewYork MarcelDekker Inc (1990)1ndash43[40] WJ Loesche NS Grossman Clin Microbiol Rev 14 (2001) 727ndash752[41] S Fleischer A Shapira O Regev N Nseir E Zussman T Dvir Biotechnol Bioeng
111 (2014) 1246ndash1257[42] R Ravichandran R Sridhar JR Venugopal S Sundarrajan S Mukherjee S
Ramakrishna Macromol Biosci 14 (2014) 515ndash525[43] C van den Bogert G van Kernebeek L Leij AM Kroon Cancer Lett 32 (1986)
341ndash351
531M Ranjbar-Mohammadi et al Materials Science and Engineering C 58 (2016) 521 ndash531